Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Prostatic Neoplasms	15/1554	1.3900642916170807E-14	3.5905360652469196E-11	0	0	59.91877842755036	1911.8189543503834	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Hepatocarcinogenesis	11/527	1.0326345920731957E-13	9.059166136437141E-11	0	0	59.28183831672204	1772.6154625494794	NR4A1;AR;JUN;CDKN1A;PRKDC;CDH1;CAV1;PIM1;ESR1;EGFR;VEGFA
Colonic Neoplasms	12/778	1.6538138157457076E-13	9.059166136437141E-11	0	0	50.17232375979112	1476.5976874710714	NR4A1;AR;JUN;CDKN1A;EPAS1;STAT1;CDH1;CAV1;EZR;ESR1;EGFR;VEGFA
Endometrial Neoplasms	9/238	1.8211952273537034E-13	9.059166136437141E-11	0	0	86.25764192139738	2530.2914329231785	AR;JUN;CDKN1A;CDH1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Stomach Carcinoma	16/2378	1.8435429055938716E-13	9.059166136437141E-11	0	0	59.67823878069433	1749.8803640257215	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;HBB;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;NFIB;PIM1;EZR
Malignant neoplasm of stomach	16/2398	2.104335920194458E-13	9.059166136437141E-11	0	0	59.109991603694375	1725.3973814700598	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;HBB;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;NFIB;PIM1;EZR
leukemia	15/1941	3.731210046660656E-13	1.376816507217782E-10	0	0	46.87435098650052	1341.3973781338234	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Triple Negative Breast Neoplasms	11/632	7.491171932752886E-13	2.418712137787588E-10	0	0	48.99263860133426	1367.868637533807	NR4A1;AR;EPAS1;STAT1;CDH1;NFIB;CAV1;PIM1;ESR1;EGFR;VEGFA
Bladder Neoplasm	13/1217	9.482953322919433E-13	2.455656194608329E-10	0	0	40.55049833887043	1122.6044731621057	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;HBB;PIK3R1;ESR1;EGFR;VEGFA;AR;CDH1
Brain Neoplasms	11/646	9.50699262333848E-13	2.455656194608329E-10	0	0	47.877840269966256	1325.334199371745	NR4A1;CDKN1A;EPAS1;STAT1;PRKDC;CDH1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Colon Carcinoma	15/2091	1.117826560131473E-12	2.49963037660055E-10	0	0	43.126204238921005	1186.8173947294047	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Sarcoma	11/658	1.161268467642532E-12	2.49963037660055E-10	0	0	46.960697725767275	1290.550799706571	AR;JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;EZR;ESR1;EGFR;VEGFA
Li-Fraumeni Syndrome	6/50	3.2456950689754883E-12	6.010062767038369E-10	0	0	226.5681818181818	5993.564806332732	AR;CDKN1A;CDH1;CAV1;ESR1;EGFR
Malignant Glioma	10/504	3.451194873142919E-12	6.010062767038369E-10	0	0	49.311740890688256	1301.4502889333348	NR4A1;AR;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;EGFR;VEGFA
Renal Cell Carcinoma	13/1348	3.490164208500795E-12	6.010062767038369E-10	0	0	36.31625468164794	958.0617414994426	JUN;CDKN1A;EPAS1;STAT1;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;EZR
Squamous cell carcinoma of esophagus	12/1023	4.202132754620558E-12	6.40194728588916E-10	0	0	37.52917903066271	983.092941753935	AR;JUN;CDKN1A;STAT1;CDH1;CAV1;PIM1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Astrocytoma	11/741	4.213438012393175E-12	6.40194728588916E-10	0	0	41.4426614481409	1085.4969462107986	AR;CDKN1A;EPAS1;PRKDC;CDH1;CAV1;PIM1;PIK3R1;ESR1;EGFR;VEGFA
Mammary Neoplasms	15/2387	7.823635587511032E-12	1.0726141631170757E-9	0	0	37.120573355817875	949.3167826786287	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Pancreatic carcinoma	14/1869	7.891523541560264E-12	1.0726141631170757E-9	0	0	34.20188679245283	874.3791673323434	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Squamous cell carcinoma	14/1876	8.305181286233649E-12	1.0726141631170757E-9	0	0	34.06015037593985	869.015497719923	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Cervix carcinoma	12/1105	1.0400575371625692E-11	1.2792707707099602E-9	0	0	34.56358645928637	874.0840676974358	AR;JUN;CDKN1A;STAT1;PRKDC;CDH1;CAV1;HBB;EZR;ESR1;EGFR;VEGFA
Glioblastoma	14/1937	1.2857433360782995E-11	1.3507355256772817E-9	0	0	32.86869474778991	824.2515121970663	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;PIM1;EZR
Malignant neoplasm of endometrium	10/577	1.3140050431619977E-11	1.3507355256772817E-9	0	0	42.802028218694886	1072.4200658778468	AR;CDKN1A;PRKDC;CDH1;CAV1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Neoplasm Metastasis	17/3920	1.3267925901556392E-11	1.3507355256772817E-9	0	0	70.03407635152446	1754.0504756814644	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;HBB;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;NFIB;PIM1;EZR
Carcinoma of lung	15/2476	1.3379769307451787E-11	1.3507355256772817E-9	0	0	35.597318163348234	891.2599260978943	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Uterine Corpus Cancer	10/579	1.3596253839570006E-11	1.3507355256772817E-9	0	0	42.64718804920914	1067.084965162985	AR;CDKN1A;PRKDC;CDH1;CAV1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Prostate carcinoma	16/3145	1.5051796420316104E-11	1.4399551908769073E-9	0	0	43.08852668584212	1073.7455648923515	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;NFIB;PIM1;EZR
Malignant neoplasm of urinary bladder	12/1144	1.5623468649031178E-11	1.4412649828731261E-9	0	0	33.303886925795055	828.6755382687527	AR;JUN;CDKN1A;EPAS1;STAT1;PRKDC;CDH1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Carcinoma of bladder	12/1162	1.8760676394398318E-11	1.6709940388527882E-9	0	0	32.751304347826085	808.9329197836104	AR;JUN;CDKN1A;EPAS1;STAT1;PRKDC;CDH1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Malignant tumor of colon	14/2001	2.0033342706160332E-11	1.7248708070004044E-9	0	0	31.697282335178663	780.8189061867428	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;EZR
Malignant neoplasm of prostate	16/3239	2.3889208342433418E-11	1.9905104886614686E-9	0	0	41.59851070431275	1017.3994979888058	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;NFIB;PIM1;EZR
Adenocarcinoma of colon	8/267	3.541108426081822E-11	2.836863024340726E-9	0	0	60.92046332046332	1465.9897996787597	JUN;CDKN1A;EPAS1;CDH1;CAV1;ESR1;EGFR;VEGFA
Tumor Progression	14/2090	3.624331389982345E-11	2.836863024340726E-9	0	0	30.1883429672447	725.750895113627	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Squamous cell carcinoma of tongue	7/153	3.9594572292347845E-11	3.0080229479745435E-9	0	0	86.45828144458281	2070.877208020756	EPAS1;CDH1;CAV1;EZR;ESR1;EGFR;VEGFA
Precancerous Conditions	9/446	5.120688607776361E-11	3.779068192538954E-9	0	0	44.725400457665906	1059.7749429159255	CDKN1A;STAT1;PRKDC;CDH1;CAV1;PIM1;ESR1;EGFR;VEGFA
Secondary malignant neoplasm of lymph node	12/1271	5.355448763572108E-11	3.842534487862988E-9	0	0	29.74265289912629	703.4233039168869	NR4A1;AR;JUN;CDKN1A;EPAS1;CDH1;CAV1;PIM1;EZR;ESR1;EGFR;VEGFA
Noninfiltrating Intraductal Carcinoma	8/287	6.301417334493237E-11	4.399070533782711E-9	0	0	56.49605734767025	1326.9602677396547	AR;CDKN1A;STAT1;CDH1;CAV1;ESR1;EGFR;VEGFA
Leukemia, Myelocytic, Acute	13/1703	6.753135915414888E-11	4.590355281451752E-9	0	0	28.141538461538463	659.0306217032305	JUN;CDKN1A;EPAS1;STAT1;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1
Lymphoma	12/1307	7.419751914818728E-11	4.914158768199172E-9	0	0	28.860231660231662	673.144424282648	NR4A1;JUN;CDKN1A;EPAS1;STAT1;PRKDC;CDH1;PIM1;HBB;ESR1;EGFR;VEGFA
Multiple Myeloma	12/1312	7.757718956340143E-11	5.009547016056648E-9	0	0	28.74153846153846	669.0957633448103	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CDH1;CAV1;PIM1;PIK3R1;ESR1;EGFR;VEGFA
Non-Small Cell Lung Carcinoma	14/2243	9.46928474771817E-11	5.965649391062447E-9	0	0	27.875953342305966	643.3876697851267	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;AR;CDH1;PIM1;EZR
Prostatic Intraepithelial Neoplasias	7/174	9.808977093358318E-11	6.032520912415366E-9	0	0	75.50626020685901	1740.052188341165	AR;CDH1;CAV1;PIM1;EZR;ESR1;EGFR
Primary malignant neoplasm of lung	14/2268	1.1006394286671747E-10	6.6115154517379356E-9	0	0	27.527950310559007	631.2147890489944	JUN;CDKN1A;EPAS1;STAT1;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Thyroid carcinoma	10/721	1.1739527422939355E-10	6.877658091516142E-9	0	0	33.88009845288326	774.6845259758692	NR4A1;AR;JUN;CDKN1A;STAT1;CDH1;CAV1;ESR1;EGFR;VEGFA
Liver carcinoma	16/3593	1.2114858676823718E-10	6.877658091516142E-9	0	0	36.689963656695554	837.7787524567198	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;HBB;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Infection	9/492	1.2248249020895955E-10	6.877658091516142E-9	0	0	40.37060041407867	921.3803542338529	STAT1;PRKDC;CDH1;NFIB;CAV1;EZR;ESR1;EGFR;VEGFA
Malignant neoplasm of pancreas	13/1846	1.8646733910945267E-10	1.024776887063226E-8	0	0	25.74326241134752	576.7202585878181	JUN;CDKN1A;EPAS1;STAT1;CAV1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Malignant Neoplasms	12/1438	2.256428703221258E-10	1.2142406959209394E-8	0	0	26.02524544179523	578.0745107040885	AR;CDKN1A;EPAS1;STAT1;PRKDC;CDH1;CAV1;PIM1;PIK3R1;ESR1;EGFR;VEGFA
Nasopharyngeal carcinoma	10/782	2.597468641999142E-10	1.3692370412824049E-8	0	0	31.104274611398964	686.5121979547574	JUN;CDKN1A;STAT1;CDH1;CAV1;HBB;EZR;ESR1;EGFR;VEGFA
Metastatic Neoplasm	9/544	2.9820119007955683E-10	1.5405073479509906E-8	0	0	36.34953271028037	797.2634872876749	AR;CDKN1A;EPAS1;CAV1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Malignant neoplasm of lung	14/2449	3.1140696705027617E-10	1.5771846978252222E-8	0	0	25.221560574948665	552.0979554544963	JUN;CDKN1A;EPAS1;STAT1;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Malignant neoplasm of liver	10/805	3.446700073847611E-10	1.712081978990073E-8	0	0	30.16823899371069	657.3186738620677	NR4A1;JUN;EPAS1;CDH1;CAV1;PIM1;PIK3R1;ESR1;EGFR;VEGFA
Chronic Lymphocytic Leukemia	11/1120	3.5810318346951264E-10	1.7452462696259456E-8	0	0	26.74262527373438	581.6574468668811	NR4A1;JUN;CDKN1A;STAT1;CDH1;CAV1;PIM1;PIK3R1;ESR1;EGFR;VEGFA
synovial sarcoma	7/217	4.6193595089802575E-10	2.2095936317955566E-8	0	0	59.915151515151514	1287.9118234770972	CDKN1A;CDH1;CAV1;HBB;EZR;EGFR;VEGFA
Invasive Ductal Breast Carcinoma	7/218	4.770296063687799E-10	2.240304496819197E-8	0	0	59.6281775096941	1279.8259628835706	AR;CDKN1A;CDH1;CAV1;ESR1;EGFR;VEGFA
Stomach Neoplasms	10/835	4.923580131240452E-10	2.2710013355346587E-8	0	0	29.025757575757577	622.0746664564797	NR4A1;AR;JUN;CDKN1A;PRKDC;CDH1;CAV1;ESR1;EGFR;VEGFA
Hepatitis B	10/839	5.158144072834975E-10	2.3239530394438445E-8	0	0	28.879674306393245	617.599750699673	NR4A1;AR;JUN;CDKN1A;STAT1;CDH1;CAV1;HBB;ESR1;EGFR
Endometrial Carcinoma	10/840	5.218322736652845E-10	2.3239530394438445E-8	0	0	28.843373493975903	616.4888879207653	AR;CDKN1A;PRKDC;CDH1;CAV1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Malignant neoplasm of ovary	13/2026	5.993126425386166E-10	2.5953903402964904E-8	0	0	23.208842523596623	492.84528803628353	JUN;CDKN1A;EPAS1;STAT1;CAV1;HBB;PIK3R1;ESR1;EGFR;VEGFA;AR;CDH1;PIM1
Lung Neoplasms	11/1177	6.078978235884678E-10	2.5953903402964904E-8	0	0	25.358490566037737	538.1328909636354	NR4A1;JUN;CDKN1A;PRKDC;CDH1;CAV1;PIM1;EZR;ESR1;EGFR;VEGFA
Glioblastoma Multiforme	10/854	6.129260966244131E-10	2.5953903402964904E-8	0	0	28.34419431279621	601.2590660427308	AR;JUN;CDKN1A;EPAS1;STAT1;PRKDC;PIM1;PIK3R1;EGFR;VEGFA
Cystic Fibrosis	9/594	6.480965945814451E-10	2.6585903498098363E-8	0	0	33.15726495726496	701.5076368143388	JUN;CDKN1A;STAT1;CAV1;HBB;EZR;ESR1;EGFR;VEGFA
Invasive carcinoma of breast	8/385	6.484366706853259E-10	2.6585903498098363E-8	0	0	41.60212201591512	880.1534960537335	AR;JUN;CDKN1A;CDH1;EZR;ESR1;EGFR;VEGFA
Adenocarcinoma of lung (disorder)	11/1187	6.651973370488794E-10	2.6846948774957116E-8	0	0	25.12949465500486	531.0097777411868	AR;JUN;CDKN1A;EPAS1;PRKDC;CDH1;CAV1;EZR;ESR1;EGFR;VEGFA
Breast Carcinoma	17/4963	6.929903054241332E-10	2.7147183348405195E-8	0	0	51.68054993934493	1089.943062108053	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;HBB;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;NFIB;PIM1;EZR
Ductal Carcinoma	7/230	6.936562528047786E-10	2.7147183348405195E-8	0	0	56.38524256013045	1189.1108946300812	AR;CDH1;NFIB;CAV1;ESR1;EGFR;VEGFA
Adenomatous Polyposis Coli	8/392	7.476019116721274E-10	2.8821727430583657E-8	0	0	40.829166666666666	857.9902524399096	AR;CDKN1A;PRKDC;CDH1;CAV1;ESR1;EGFR;VEGFA
Carcinogenesis	16/4065	8.301620618659148E-10	3.127595913183123E-8	0	0	31.4803655223512	658.2355604860711	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;NFIB;PIM1;EZR
Undifferentiated carcinoma	7/237	8.550803668597966E-10	3.127595913183123E-8	0	0	54.649802371541504	1141.078345602469	CDKN1A;CDH1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Malignant tumor of cervix	10/884	8.574642658916028E-10	3.127595913183123E-8	0	0	27.32837528604119	570.5356279854714	AR;JUN;CDKN1A;PRKDC;CDH1;CAV1;EZR;ESR1;EGFR;VEGFA
Carcinoma, Transitional Cell	8/399	8.596953536043426E-10	3.127595913183123E-8	0	0	40.08388746803069	836.7288253496401	AR;CDKN1A;CDH1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Malignant neoplasm of breast	17/5054	9.389584120283947E-10	3.368513303151866E-8	0	0	50.439745880484416	1048.4531641433036	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;HBB;PIK3R1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;NFIB;PIM1;EZR
Neoplasms	11/1236	1.0227998919777232E-9	3.6190303027102185E-8	0	0	24.061457725947523	498.0895467732666	NR4A1;AR;EPAS1;STAT1;NFIB;CAV1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Endometrial adenocarcinoma	6/129	1.1155561948737567E-9	3.893894123457991E-8	0	0	80.72764227642277	1664.1125725366167	AR;CDKN1A;CAV1;ESR1;EGFR;VEGFA
Central neuroblastoma	12/1655	1.1494579985546314E-9	3.9587333470221506E-8	0	0	22.323797930614727	459.51250545767255	AR;JUN;CDKN1A;EPAS1;STAT1;PRKDC;NFIB;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Carcinoma, Lobular	5/58	1.4309501659587198E-9	4.863347735093912E-8	0	0	144.62264150943398	2945.2295602586096	AR;CDH1;NFIB;ESR1;VEGFA
Neuroblastoma	12/1698	1.545331607269831E-9	5.183885118932433E-8	0	0	21.703440094899168	440.3199855201377	AR;JUN;CDKN1A;EPAS1;STAT1;PRKDC;NFIB;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Ovarian Carcinoma	13/2203	1.7066552175410573E-9	5.651654393472501E-8	0	0	21.122922374429223	426.4449849730824	JUN;CDKN1A;EPAS1;STAT1;CAV1;HBB;PIK3R1;ESR1;EGFR;VEGFA;AR;CDH1;PIM1
Glioma	13/2211	1.7855450715099174E-9	5.787429549811319E-8	0	0	21.036578707916288	423.7512089719963	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;PIK3R1;ESR1;EGFR;VEGFA;AR;CDH1;EZR
Meningioma	8/438	1.7924675338169007E-9	5.787429549811319E-8	0	0	36.375813953488375	732.5969856135329	AR;CDKN1A;CDH1;CAV1;EZR;ESR1;EGFR;VEGFA
cervical cancer	10/965	2.0068835092449153E-9	6.399728523925453E-8	0	0	24.904450261780106	498.75352597615324	AR;JUN;CDKN1A;PRKDC;CDH1;CAV1;EZR;ESR1;EGFR;VEGFA
Anaplasia	7/283	2.937217743924566E-9	9.252235893362383E-8	0	0	45.43544137022398	892.6157326159572	AR;JUN;CDH1;CAV1;ESR1;EGFR;VEGFA
Hyperactive behavior	9/709	3.068367363341574E-9	9.548907107844922E-8	0	0	27.545714285714286	539.9544029819655	AR;STAT1;CDH1;NFIB;CAV1;EZR;ESR1;EGFR;VEGFA
Thyroid Neoplasm	8/476	3.4457945937706647E-9	1.0595818375844794E-7	0	0	33.35726495726496	650.0033778798564	AR;JUN;CDKN1A;CDH1;HBB;ESR1;EGFR;VEGFA
Colorectal Carcinoma	14/2931	3.497815513339799E-9	1.0629244083478471E-7	0	0	20.475659924580047	398.684178943613	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Adenocarcinoma of large intestine	7/297	4.1049957015609135E-9	1.2329306857130046E-7	0	0	43.21128526645768	834.4557717689023	CDKN1A;PRKDC;CDH1;PIM1;PIK3R1;EGFR;VEGFA
Anemia	8/490	4.3250034742551434E-9	1.2840786177012685E-7	0	0	32.365145228215766	623.3155708194267	AR;CDKN1A;EPAS1;STAT1;CAV1;HBB;EGFR;VEGFA
Malignant neoplasm of mouth	8/492	4.465263324175948E-9	1.3106562689030086E-7	0	0	32.228099173553716	619.6476533614273	AR;JUN;CDKN1A;STAT1;CDH1;CAV1;EGFR;VEGFA
Autoimmune Diseases	10/1060	4.971166072376081E-9	1.4427552769603838E-7	0	0	22.538095238095238	430.9196226970033	AR;CDKN1A;STAT1;PRKDC;CAV1;PIM1;PIK3R1;ESR1;EGFR;VEGFA
Herpes Simplex Infections	8/503	5.309472364070449E-9	1.5158969840304788E-7	0	0	31.494141414141414	600.0822330852503	AR;CDKN1A;STAT1;NFIB;HBB;ESR1;EGFR;VEGFA
Polycythemia	5/75	5.34055848032418E-9	1.5158969840304788E-7	0	0	109.4065934065934	2083.9697459835165	EPAS1;HBB;PIK3R1;EGFR;VEGFA
Breast adenocarcinoma	6/168	5.483925375645907E-9	1.5396716570971062E-7	0	0	61.17283950617284	1163.5957827680431	AR;CDKN1A;CDH1;CAV1;ESR1;VEGFA
Cyst	6/169	5.682850637139908E-9	1.5783659350249874E-7	0	0	60.79447852760736	1154.2325920867622	AR;EPAS1;CDH1;CAV1;ESR1;VEGFA
Tumor Angiogenesis	8/511	6.007336202309071E-9	1.6507392989962053E-7	0	0	30.98051689860835	586.4699961902941	AR;JUN;CDKN1A;EPAS1;CAV1;EZR;EGFR;VEGFA
Carcinomatosis	6/176	7.249657622168668E-9	1.9616133642583457E-7	0	0	58.27058823529412	1092.1255214554353	CDH1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Osteosarcoma	10/1103	7.290549088997336E-9	1.9616133642583457E-7	0	0	21.60224153705398	404.7544375930222	JUN;CDKN1A;EPAS1;PRKDC;NFIB;CAV1;EZR;ESR1;EGFR;VEGFA
Polycystic Ovary Syndrome	8/526	7.532365517893741E-9	2.0057835188370655E-7	0	0	30.06023166023166	562.2482773479911	NR4A1;AR;CDKN1A;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Insulin Resistance	5/81	7.902335437581374E-9	2.0828298403339478E-7	0	0	100.73886639676114	1879.3951205384299	NR4A1;AR;CAV1;PIK3R1;EGFR
Secondary malignant neoplasm of bone	7/330	8.506587099514742E-9	2.2194459068733917E-7	0	0	38.73149451168027	719.7250927024485	AR;PRKDC;CDH1;EZR;ESR1;EGFR;VEGFA
Malignant mesothelioma	7/335	9.436955888332865E-9	2.437565705956379E-7	0	0	38.13137472283814	704.6156555806098	AR;JUN;CDKN1A;CDH1;ESR1;EGFR;VEGFA
Prostatic Hyperplasia	5/85	1.0094890732286555E-8	2.581693342722393E-7	0	0	95.6826923076923	1761.6366683441408	AR;NFIB;ESR1;EGFR;VEGFA
Diabetic Nephropathy	8/561	1.2453831620779622E-8	3.153749713379781E-7	0	0	28.107052441229655	511.5831369268637	JUN;CDKN1A;STAT1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Prolactinoma	5/91	1.4265582125129245E-8	3.5774755950688196E-7	0	0	88.98032200357781	1607.4665368289864	CDKN1A;CDH1;ESR1;EGFR;VEGFA
Aplasia Cutis Congenita	6/199	1.5120237314542775E-8	3.7553435561023064E-7	0	0	51.266839378238345	923.1738588460523	JUN;NFIB;PIM1;ESR1;EGFR;VEGFA
Renal fibrosis	6/202	1.653368071366927E-8	4.0672854555626407E-7	0	0	50.474489795918366	904.3951587749052	NR4A1;EPAS1;STAT1;EZR;EGFR;VEGFA
Colorectal Cancer	14/3298	1.68996619105663E-8	4.118096859904977E-7	0	0	17.796285018270403	318.48182231523526	JUN;CDKN1A;EPAS1;STAT1;PRKDC;CAV1;ESR1;EGFR;VEGFA;NR4A1;AR;CDH1;PIM1;EZR
Anaplastic carcinoma	6/204	1.7535369052252407E-8	4.1938757649970343E-7	0	0	49.95959595959596	892.2307177360384	CDH1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Papilloma	6/204	1.7535369052252407E-8	4.1938757649970343E-7	0	0	49.95959595959596	892.2307177360384	AR;CDKN1A;CAV1;ESR1;EGFR;VEGFA
Thymoma	6/205	1.8054728807630418E-8	4.278473808266915E-7	0	0	49.70603015075377	886.2514694059296	AR;STAT1;CDH1;ESR1;EGFR;VEGFA
Medulloblastoma	8/590	1.844018968454952E-8	4.33009181410831E-7	0	0	26.666666666666668	474.8995555277358	NR4A1;AR;PRKDC;CDH1;EZR;ESR1;EGFR;VEGFA
Nephroblastoma	7/370	1.8712413063132157E-8	4.3544290938802124E-7	0	0	34.39343851740546	611.9995528819938	AR;STAT1;CDH1;HBB;ESR1;EGFR;VEGFA
Hodgkin Disease	8/592	1.89320677197185E-8	4.366208117860079E-7	0	0	26.572602739726026	472.5248807564132	AR;JUN;CDKN1A;STAT1;PIM1;HBB;PIK3R1;VEGFA
Myeloid Leukemia, Chronic	9/876	1.9386750473710114E-8	4.4315023427958604E-7	0	0	22.047289504036907	391.53067030743887	CDKN1A;EPAS1;STAT1;PRKDC;CDH1;CAV1;ESR1;EGFR;VEGFA
Liver and Intrahepatic Biliary Tract Carcinoma	8/607	2.2997538775281233E-8	5.210758127767669E-7	0	0	25.887145242070115	455.2999687633296	NR4A1;EPAS1;CDH1;CAV1;PIM1;ESR1;EGFR;VEGFA
Mesothelioma	7/383	2.3724736718865316E-8	5.328782169115575E-7	0	0	33.18230174081238	582.5732961091943	CDKN1A;STAT1;CDH1;PIM1;ESR1;EGFR;VEGFA
Carcinoma	6/216	2.4658395978948186E-8	5.490744552898548E-7	0	0	47.076190476190476	824.6876902465111	AR;CDH1;PIK3R1;EZR;ESR1;EGFR
Endometriosis of ovary	4/36	2.6560936955864013E-8	5.863837620256132E-7	0	0	178.125	3107.181192038868	NR4A1;AR;CDH1;ESR1
Diabetes	10/1268	2.7738052616914193E-8	6.071812704194014E-7	0	0	18.604928457869633	323.73432507677734	AR;CDKN1A;STAT1;CAV1;PIM1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Rhabdomyosarcoma	7/397	3.035464330992663E-8	6.552749785719691E-7	0	0	31.968298368298367	553.3813575764817	CDKN1A;STAT1;CAV1;EZR;ESR1;EGFR;VEGFA
Acute Erythroblastic Leukemia	6/224	3.06215349734257E-8	6.552749785719691E-7	0	0	45.330275229357795	784.2845817822375	CDKN1A;STAT1;HBB;ESR1;EGFR;VEGFA
Arthritis	8/630	3.0696195279600565E-8	6.552749785719691E-7	0	0	24.90032154340836	430.75382776541875	AR;JUN;CDKN1A;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Conventional (Clear Cell) Renal Cell Carcinoma	8/631	3.107620521425471E-8	6.579494923640977E-7	0	0	24.859069020866773	429.7343364562166	AR;CDKN1A;EPAS1;STAT1;CDH1;CAV1;EGFR;VEGFA
Adenocarcinoma	11/1712	3.166976108830778E-8	6.650649828544635E-7	0	0	16.888468967834047	291.6284527406187	AR;JUN;CDKN1A;EPAS1;STAT1;CDH1;CAV1;PIM1;ESR1;EGFR;VEGFA
Vascular Diseases	7/401	3.2515144637705195E-8	6.773114403160687E-7	0	0	31.637286571296723	545.4761704578547	NR4A1;JUN;STAT1;CAV1;ESR1;EGFR;VEGFA
Squamous cell carcinoma of the head and neck	9/934	3.377618268951636E-8	6.979510390961661E-7	0	0	20.602162162162163	354.4295014804255	JUN;CDKN1A;STAT1;PRKDC;CDH1;CAV1;ESR1;EGFR;VEGFA
Apocrine Carcinoma	3/8	3.4176008683086065E-8	7.006081780032643E-7	0	0	799.08	13737.577149046836	AR;CDH1;ESR1
ovarian neoplasm	9/938	3.5047286396060895E-8	7.128121319765771E-7	0	0	20.509149623250806	352.07170439823943	AR;JUN;CDKN1A;CDH1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Metastasis from malignant tumor of prostate	6/232	3.772998080743957E-8	7.613792220751283E-7	0	0	43.70796460176991	747.0919699004364	AR;CDKN1A;CDH1;CAV1;EGFR;VEGFA
Asthma	10/1313	3.8684986222649606E-8	7.745993752953793E-7	0	0	17.919224865694552	305.84200178200285	AR;JUN;CDKN1A;STAT1;PRKDC;CDH1;CAV1;ESR1;EGFR;VEGFA
Neoplasm Recurrence, Local	4/40	4.1116782749314184E-8	8.169588449344502E-7	0	0	158.3015873015873	2692.211264421005	AR;ESR1;EGFR;VEGFA
Epithelial ovarian cancer	10/1329	4.341581081903774E-8	8.560537354624006E-7	0	0	17.68669446550417	299.8326648855457	AR;JUN;CDKN1A;STAT1;CDH1;CAV1;EZR;ESR1;EGFR;VEGFA
Benign Prostatic Hyperplasia	7/420	4.4650809543568064E-8	8.737351594775477E-7	0	0	30.152542372881356	510.3134890960462	AR;JUN;NFIB;CAV1;PIM1;ESR1;EGFR
Malignant neoplasm of kidney	7/421	4.538359241069952E-8	8.813971368183224E-7	0	0	30.078173034694775	508.56521461194933	CDKN1A;EPAS1;CDH1;CAV1;PIK3R1;EGFR;VEGFA
Metastatic Prostate Carcinoma	6/241	4.7304349655658194E-8	9.118442922430232E-7	0	0	42.01489361702128	708.6510762727775	AR;CDKN1A;CDH1;CAV1;EGFR;VEGFA
Degenerative polyarthritis	9/976	4.938250531641253E-8	9.448519350540264E-7	0	0	19.66390899689762	330.819108379303	AR;JUN;CDKN1A;EPAS1;CAV1;PIK3R1;EZR;ESR1;VEGFA
Small cell carcinoma of lung	8/673	5.1192611549769976E-8	9.72283203184234E-7	0	0	23.238496240601503	390.12022061415973	AR;CDKN1A;EPAS1;PRKDC;CDH1;CAV1;EGFR;VEGFA
Cirrhosis	7/433	5.500456057128953E-8	1.0370567879973786E-6	0	0	29.21297481860862	488.31969739987784	CDKN1A;STAT1;CDH1;CAV1;ESR1;EGFR;VEGFA
Liver Cirrhosis	8/683	5.73767914689871E-8	1.0739438577129976E-6	0	0	22.88237037037037	381.5320842949187	AR;CDKN1A;STAT1;CDH1;CAV1;ESR1;EGFR;VEGFA
Esophageal carcinoma	8/685	5.868822008450012E-8	1.0905875717860706E-6	0	0	22.81240768094535	379.850011901609	AR;CDKN1A;CDH1;CAV1;EZR;ESR1;EGFR;VEGFA
Hyperplasia	5/123	6.514039884142523E-8	1.2018403586242954E-6	0	0	64.7457627118644	1071.330065975597	AR;CDH1;CAV1;EGFR;VEGFA
Uterine Cervical Neoplasm	5/124	6.78405388942715E-8	1.2427809359142075E-6	0	0	64.19844861021332	1059.6663914970775	CDKN1A;EPAS1;CDH1;EGFR;VEGFA
Pancreatic Ductal Adenocarcinoma	8/701	7.014624785468546E-8	1.2759701282299476E-6	0	0	22.267243867243867	366.8012610719233	CDKN1A;EPAS1;CDH1;CAV1;PIM1;PIK3R1;EGFR;VEGFA
Biliary Tract Cancer	5/128	7.954419556260019E-8	1.43220459534362E-6	0	0	62.09818636647905	1015.116137068032	AR;CDH1;ESR1;EGFR;VEGFA
Primary malignant neoplasm	9/1032	7.984415862542828E-8	1.43220459534362E-6	0	0	18.532746823069402	302.88418622967487	AR;EPAS1;PRKDC;CDH1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Refractory anemias	6/266	8.492547643402388E-8	1.5128448664074737E-6	0	0	37.926923076923075	617.5068837711747	AR;JUN;CDKN1A;STAT1;ESR1;EGFR
Osteosarcoma of bone	9/1042	8.674499934957472E-8	1.5346735158900788E-6	0	0	18.343659244917717	298.2732751915646	CDKN1A;EPAS1;PRKDC;NFIB;CAV1;EZR;ESR1;EGFR;VEGFA
Neoplastic Cell Transformation	5/131	8.933114465300717E-8	1.569675827474269E-6	0	0	60.61050061050061	983.7639226439984	JUN;EPAS1;CDH1;PIM1;ESR1
precancerous lesions	5/132	9.279769471715918E-8	1.6195705773947443E-6	0	0	60.13022410660206	973.6793409806726	CDKN1A;CDH1;ESR1;EGFR;VEGFA
Leukemogenesis	8/730	9.589117714139888E-8	1.659495486573695E-6	0	0	21.34072022160665	344.86714550878855	NR4A1;JUN;CDKN1A;EPAS1;CDH1;PIM1;EGFR;VEGFA
PACHYONYCHIA CONGENITA 3	5/133	9.63702373155456E-8	1.659495486573695E-6	0	0	59.65745192307692	963.7702178510353	AR;CDKN1A;PIM1;ESR1;VEGFA
Lip and Oral Cavity Carcinoma	7/473	1.0053339700676038E-7	1.7197202944931264E-6	0	0	26.65079984393289	429.4183642717298	AR;CDKN1A;STAT1;CDH1;CAV1;EGFR;VEGFA
Erythroblastosis	4/50	1.0303520171829828E-7	1.7406919911350024E-6	0	0	123.82608695652173	1992.1382507319795	AR;JUN;CAV1;EGFR
melanoma	12/2454	1.0310719111252628E-7	1.7406919911350024E-6	0	0	14.365274365274365	231.10130393799844	NR4A1;AR;JUN;CDKN1A;EPAS1;STAT1;PRKDC;CDH1;CAV1;ESR1;EGFR;VEGFA
Mammary Neoplasms, Human	7/476	1.0495803597009392E-7	1.7604325124074844E-6	0	0	26.476255088195387	425.46561470540087	AR;JUN;CDH1;CAV1;PIM1;ESR1;EGFR
Metaplasia	4/51	1.1174161743624923E-7	1.8621199860505274E-6	0	0	121.1854103343465	1939.8241482083695	CDH1;ESR1;EGFR;VEGFA
Endometriosis	8/749	1.1686897661148741E-7	1.9350805550478974E-6	0	0	20.773009446693656	331.58318871939986	NR4A1;AR;JUN;CDH1;EZR;ESR1;EGFR;VEGFA
Invasive Lobular Breast Carcinoma	4/52	1.2098570270927802E-7	1.990484522917612E-6	0	0	118.6547619047619	1889.884809446178	AR;CDH1;ESR1;VEGFA
Obesity	11/1961	1.2984249772306442E-7	2.1226783013840214E-6	0	0	14.531282051282052	230.42172104170115	NR4A1;AR;JUN;CDKN1A;EPAS1;STAT1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
granulosa cell tumor	4/53	1.3078887834102304E-7	2.124702344370204E-6	0	0	116.22740524781341	1842.1673465566598	AR;ESR1;EGFR;VEGFA
Lymphatic Metastasis	5/142	1.336960592324075E-7	2.158355756233179E-6	0	0	55.71308253790006	881.8097797617976	CDH1;EZR;ESR1;EGFR;VEGFA
Anoxia	6/288	1.3584437968961445E-7	2.1794163524116405E-6	0	0	34.9290780141844	552.290054442242	AR;JUN;EPAS1;STAT1;ESR1;VEGFA
Fanconi Anemia	6/290	1.415082872220449E-7	2.2562710240403825E-6	0	0	34.679577464788736	546.9284102310851	AR;CDKN1A;STAT1;PRKDC;CDH1;ESR1
Diabetes Mellitus	10/1507	1.4300827157058456E-7	2.2661985611461345E-6	0	0	15.43503674014696	243.26178758005804	AR;CDKN1A;STAT1;CAV1;PIM1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Renal carcinoma	7/500	1.4668254621271185E-7	2.2997693284931397E-6	0	0	25.156371012354786	395.8353754919173	CDKN1A;EPAS1;CDH1;CAV1;PIK3R1;EGFR;VEGFA
Mammary Carcinoma, Animal	5/145	1.4840725645582278E-7	2.2997693284931397E-6	0	0	54.510989010989015	857.0929392936039	CDH1;PIK3R1;EZR;ESR1;EGFR
Animal Mammary Neoplasms	5/145	1.4840725645582278E-7	2.2997693284931397E-6	0	0	54.510989010989015	857.0929392936039	CDH1;PIK3R1;EZR;ESR1;EGFR
Myeloid Leukemia	7/501	1.4868814473803885E-7	2.2997693284931397E-6	0	0	25.10415899889584	394.6728946351343	JUN;CDKN1A;EPAS1;STAT1;PIM1;ESR1;VEGFA
Insulin Sensitivity	4/55	1.521601693896974E-7	2.3394626043665976E-6	0	0	111.65826330532212	1752.8485018582535	NR4A1;AR;PIK3R1;EGFR
Epithelioma	6/298	1.6614924169728087E-7	2.524491125318097E-6	0	0	33.715753424657535	526.3157029221218	AR;CDH1;NFIB;ESR1;EGFR;VEGFA
Fibrosarcoma	6/298	1.6614924169728087E-7	2.524491125318097E-6	0	0	33.715753424657535	526.3157029221218	JUN;CDKN1A;STAT1;CAV1;EGFR;VEGFA
Adenocarcinoma Of Esophagus	6/299	1.6946359777446407E-7	2.5597922400669044E-6	0	0	33.598976109215016	523.8291274715657	AR;CDKN1A;CDH1;ESR1;EGFR;VEGFA
Choriocarcinoma	6/300	1.7283226824992137E-7	2.5954985400555054E-6	0	0	33.48299319727891	521.3618207479343	STAT1;CAV1;EZR;ESR1;EGFR;VEGFA
Atherosclerosis	9/1134	1.7915864831891777E-7	2.6749525353049976E-6	0	0	16.761777777777777	260.3941192215919	NR4A1;AR;CDKN1A;STAT1;CDH1;CAV1;ESR1;EGFR;VEGFA
Pulmonary Hypertension	5/151	1.816763040384174E-7	2.69695340994961E-6	0	0	52.2550052687039	811.0519894883162	JUN;CDKN1A;EPAS1;CAV1;VEGFA
Carcinoma of Male Breast	4/58	1.889685878489652E-7	2.7891763566507264E-6	0	0	105.43915343915344	1632.375764171635	AR;ESR1;EGFR;VEGFA
Breast Cancer, Familial	5/154	2.0039201016213375E-7	2.9243647584677483E-6	0	0	51.19514713474445	789.5822596106763	CDH1;CAV1;ESR1;EGFR;VEGFA
Invasive Carcinoma	5/154	2.0039201016213375E-7	2.9243647584677483E-6	0	0	51.19514713474445	789.5822596106763	STAT1;CDH1;ESR1;EGFR;VEGFA
Infection caused by Helicobacter pylori	6/308	2.0182180783673785E-7	2.9286838743949094E-6	0	0	32.58278145695364	502.29227078108426	JUN;CDH1;CAV1;PIM1;EGFR;VEGFA
Fibroid Tumor	6/310	2.0966255191363976E-7	3.025465763089003E-6	0	0	32.36513157894737	497.70343597898926	AR;CDKN1A;CAV1;ESR1;EGFR;VEGFA
Sporadic Breast Carcinoma	5/159	2.3495567717762056E-7	3.371613967498855E-6	0	0	49.52047952047952	755.8741096598384	AR;CDH1;CAV1;ESR1;VEGFA
Agenesis of corpus callosum	6/317	2.391092704773583E-7	3.412261025652025E-6	0	0	31.625401929260452	482.1717946128254	JUN;NFIB;PIM1;ESR1;EGFR;VEGFA
Mammary Neoplasms, Experimental	5/160	2.4240304379059183E-7	3.440258583028015E-6	0	0	49.1985111662531	749.4243911719028	CDH1;PIK3R1;EZR;ESR1;EGFR
Metastatic malignant neoplasm to brain	5/163	2.658745092739534E-7	3.7527533194241624E-6	0	0	48.2570593962999	730.6235289546969	CDH1;CAV1;ESR1;EGFR;VEGFA
Salivary gland carcinoma	3/15	2.765972347443499E-7	3.8828840073079115E-6	0	0	332.8333333333333	5026.017453317348	PRKDC;CDH1;EGFR
Solid Neoplasm	8/840	2.816572769150438E-7	3.923073626049409E-6	0	0	18.41346153846154	277.72241162909455	CDKN1A;EPAS1;CDH1;PIM1;EZR;ESR1;EGFR;VEGFA
TARSAL-CARPAL COALITION SYNDROME	5/165	2.824977523984476E-7	3.923073626049409E-6	0	0	47.64903846153846	718.52821369447	AR;CDKN1A;ESR1;EGFR;VEGFA
Anaplastic astrocytoma	5/166	2.9111259931010016E-7	4.021090074962506E-6	0	0	47.350692785475395	712.6068887646074	AR;CAV1;ESR1;EGFR;VEGFA
Diarrhea	6/329	2.9748560494862654E-7	4.077528912490058E-6	0	0	30.431888544891642	457.3273778594773	CDKN1A;STAT1;CAV1;PIK3R1;EGFR;VEGFA
Transitional cell carcinoma of bladder	5/167	2.999343760639222E-7	4.077528912490058E-6	0	0	47.05603038936372	706.7675599942188	AR;CDH1;CAV1;EGFR;VEGFA
Progressive Neoplastic Disease	5/167	2.999343760639222E-7	4.077528912490058E-6	0	0	47.05603038936372	706.7675599942188	AR;HBB;ESR1;EGFR;VEGFA
Fibrosis	5/169	3.182132980508553E-7	4.254918214494819E-6	0	0	46.47748592870544	695.3284700123369	CDKN1A;STAT1;CAV1;EGFR;VEGFA
Progressive cGVHD	5/169	3.182132980508553E-7	4.254918214494819E-6	0	0	46.47748592870544	695.3284700123369	AR;HBB;ESR1;EGFR;VEGFA
Giant Cell Tumor of Bone	4/66	3.1957186744560386E-7	4.254918214494819E-6	0	0	91.79723502304148	1372.9454853996965	AR;ESR1;EGFR;VEGFA
Diffuse Astrocytoma	4/66	3.1957186744560386E-7	4.254918214494819E-6	0	0	91.79723502304148	1372.9454853996965	AR;CAV1;ESR1;EGFR
Condyloma	3/16	3.4023684359545693E-7	4.506829574395206E-6	0	0	307.2153846153846	4575.550383400204	CDKN1A;JUN;ESR1
Human papilloma virus infection	4/68	3.6069928048294073E-7	4.753501232078755E-6	0	0	88.91964285714286	1319.1425747070546	CDKN1A;CAV1;ESR1;EGFR
Diffuse Large B-Cell Lymphoma	7/575	3.781585373051771E-7	4.95829188761052E-6	0	0	21.750640204865558	321.647430244111	NR4A1;CDKN1A;STAT1;CDH1;PIM1;EZR;VEGFA
Malignant neoplasm of salivary gland	4/69	3.8268176173260676E-7	4.992257528057188E-6	0	0	87.54725274725274	1293.603643494621	CDKN1A;CDH1;EGFR;VEGFA
Anaplastic thyroid carcinoma	5/176	3.8925528517615795E-7	5.02723200805008E-6	0	0	44.5591542959964	657.6499150131071	CDKN1A;CAV1;HBB;EGFR;VEGFA
Multiple malignancy	5/176	3.8925528517615795E-7	5.02723200805008E-6	0	0	44.5591542959964	657.6499150131071	CDKN1A;PRKDC;CAV1;EGFR;VEGFA
Glaucoma, Open-Angle	4/70	4.056473213159845E-7	5.21287080079198E-6	0	0	86.21645021645021	1268.9148950937722	CDKN1A;CDH1;CAV1;ESR1
Uterine Fibroids	6/349	4.206042674563395E-7	5.378320905147153E-6	0	0	28.628279883381925	420.3081932141394	AR;CDKN1A;CAV1;ESR1;EGFR;VEGFA
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	4/73	4.807282861323554E-7	6.116853020097901E-6	0	0	82.45548654244307	1199.5594185011416	CDKN1A;CDH1;PIK3R1;ESR1
Malignant neoplasm of other specified sites of female breast	3/18	4.952185885824742E-7	6.223159172441886E-6	0	0	266.2266666666667	3865.149717040108	STAT1;CAV1;ESR1
Myoma	3/18	4.952185885824742E-7	6.223159172441886E-6	0	0	266.2266666666667	3865.149717040108	CAV1;ESR1;VEGFA
Lymphoma, Follicular	6/359	4.96310797337603E-7	6.223159172441886E-6	0	0	27.80311614730878	403.5917994622524	NR4A1;CDKN1A;STAT1;PIM1;ESR1;VEGFA
Hereditary gingival fibromatosis	4/74	5.079138521927329E-7	6.307410962566486E-6	0	0	81.2734693877551	1177.8926521230856	CAV1;EZR;EGFR;VEGFA
Acoustic Neuroma	4/74	5.079138521927329E-7	6.307410962566486E-6	0	0	81.2734693877551	1177.8926521230856	CDKN1A;CAV1;EGFR;VEGFA
Malignant Fibrous Histiocytoma	4/75	5.362282161408622E-7	6.595607058532606E-6	0	0	80.12474849094568	1156.8976859923102	EPAS1;STAT1;EZR;EGFR
Ovarian Cysts	4/75	5.362282161408622E-7	6.595607058532606E-6	0	0	80.12474849094568	1156.8976859923102	PIK3R1;ESR1;EGFR;VEGFA
Carcinoma, Spindle-Cell	5/188	5.397913708212379E-7	6.607967349911172E-6	0	0	41.612021857923494	600.5481583434978	CDH1;PIK3R1;EZR;ESR1;EGFR
Varicosity	4/76	5.657016417946831E-7	6.8601283603552415E-6	0	0	79.0079365079365	1136.5448918031952	JUN;EPAS1;ESR1;VEGFA
Early-Stage Breast Carcinoma	4/76	5.657016417946831E-7	6.8601283603552415E-6	0	0	79.0079365079365	1136.5448918031952	AR;ESR1;EGFR;VEGFA
Hypertensive disease	9/1310	6.115492018512233E-7	7.381456020475278E-6	0	0	14.358954650269023	205.43744718933578	AR;JUN;CDKN1A;EPAS1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Disseminated Malignant Neoplasm	5/195	6.468407724445486E-7	7.771114954531485E-6	0	0	40.064777327935225	570.9697793945512	AR;CAV1;ESR1;EGFR;VEGFA
Liver neoplasms	9/1321	6.56401727633374E-7	7.849470659615764E-6	0	0	14.230182926829269	202.58789743153784	AR;JUN;CDKN1A;STAT1;CAV1;HBB;ESR1;EGFR;VEGFA
Tonsillar Carcinoma	3/20	6.910743741904565E-7	8.226014325041239E-6	0	0	234.88235294117646	3331.8104950828997	PRKDC;CDH1;EGFR
Cardiac Arrest	5/201	7.513822958515328E-7	8.902846193506923E-6	0	0	38.826530612244895	547.506546589151	AR;CDKN1A;STAT1;HBB;EGFR
Immunologic Deficiency Syndromes	7/641	7.86218220736246E-7	9.273066959642574E-6	0	0	19.42013191855463	272.96998498172843	AR;STAT1;PRKDC;HBB;PIK3R1;EGFR;VEGFA
Carcinoma, Neuroendocrine	4/83	8.070890443806072E-7	9.475959098341401E-6	0	0	71.98191681735986	1009.8941880914374	AR;CDKN1A;CAV1;EGFR
Cervical Intraepithelial Neoplasia	5/205	8.281937310471311E-7	9.679748449297464E-6	0	0	38.042307692307695	532.7451896546271	CDKN1A;EZR;ESR1;EGFR;VEGFA
Lung diseases	6/393	8.422474400114859E-7	9.799662781755262E-6	0	0	25.316537467700257	354.1072701872667	JUN;CDKN1A;PRKDC;EZR;EGFR;VEGFA
Polycythemia Vera	5/207	8.688584929277218E-7	1.006395285754397E-5	0	0	37.66184310738766	525.6119049016021	AR;STAT1;NFIB;HBB;VEGFA
Hurthle Cell Tumor	4/85	8.882963173680829E-7	1.0214608154493301E-5	0	0	70.19753086419753	978.1296193732132	CDH1;ESR1;EGFR;VEGFA
Addictive Behavior	5/208	8.897742294854791E-7	1.0214608154493301E-5	0	0	37.474422129594544	522.10481952785	AR;JUN;PRKDC;ESR1;EGFR
Cystadenocarcinoma, Serous	4/86	9.311058374131898E-7	1.0564358623045495E-5	0	0	69.33797909407666	962.8890885209128	AR;ESR1;EGFR;VEGFA
Herpes NOS	4/86	9.311058374131898E-7	1.0564358623045495E-5	0	0	69.33797909407666	962.8890885209128	STAT1;HBB;ESR1;VEGFA
Adenoid cystic carcinoma of salivary gland	3/22	9.325101688170238E-7	1.0564358623045495E-5	0	0	210.13684210526316	2917.831119346567	NFIB;PIM1;VEGFA
Pancreatic Neoplasm	7/665	1.0061595171629664E-6	1.1348952108436429E-5	0	0	18.688588007736943	258.0776253259226	NR4A1;JUN;CDH1;CAV1;EZR;EGFR;VEGFA
Retroviridae Infections	4/88	1.0213080336239917E-6	1.1469733264568568E-5	0	0	67.68027210884354	933.6105300577225	HBB;EZR;EGFR;VEGFA
Adenoma	8/1000	1.0611565372899213E-6	1.1865659462423665E-5	0	0	15.314516129032258	210.66879899260064	AR;CDKN1A;CDH1;NFIB;CAV1;ESR1;EGFR;VEGFA
Metastatic melanoma	6/417	1.1896830065100638E-6	1.3245479335411615E-5	0	0	23.809002433090026	324.7982128891631	JUN;STAT1;PRKDC;CAV1;EGFR;VEGFA
Familial erythrocytosis	3/25	1.3903678488211E-6	1.534752202352522E-5	0	0	181.45454545454547	2447.0855130872887	EPAS1;HBB;PIK3R1
Uterine Carcinosarcoma	3/25	1.3903678488211E-6	1.534752202352522E-5	0	0	181.45454545454547	2447.0855130872887	PIK3R1;EGFR;VEGFA
Endometrioma	5/229	1.4292669652609202E-6	1.5709772643697687E-5	0	0	33.925137362637365	456.57633364219726	NR4A1;AR;ESR1;EGFR;VEGFA
Steroid Sulfatase Deficiency Disease	4/96	1.4484228682334973E-6	1.585286554511493E-5	0	0	61.77018633540373	830.5023339486978	EPAS1;EZR;EGFR;VEGFA
Pulmonary Fibrosis	6/432	1.4610570938061714E-6	1.5923672883128018E-5	0	0	22.953051643192488	308.4052434194111	STAT1;CDH1;CAV1;EZR;EGFR;VEGFA
Tumor Initiation	5/234	1.5894333021968444E-6	1.7250026132665753E-5	0	0	33.176016123614374	442.97058032216756	AR;CDH1;CAV1;EGFR;VEGFA
Mucinous neoplasm	3/27	1.7662014912162843E-6	1.908827804105298E-5	0	0	166.31666666666666	2203.143556822064	PIM1;EGFR;VEGFA
Hypercholesterolemia	5/240	1.799984498814845E-6	1.9356651852612465E-5	0	0	32.319148936170215	427.5090569126736	NR4A1;AR;CAV1;ESR1;VEGFA
Colorectal Neoplasms	8/1073	1.8060213304218368E-6	1.9356651852612465E-5	0	0	14.209953051643193	187.91787992868626	CDKN1A;CDH1;CAV1;PIK3R1;EZR;ESR1;EGFR;VEGFA
Inflammatory Breast Carcinoma	4/102	1.8466533021347333E-6	1.9673428521033402E-5	0	0	57.970845481049565	765.3389619025698	CAV1;ESR1;EGFR;VEGFA
Alzheimer's Disease	10/1982	1.8508103486686476E-6	1.9673428521033402E-5	0	0	11.416075050709939	150.69090052128803	AR;JUN;CDKN1A;STAT1;CDH1;NFIB;CAV1;ESR1;EGFR;VEGFA
B-Cell Lymphomas	7/730	1.8769994804104336E-6	1.9870039581557993E-5	0	0	16.95121337859927	223.51592091949533	NR4A1;CDKN1A;CDH1;PIM1;PIK3R1;ESR1;VEGFA
Ichthyosis, X-Linked	4/103	1.9201884544222363E-6	2.024427256233729E-5	0	0	57.38239538239538	755.3294755058888	EPAS1;EZR;EGFR;VEGFA
Arteriosclerosis	8/1087	1.991070774351176E-6	2.090624313068735E-5	0	0	14.015199258572753	183.97525001406564	NR4A1;AR;CDKN1A;STAT1;CAV1;ESR1;EGFR;VEGFA
Kidney Neoplasm	5/246	2.0319560429879748E-6	2.1249159753190036E-5	0	0	31.504947334822855	412.9199596189456	CDKN1A;EPAS1;CDH1;EGFR;VEGFA
Biliary Atresia	4/105	2.0737576993947478E-6	2.1512113002155152E-5	0	0	56.24045261669024	735.9709024259415	EPAS1;STAT1;EGFR;VEGFA
Mixed Salivary Gland Tumor	4/105	2.0737576993947478E-6	2.1512113002155152E-5	0	0	56.24045261669024	735.9709024259415	AR;NFIB;EGFR;VEGFA
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	5/249	2.1564549867479017E-6	2.228049292307932E-5	0	0	31.112862547288778	405.93091444675844	AR;CDKN1A;STAT1;CDH1;ESR1
Salivary duct carcinoma	3/29	2.203917300185414E-6	2.2590152326900495E-5	0	0	153.5076923076923	1999.4797825786989	AR;ESR1;EGFR
Stage IV Breast Cancer AJCC v6 and v7	3/29	2.203917300185414E-6	2.2590152326900495E-5	0	0	153.5076923076923	1999.4797825786989	AR;ESR1;VEGFA
Head and Neck Neoplasms	4/107	2.2362642597041835E-6	2.283110902298777E-5	0	0	55.142857142857146	717.4473823791876	AR;EPAS1;EGFR;VEGFA
Lupus Erythematosus, Systemic	8/1113	2.378100493558916E-6	2.412964236733425E-5	0	0	13.66660633484163	176.9717349294734	AR;JUN;CDKN1A;STAT1;PRKDC;ESR1;EGFR;VEGFA
Malignant Head and Neck Neoplasm	6/470	2.382136586786773E-6	2.412964236733425E-5	0	0	21.032327586206897	272.3163295310591	AR;JUN;CDKN1A;STAT1;EGFR;VEGFA
Urothelial Carcinoma	5/257	2.5180477098343127E-6	2.5406707947273555E-5	0	0	30.112942612942614	388.2168594291009	AR;CDKN1A;PIK3R1;EGFR;VEGFA
Down Syndrome	6/475	2.5325260102753874E-6	2.5453364531289203E-5	0	0	20.80277185501066	268.07062020664074	CDKN1A;EPAS1;STAT1;NFIB;ESR1;VEGFA
Lymphoma, T-Cell, Cutaneous	5/260	2.6653343648472187E-6	2.668433590852855E-5	0	0	29.754147812971343	381.89987395916665	NR4A1;JUN;STAT1;PIM1;VEGFA
Cholera	4/112	2.683818051275421E-6	2.676564488974677E-5	0	0	52.576719576719576	674.4683613471645	CAV1;ESR1;EGFR;VEGFA
ESTROGEN RESISTANCE	3/31	2.7081250704780845E-6	2.69041809886342E-5	0	0	142.52857142857144	1827.1099620264538	AR;ESR1;EGFR
Carcinoma, Endometrioid	4/114	2.880248453603746E-6	2.850452779945776E-5	0	0	51.615584415584415	658.4927346146395	CDH1;EZR;ESR1;EGFR
Hyperglycemia	6/488	2.960256071920529E-6	2.9184509289201242E-5	0	0	20.228215767634854	257.50993595480355	JUN;CDKN1A;EPAS1;PIK3R1;ESR1;VEGFA
Grade I Astrocytoma	3/32	2.9865982006794387E-6	2.9332255332148253E-5	0	0	137.60689655172413	1750.5490084496623	AR;ESR1;EGFR
Cytomegalovirus Infections	5/270	3.205975722281957E-6	3.136755791914505E-5	0	0	28.616835994194485	362.01711422969225	JUN;STAT1;CDH1;EGFR;VEGFA
Mixed oligoastrocytoma	3/33	3.283413386010621E-6	3.2003987834209185E-5	0	0	133.01333333333332	1679.5097473860005	AR;CAV1;ESR1
Von Hippel-Lindau Syndrome	4/119	3.417907377031168E-6	3.318967952959214E-5	0	0	49.35900621118012	621.2562467798413	AR;EPAS1;EGFR;VEGFA
Secondary malignant neoplasm of liver	6/508	3.7323384744767667E-6	3.6107229511511194E-5	0	0	19.40239043824701	242.50030316161485	AR;HBB;EZR;ESR1;EGFR;VEGFA
Pilocytic Astrocytoma	4/122	3.774243281451781E-6	3.6376382074589366E-5	0	0	48.09685230024213	600.6003359892297	AR;ESR1;EGFR;VEGFA
Hepatitis B Virus-Related Hepatocellular Carcinoma	3/35	3.934349680985112E-6	3.763861194809091E-5	0	0	124.6875	1551.8313178350186	CDH1;CAV1;ESR1
Prostate Cancer, Hereditary, 7	3/35	3.934349680985112E-6	3.763861194809091E-5	0	0	124.6875	1551.8313178350186	AR;CAV1;ESR1
Experimental Organism Basal Cell Carcinoma	5/282	3.964924207855484E-6	3.77911410660174E-5	0	0	27.360455429047487	340.3099963075363	AR;JUN;STAT1;EGFR;VEGFA
Squamous cell carcinoma of lung	5/283	4.0340333112058985E-6	3.8308485451635426E-5	0	0	27.2606530160487	338.5975885919736	CDKN1A;STAT1;PRKDC;EGFR;VEGFA
Malignant neoplasm of large intestine	6/516	4.0839454710523884E-6	3.8640407149187984E-5	0	0	19.090196078431372	236.87968644207194	STAT1;CDH1;CAV1;PIM1;EGFR;VEGFA
Lupus Vulgaris	5/284	4.104087019638644E-6	3.868925829097306E-5	0	0	27.161566032533774	336.8992243477082	AR;CDKN1A;STAT1;ESR1;EGFR
polyps	5/285	4.1750946582843015E-6	3.921552546308491E-5	0	0	27.063186813186814	335.21474070656933	JUN;CDKN1A;CDH1;ESR1;EGFR
Astrocytoma, low grade	3/36	4.289607374823355E-6	4.001600581405698E-5	0	0	120.9030303030303	1494.2786783139097	CDKN1A;EGFR;VEGFA
Nodule	4/126	4.291302210798987E-6	4.001600581405698E-5	0	0	46.51053864168618	574.820041366094	AR;CDH1;EGFR;VEGFA
Aortic Aneurysm, Abdominal	5/288	4.393935227778669E-6	4.0825664364576634E-5	0	0	26.77222071215004	330.24298127283276	AR;JUN;STAT1;ESR1;VEGFA
Sessile Serrated Adenoma/Polyp	3/37	4.665480298250301E-6	4.288589185188799E-5	0	0	117.34117647058824	1440.400463498295	AR;HBB;VEGFA
Tubular Aggregate Myopathy	3/37	4.665480298250301E-6	4.288589185188799E-5	0	0	117.34117647058824	1440.400463498295	ESR1;EGFR;VEGFA
Juvenile Pilocytic Astrocytoma	3/37	4.665480298250301E-6	4.288589185188799E-5	0	0	117.34117647058824	1440.400463498295	AR;ESR1;EGFR
early pregnancy	4/129	4.7122093384722295E-6	4.316183234494244E-5	0	0	45.38742857142857	556.6928643235082	EPAS1;ESR1;EGFR;VEGFA
Pituitary Neoplasms	5/296	5.021860591324154E-6	4.583556857735084E-5	0	0	26.025641025641026	317.55732584782703	CDKN1A;CDH1;ESR1;EGFR;VEGFA
Idiopathic pulmonary arterial hypertension	5/297	5.105063002624987E-6	4.643090752035332E-5	0	0	25.93519494204426	316.02755425997753	AR;CAV1;PIM1;ESR1;VEGFA
Lymphoma, Non-Hodgkin	6/539	5.2484304870412215E-6	4.7567354203605174E-5	0	0	18.244840525328332	221.81313529281394	AR;CDKN1A;PIM1;HBB;ESR1;VEGFA
Hereditary Diffuse Gastric Cancer	5/300	5.361192160390233E-6	4.841943828772018E-5	0	0	25.66753585397653	311.50953627279847	JUN;CDKN1A;CDH1;CAV1;EGFR
Skin Carcinogenesis	4/134	5.48066995986922E-6	4.899057718715258E-5	0	0	43.63076923076923	528.5554950892113	AR;STAT1;EGFR;VEGFA
Thyroid Gland Follicular Adenoma	4/134	5.48066995986922E-6	4.899057718715258E-5	0	0	43.63076923076923	528.5554950892113	NR4A1;CDKN1A;ESR1;VEGFA
Subependymal Giant Cell Astrocytoma	3/39	5.4813305486206335E-6	4.899057718715258E-5	0	0	110.81111111111112	1342.383827375702	AR;ESR1;VEGFA
Hormone refractory prostate cancer	4/135	5.64484961433218E-6	5.027809156489663E-5	0	0	43.29552889858233	523.2163789341946	AR;PIM1;ESR1;EGFR
Lupus Erythematosus	5/304	5.718296725831705E-6	5.075725238083606E-5	0	0	25.319012091587343	305.6470520942254	AR;CDKN1A;STAT1;ESR1;EGFR
Cholelithiasis	4/136	5.812642338918907E-6	5.14179971281765E-5	0	0	42.96536796536797	517.9679322161244	AR;HBB;ESR1;VEGFA
Hamartoma Syndrome, Multiple	4/138	6.1592707170728686E-6	5.429828075835911E-5	0	0	42.31982942430704	507.73436166157694	AR;CAV1;EGFR;VEGFA
Lupus Erythematosus, Discoid	5/309	6.19068295467624E-6	5.438957167322697E-5	0	0	24.896255060728745	298.5674710672538	AR;CDKN1A;STAT1;ESR1;EGFR
Virus Diseases	7/875	6.239116268648293E-6	5.4629279057350986E-5	0	0	14.013196480938417	167.94356362489484	JUN;CDKN1A;STAT1;CDH1;ESR1;EGFR;VEGFA
Hematologic Neoplasms	6/557	6.337638555693285E-6	5.5304460774850523E-5	0	0	17.632486388384756	211.04330586873027	NR4A1;CDKN1A;CDH1;PIM1;EGFR;VEGFA
Intestinal Polyps	3/41	6.386404770139251E-6	5.554236875848379E-5	0	0	104.96842105263158	1255.5628770805151	JUN;EGFR;VEGFA
Steatohepatitis	6/569	7.161230096339031E-6	6.207200449276415E-5	0	0	17.24600355239787	204.3104514070469	AR;CDKN1A;EPAS1;CAV1;EGFR;VEGFA
Disease Exacerbation	4/144	7.291220729189722E-6	6.29099002091473E-5	0	0	40.49387755102041	478.9955812558664	STAT1;CDH1;ESR1;EGFR
Papillary thyroid carcinoma	6/571	7.306608618948583E-6	6.29099002091473E-5	0	0	17.183185840707964	203.22092231555163	JUN;CDKN1A;CDH1;ESR1;EGFR;VEGFA
Carcinoma of urinary bladder, superficial	3/43	7.3851863863581E-6	6.316535243696348E-5	0	0	99.71	1178.176790402359	CDKN1A;CDH1;VEGFA
intracranial glioma	3/43	7.3851863863581E-6	6.316535243696348E-5	0	0	99.71	1178.176790402359	CDKN1A;CDH1;EGFR
Gastrointestinal Stromal Tumors	5/323	7.678068219026524E-6	6.545363105526571E-5	0	0	23.78326076439284	280.0988529545632	CDKN1A;CDH1;EZR;EGFR;VEGFA
Hematological Disease	4/147	7.9115853392011E-6	6.642933262993556E-5	0	0	39.63836163836164	465.6390631770464	AR;HBB;EGFR;VEGFA
Monosomy	4/147	7.9115853392011E-6	6.642933262993556E-5	0	0	39.63836163836164	465.6390631770464	CDKN1A;STAT1;ESR1;EGFR
Arthritis, Adjuvant-Induced	3/44	7.921112833921855E-6	6.642933262993556E-5	0	0	97.27317073170731	1142.5686063472676	STAT1;EGFR;VEGFA
Arthritis, Collagen-Induced	3/44	7.921112833921855E-6	6.642933262993556E-5	0	0	97.27317073170731	1142.5686063472676	STAT1;EGFR;VEGFA
Arthritis, Experimental	3/44	7.921112833921855E-6	6.642933262993556E-5	0	0	97.27317073170731	1142.5686063472676	STAT1;EGFR;VEGFA
Juvenile arthritis	5/326	8.030456791004513E-6	6.712838152480471E-5	0	0	23.55739276300024	276.381672275172	AR;JUN;STAT1;ESR1;VEGFA
Ulcerative Colitis	7/915	8.372022443382843E-6	6.975785152018672E-5	0	0	13.36784140969163	156.27828827249374	NR4A1;CDKN1A;STAT1;CDH1;ESR1;EGFR;VEGFA
Lipoatrophy	3/45	8.482137967085975E-6	7.04481105111996E-5	0	0	94.95238095238095	1108.810988296513	CAV1;PIK3R1;ESR1
Single tumor	3/46	9.06881635847199E-6	7.483946534802923E-5	0	0	92.73953488372094	1076.768024485912	CDKN1A;ESR1;EGFR
Malignant neoplasm of male breast	3/46	9.06881635847199E-6	7.483946534802923E-5	0	0	92.73953488372094	1076.768024485912	AR;ESR1;EGFR
Familial lichen amyloidosis	4/153	9.26836341933269E-6	7.624262010234502E-5	0	0	38.030680728667306	440.7338981270675	AR;CDH1;EGFR;VEGFA
Hemangioblastoma	3/47	9.681701283948504E-6	7.938995052837772E-5	0	0	90.62727272727273	1046.3165975994118	EPAS1;EGFR;VEGFA
Biliary cirrhosis	4/155	9.756623720083122E-6	7.975113629422374E-5	0	0	37.52317880794702	432.9260825225431	CDKN1A;STAT1;CAV1;ESR1
Rheumatoid Arthritis	9/1833	1.010518686703401E-5	8.233974030772507E-5	0	0	9.955043859649123	114.50751086424978	NR4A1;AR;JUN;CDKN1A;EPAS1;STAT1;ESR1;EGFR;VEGFA
Liver diseases	6/606	1.026661325069838E-5	8.339201895142739E-5	0	0	16.151666666666667	185.52795011185438	JUN;CDKN1A;PIM1;ESR1;EGFR;VEGFA
Colitis	6/608	1.046147102410985E-5	8.47084001732782E-5	0	0	16.096345514950166	184.58985581696567	NR4A1;STAT1;PIK3R1;EZR;EGFR;VEGFA
Recurrent tumor	5/347	1.0867445854354571E-5	8.77206645056183E-5	0	0	22.087269455690507	252.45172193040813	AR;CAV1;ESR1;EGFR;VEGFA
Dryness of eye	3/49	1.0988297371513793E-5	8.839824842666207E-5	0	0	86.67826086956522	989.7513001455751	AR;ESR1;EGFR
Encephalomyelitis	5/348	1.1019835847226165E-5	8.839824842666207E-5	0	0	22.021753756447634	251.3962371352208	NR4A1;AR;STAT1;ESR1;VEGFA
Familial multiple trichoepitheliomata	4/161	1.1335715215242392E-5	9.037084074373795E-5	0	0	36.07825295723385	410.84298804328665	CDH1;ESR1;EGFR;VEGFA
Polycystic Kidney, Autosomal Dominant	4/161	1.1335715215242392E-5	9.037084074373795E-5	0	0	36.07825295723385	410.84298804328665	JUN;ESR1;EGFR;VEGFA
androgen independent prostate cancer	4/163	1.190171477525011E-5	9.459116696760318E-5	0	0	35.62084456424079	403.89863220315254	AR;CDKN1A;ESR1;EGFR
Malignant neoplasm of female breast	3/51	1.2406326585066697E-5	9.829920726756833E-5	0	0	83.05833333333334	938.3352419807647	AR;ESR1;EGFR
Classical Hodgkin's Lymphoma	4/166	1.2789477777443162E-5	1.0102514097595011E-4	0	0	34.95590828924162	393.84429572414575	JUN;CDKN1A;STAT1;VEGFA
Follicular thyroid carcinoma	4/167	1.3095972569790566E-5	1.0313078398710071E-4	0	0	34.739702015775634	390.5856196264213	NR4A1;CAV1;EGFR;VEGFA
Idiopathic crescentic glomerulonephritis	3/52	1.3158498087175051E-5	1.0330820838654456E-4	0	0	81.35918367346939	914.3505291779086	JUN;EGFR;VEGFA
Esophageal Neoplasms	6/637	1.3642273808897699E-5	1.0678179772237198E-4	0	0	15.333597464342313	171.7721295592527	AR;CDKN1A;CDH1;EZR;EGFR;VEGFA
Leukemia, T-Cell	5/364	1.3694255251554129E-5	1.0686483780895563E-4	0	0	21.0231412041997	235.42836445850423	JUN;CDKN1A;STAT1;PIM1;VEGFA
Kidney Diseases	6/639	1.38877308698961E-5	1.080482193883784E-4	0	0	15.283570300157978	170.93916505988088	NR4A1;CDKN1A;EZR;ESR1;EGFR;VEGFA
In situ cancer	2/7	1.602207143126473E-5	1.2306757769451354E-4	0	0	499.425	5514.4227735186505	EGFR;VEGFA
Adenoid cystic breast carcinoma	2/7	1.602207143126473E-5	1.2306757769451354E-4	0	0	499.425	5514.4227735186505	NFIB;ESR1
Advanced breast cancer	2/7	1.602207143126473E-5	1.2306757769451354E-4	0	0	499.425	5514.4227735186505	ESR1;EGFR
Carcinoma of Endocrine Gland	2/7	1.602207143126473E-5	1.2306757769451354E-4	0	0	499.425	5514.4227735186505	AR;ESR1
Well Differentiated Oligodendroglioma	4/176	1.610408101461308E-5	1.2306757769451354E-4	0	0	32.906976744186046	363.17580330418485	CDH1;CAV1;EGFR;VEGFA
Mammary Tumorigenesis	4/176	1.610408101461308E-5	1.2306757769451354E-4	0	0	32.906976744186046	363.17580330418485	CAV1;ESR1;EGFR;VEGFA
Refractory cancer	4/177	1.6467176369456047E-5	1.2473853123789642E-4	0	0	32.71511147811726	360.32886600412843	AR;PIK3R1;ESR1;EGFR
Intrahepatic Cholangiocarcinoma	4/177	1.6467176369456047E-5	1.2473853123789642E-4	0	0	32.71511147811726	360.32886600412843	CDKN1A;CDH1;EGFR;VEGFA
Parathyroid Neoplasms	3/56	1.6467610976431543E-5	1.2473853123789642E-4	0	0	75.20377358490566	828.3030165140658	ESR1;EGFR;VEGFA
Malignant neoplasm of colon stage IV	3/57	1.7372707591100336E-5	1.3120965996436305E-4	0	0	73.80740740740741	808.9742160011882	CAV1;EGFR;VEGFA
Gastric Adenocarcinoma	5/383	1.7502763488472256E-5	1.3180652504584208E-4	0	0	19.947089947089946	218.4835036775039	CDKN1A;STAT1;ESR1;EGFR;VEGFA
Gastritis	4/181	1.7980181725676378E-5	1.3500816685297118E-4	0	0	31.969330104923326	349.30458685254604	JUN;CDH1;CAV1;EGFR
Nerve Sheath Tumors	3/58	1.831001175616155E-5	1.3708626193091388E-4	0	0	72.46181818181819	790.4180457368639	AR;EGFR;VEGFA
Cardiomyopathy, Familial Idiopathic	5/388	1.8630735111210513E-5	1.3876153161780248E-4	0	0	19.68166298453505	214.34704604247392	AR;CDH1;ESR1;EGFR;VEGFA
Malignant neoplasm of esophagus	6/673	1.864121233889952E-5	1.3876153161780248E-4	0	0	14.479010494752623	157.6783892514741	AR;CDKN1A;CDH1;EZR;EGFR;VEGFA
oligodendroglioma	4/183	1.8773944080888316E-5	1.3934798149693828E-4	0	0	31.608938547486034	344.0013616171892	CDH1;CAV1;EGFR;VEGFA
Fibromatosis, Aggressive	3/59	1.9280061336952568E-5	1.4269455138495268E-4	0	0	71.16428571428571	772.590733056165	AR;ESR1;VEGFA
Carcinoma breast stage IV	5/392	1.9573376620636625E-5	1.444515194602983E-4	0	0	19.47425959053866	211.12707435311887	AR;CDH1;ESR1;EGFR;VEGFA
Secondary malignant neoplasm of lung	6/683	2.0265923088897417E-5	1.4884092025367965E-4	0	0	14.257754800590842	154.07742170283615	AR;CAV1;EZR;ESR1;EGFR;VEGFA
Dry Eye Syndromes	3/60	2.028339292655642E-5	1.4884092025367965E-4	0	0	69.91228070175438	755.4516971108675	AR;ESR1;EGFR
Ataxia Telangiectasia	5/396	2.0552893093869725E-5	1.5039128289366996E-4	0	0	19.271099744245525	207.98351441902784	AR;CDKN1A;PRKDC;CAV1;EGFR
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	3/61	2.1320541846544042E-5	1.5448389237888313E-4	0	0	68.70344827586207	738.9632657780077	ESR1;EGFR;VEGFA
Altitude Sickness	2/8	2.1351432280008236E-5	1.5448389237888313E-4	0	0	416.1666666666667	4475.619360309719	EPAS1;VEGFA
Melanoma recurrent	2/8	2.1351432280008236E-5	1.5448389237888313E-4	0	0	416.1666666666667	4475.619360309719	EGFR;VEGFA
Chronic cholecystitis	2/8	2.1351432280008236E-5	1.5448389237888313E-4	0	0	416.1666666666667	4475.619360309719	CDH1;VEGFA
Low grade glioma	3/62	2.2392042155773425E-5	1.6021785287635113E-4	0	0	67.53559322033898	723.0904219777843	CDH1;EGFR;VEGFA
Cancer of Nasopharynx	3/62	2.2392042155773425E-5	1.6021785287635113E-4	0	0	67.53559322033898	723.0904219777843	CDH1;EGFR;VEGFA
Osteomyelitis	3/62	2.2392042155773425E-5	1.6021785287635113E-4	0	0	67.53559322033898	723.0904219777843	STAT1;HBB;PIK3R1
Phyllodes Tumor	3/62	2.2392042155773425E-5	1.6021785287635113E-4	0	0	67.53559322033898	723.0904219777843	AR;ESR1;EGFR
Burkitt Lymphoma	5/407	2.3445069077027884E-5	1.6674845051482243E-4	0	0	18.733256792958286	199.71244740801038	CDKN1A;PIM1;PIK3R1;EGFR;VEGFA
Bulbo-Spinal Atrophy, X-Linked	3/63	2.3498426630815085E-5	1.6674845051482243E-4	0	0	66.40666666666667	707.8005760187399	AR;STAT1;VEGFA
gliosarcoma	3/63	2.3498426630815085E-5	1.6674845051482243E-4	0	0	66.40666666666667	707.8005760187399	ESR1;EGFR;VEGFA
Hepatic methionine adenosyltransferase deficiency	3/65	2.5817972916144123E-5	1.8220716951475484E-4	0	0	64.25806451612904	678.8504467854607	AR;CAV1;EGFR
Mammary Ductal Carcinoma	3/65	2.5817972916144123E-5	1.8220716951475484E-4	0	0	64.25806451612904	678.8504467854607	CDH1;CAV1;ESR1
Prostatic Cancer, Castration-Resistant	2/9	2.7437270887714988E-5	1.9154181271072382E-4	0	0	356.69642857142856	3746.5995382949022	AR;EGFR
Vulvar Vestibulitis	2/9	2.7437270887714988E-5	1.9154181271072382E-4	0	0	356.69642857142856	3746.5995382949022	AR;ESR1
Lung cancer stage I	2/9	2.7437270887714988E-5	1.9154181271072382E-4	0	0	356.69642857142856	3746.5995382949022	EGFR;VEGFA
Bronchial carcinoid	2/9	2.7437270887714988E-5	1.9154181271072382E-4	0	0	356.69642857142856	3746.5995382949022	EGFR;VEGFA
Malignant neoplasm of gallbladder	4/203	2.8201637279818705E-5	1.95337080202357E-4	0	0	28.403445800430724	297.5582054837722	CDH1;ESR1;EGFR;VEGFA
Arteriopathic disease	3/67	2.8283417729648286E-5	1.95337080202357E-4	0	0	62.24375	651.8934130016395	CAV1;ESR1;VEGFA
neurofibroma	3/67	2.8283417729648286E-5	1.95337080202357E-4	0	0	62.24375	651.8934130016395	AR;EGFR;VEGFA
Oxyphilic Adenoma	3/67	2.8283417729648286E-5	1.95337080202357E-4	0	0	62.24375	651.8934130016395	CDH1;CAV1;ESR1
Multiple Sclerosis	7/1106	2.880416532033993E-5	1.9840309072650144E-4	0	0	10.933989577301679	114.31475772746745	NR4A1;AR;STAT1;CAV1;ESR1;EGFR;VEGFA
Squamous cell carcinoma of skin	4/205	2.9305158913732523E-5	2.0131708902705082E-4	0	0	28.117981520966595	293.4883768531646	CDKN1A;STAT1;EGFR;VEGFA
Precocious Puberty	3/68	2.9572170641587585E-5	2.0261251131888788E-4	0	0	61.283076923076926	639.101403760399	AR;CAV1;ESR1
Mucoepidermoid Carcinoma	3/69	3.089897793342267E-5	2.1114301587838824E-4	0	0	60.35151515151515	626.7376572061125	CDH1;EGFR;VEGFA
Adenoid Cystic Carcinoma	4/208	3.1019517985521164E-5	2.1140742732612445E-4	0	0	27.70028011204482	287.55366992831864	PRKDC;CDH1;NFIB;EGFR
Germ cell tumor	4/210	3.220262534093411E-5	2.1774707134982412E-4	0	0	27.428571428571427	283.70640209582655	AR;ESR1;EGFR;VEGFA
Glomerulonephritis	4/210	3.220262534093411E-5	2.1774707134982412E-4	0	0	27.428571428571427	283.70640209582655	JUN;STAT1;ESR1;VEGFA
Neurofibromatosis 1	4/210	3.220262534093411E-5	2.1774707134982412E-4	0	0	27.428571428571427	283.70640209582655	AR;EPAS1;ESR1;EGFR
Neurofibromatoses	3/71	3.3668850292685725E-5	2.2706694596868728E-4	0	0	58.57058823529412	603.2148259168996	AR;EGFR;VEGFA
Carcinoid Tumor	4/213	3.4039000481828584E-5	2.289654641785501E-4	0	0	27.03075871496924	278.0925434498259	JUN;CDKN1A;EGFR;VEGFA
Bile Duct Neoplasms	2/10	3.427837406961788E-5	2.2938093321715796E-4	0	0	312.09375	3208.634562990342	CDKN1A;EGFR
Denys-Drash Syndrome	2/10	3.427837406961788E-5	2.2938093321715796E-4	0	0	312.09375	3208.634562990342	EGFR;VEGFA
Aortic Valve Insufficiency	4/214	3.46678671486819E-5	2.3138785748073735E-4	0	0	26.900680272108843	276.2618440644177	JUN;CAV1;ESR1;VEGFA
Rectal Neoplasms	3/72	3.511295954409851E-5	2.3375457345981043E-4	0	0	57.71884057971015	592.0187007331773	CDH1;EGFR;VEGFA
Restenosis	4/215	3.530522385785943E-5	2.3443031677339567E-4	0	0	26.77183480027082	274.4509188538649	NR4A1;JUN;ESR1;VEGFA
Adenocarcinoma of prostate	4/216	3.595114248530108E-5	2.381071821526479E-4	0	0	26.644204851752022	272.6594655788251	AR;ESR1;EGFR;VEGFA
Infertility	3/73	3.6597211534267284E-5	2.4059162989269368E-4	0	0	56.89142857142857	581.1765793492738	AR;ESR1;VEGFA
Dysplastic Nevus	3/73	3.6597211534267284E-5	2.4059162989269368E-4	0	0	56.89142857142857	581.1765793492738	CDKN1A;STAT1;EGFR
Severe Combined Immunodeficiency	4/217	3.660569514046791E-5	2.4059162989269368E-4	0	0	26.517773306505703	270.8871879828486	STAT1;PRKDC;PIK3R1;VEGFA
Hamartoma	3/74	3.812212524462508E-5	2.4992246067732633E-4	0	0	56.08732394366197	570.6725771438854	CDKN1A;EGFR;VEGFA
Cerebrovascular accident	6/768	3.9266797553008804E-5	2.567750331124601E-4	0	0	12.611548556430446	127.94581527175919	STAT1;CAV1;HBB;PIK3R1;ESR1;VEGFA
Eczema	5/454	3.95625297744737E-5	2.5805559193804435E-4	0	0	16.73205413739935	169.6233422854922	JUN;STAT1;CDH1;EGFR;VEGFA
Breast Fibrocystic Disease	3/75	3.968821839085072E-5	2.582233453490363E-4	0	0	55.30555555555556	560.4917293042834	AR;ESR1;EGFR
Cholangiocarcinoma	5/455	3.998018124351218E-5	2.594693672160602E-4	0	0	16.694017094017095	169.06242616875207	STAT1;CDH1;ESR1;EGFR;VEGFA
Acromegaly	3/76	4.12960074597834E-5	2.6733731145017677E-4	0	0	54.54520547945206	550.6199257975323	CDKN1A;CAV1;VEGFA
Sinonasal undifferentiated carcinoma	2/11	4.187352980469567E-5	2.675763936346067E-4	0	0	277.40277777777777	2796.4576447395143	EGFR;VEGFA
Hyperoxia	2/11	4.187352980469567E-5	2.675763936346067E-4	0	0	277.40277777777777	2796.4576447395143	CDKN1A;JUN
Bilateral pheochromocytoma and islet cell adenoma of the pancreas	2/11	4.187352980469567E-5	2.675763936346067E-4	0	0	277.40277777777777	2796.4576447395143	EPAS1;VEGFA
Nasopharyngeal Angiofibroma	2/11	4.187352980469567E-5	2.675763936346067E-4	0	0	277.40277777777777	2796.4576447395143	AR;VEGFA
Non-Hereditary Clear Cell Renal Cell Carcinoma	2/11	4.187352980469567E-5	2.675763936346067E-4	0	0	277.40277777777777	2796.4576447395143	EPAS1;VEGFA
Exanthema	4/225	4.216166945771774E-5	2.675763936346067E-4	0	0	25.547511312217196	257.36560485192757	STAT1;PIK3R1;EGFR;VEGFA
Gastrointestinal Carcinoid Tumor	4/225	4.216166945771774E-5	2.675763936346067E-4	0	0	25.547511312217196	257.36560485192757	STAT1;ESR1;EGFR;VEGFA
Pulmonary Emphysema	4/225	4.216166945771774E-5	2.675763936346067E-4	0	0	25.547511312217196	257.36560485192757	JUN;EPAS1;CAV1;VEGFA
Graft-vs-Host Disease	4/226	4.2897210626416407E-5	2.699015519546215E-4	0	0	25.43114543114543	255.75349573882582	STAT1;CAV1;EGFR;VEGFA
High-Grade Prostatic Intraepithelial Neoplasia	3/77	4.2946007686159284E-5	2.699015519546215E-4	0	0	53.8054054054054	541.043851830327	CAV1;PIM1;EGFR
Non-small cell lung cancer stage I	3/77	4.2946007686159284E-5	2.699015519546215E-4	0	0	53.8054054054054	541.043851830327	ESR1;EGFR;VEGFA
Parathyroid Adenoma	3/77	4.2946007686159284E-5	2.699015519546215E-4	0	0	53.8054054054054	541.043851830327	CDKN1A;CAV1;ESR1
Giant Cell Glioblastoma	3/78	4.463873306577501E-5	2.7850687804081365E-4	0	0	53.08533333333333	531.7509331385238	PIM1;EGFR;VEGFA
Pleural Effusion, Malignant	3/78	4.463873306577501E-5	2.7850687804081365E-4	0	0	53.08533333333333	531.7509331385238	ESR1;EGFR;VEGFA
Androgen-Insensitivity Syndrome	3/78	4.463873306577501E-5	2.7850687804081365E-4	0	0	53.08533333333333	531.7509331385238	AR;ESR1;EGFR
Anemia, Sickle Cell	4/231	4.67169237841486E-5	2.9077063646856826E-4	0	0	24.86469477658905	247.9359185770597	JUN;EPAS1;HBB;VEGFA
Diabetes Mellitus, Non-Insulin-Dependent	8/1672	4.783363665594138E-5	2.9685641682089786E-4	0	0	8.80673076923077	87.60743315931401	AR;CDKN1A;EPAS1;CAV1;PIK3R1;ESR1;EGFR;VEGFA
Extrahepatic Cholangiocarcinoma	3/80	4.8154409077799535E-5	2.9685641682089786E-4	0	0	51.701298701298704	513.9676695829695	CDH1;EGFR;VEGFA
Luminal B Breast Carcinoma	3/80	4.8154409077799535E-5	2.9685641682089786E-4	0	0	51.701298701298704	513.9676695829695	CDH1;ESR1;EGFR
Paroxysmal kinesigenic choreoathetosis	3/80	4.8154409077799535E-5	2.9685641682089786E-4	0	0	51.701298701298704	513.9676695829695	JUN;EGFR;VEGFA
Hamman-Rich syndrome	4/233	4.831248014676005E-5	2.9712175290257434E-4	0	0	24.64504054897068	244.91799270405573	CDKN1A;CAV1;EGFR;VEGFA
Hepatoblastoma	4/235	4.994761282643948E-5	3.044673572345054E-4	0	0	24.429189857761287	241.95978661720616	CDKN1A;ESR1;EGFR;VEGFA
Neoplasms, Experimental	3/81	4.997838152049178E-5	3.044673572345054E-4	0	0	51.03589743589744	505.45544613076794	EPAS1;CDH1;VEGFA
Peptic Ulcer	3/81	4.997838152049178E-5	3.044673572345054E-4	0	0	51.03589743589744	505.45544613076794	CDKN1A;EGFR;VEGFA
Primary immune deficiency disorder	3/81	4.997838152049178E-5	3.044673572345054E-4	0	0	51.03589743589744	505.45544613076794	STAT1;PRKDC;PIK3R1
Hyaline Membrane Disease	2/12	5.022152730310081E-5	3.045122183659845E-4	0	0	249.65	2471.3020247349314	EPAS1;VEGFA
Acute mountain sickness	2/12	5.022152730310081E-5	3.045122183659845E-4	0	0	249.65	2471.3020247349314	EPAS1;VEGFA
Malignant neoplasm of tongue	3/82	5.1847122736150155E-5	3.1363259491212146E-4	0	0	50.3873417721519	497.1825388851601	CAV1;EZR;VEGFA
Medullary carcinoma of thyroid	4/239	5.333904831390684E-5	3.21903649053321E-4	0	0	24.00851063829787	236.21593997460735	JUN;ESR1;EGFR;VEGFA
Pain	5/485	5.419289404121631E-5	3.2629427810830237E-4	0	0	15.626602564102564	153.4995038674967	AR;HBB;ESR1;EGFR;VEGFA
Chondrosarcoma	4/241	5.509658011475255E-5	3.30963875433502E-4	0	0	23.803496081977094	233.42714933102332	CDKN1A;EPAS1;EGFR;VEGFA
Psoriasis	6/818	5.590303798150299E-5	3.3502911161536477E-4	0	0	11.804187192118226	115.58532415654186	JUN;CDKN1A;EPAS1;CAV1;EGFR;VEGFA
Breast Neoplasms, Male	2/13	5.932115701720912E-5	3.522449392539107E-4	0	0	226.9431818181818	2208.734624235031	AR;ESR1
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma	2/13	5.932115701720912E-5	3.522449392539107E-4	0	0	226.9431818181818	2208.734624235031	STAT1;EGFR
cancer angiogenesis	2/13	5.932115701720912E-5	3.522449392539107E-4	0	0	226.9431818181818	2208.734624235031	AR;VEGFA
Cerebral metastasis	2/13	5.932115701720912E-5	3.522449392539107E-4	0	0	226.9431818181818	2208.734624235031	EGFR;VEGFA
Gastroesophageal reflux disease	4/246	5.9675672710683443E-5	3.5353729956810856E-4	0	0	23.305785123966942	226.68572593692946	CAV1;EZR;EGFR;VEGFA
Congenital chromosomal disease	5/497	6.0865639412592976E-5	3.597618915394226E-4	0	0	15.236085053158224	147.89426658791905	AR;EPAS1;CDH1;EGFR;VEGFA
Amyloidosis	6/833	6.187097583823635E-5	3.6326426324884094E-4	0	0	11.581015719467956	112.22536236403806	PRKDC;NFIB;CAV1;ESR1;EGFR;VEGFA
Malignant Childhood Neoplasm	3/87	6.188009130061557E-5	3.6326426324884094E-4	0	0	47.37619047619047	459.0900697773556	EZR;ESR1;VEGFA
Chronic active hepatitis	3/87	6.188009130061557E-5	3.6326426324884094E-4	0	0	47.37619047619047	459.0900697773556	AR;STAT1;ESR1
Iron Overload	3/88	6.402806649405614E-5	3.7417306731707465E-4	0	0	46.8164705882353	452.06868980007044	EPAS1;HBB;VEGFA
Chordoma	3/88	6.402806649405614E-5	3.7417306731707465E-4	0	0	46.8164705882353	452.06868980007044	AR;ESR1;EGFR
Malignant neoplasm of thyroid	5/505	6.565663109451432E-5	3.8282410410187467E-4	0	0	14.986153846153845	144.3327260291802	JUN;CDKN1A;CAV1;EGFR;VEGFA
Bronchioloalveolar Adenocarcinoma	3/89	6.622433947422104E-5	3.8526456950881296E-4	0	0	46.269767441860466	445.22910194588906	CAV1;EGFR;VEGFA
Myxoma of heart	2/14	6.917121064943945E-5	4.0150390361236424E-4	0	0	208.02083333333334	1992.6161300549122	EGFR;VEGFA
Embryonal Rhabdomyosarcoma	3/91	7.076377456637316E-5	4.098269724326051E-4	0	0	45.21363636363636	432.06889459705354	PRKDC;ESR1;EGFR
Adenoma of large intestine	4/258	7.179612720519493E-5	4.1487560754142845E-4	0	0	22.191226096737907	211.7415787111765	CDH1;ESR1;EGFR;VEGFA
Adrenal Cortical Adenoma	3/92	7.310793154352946E-5	4.2151291780566206E-4	0	0	44.70337078651686	425.73584607558536	CDKN1A;ESR1;EGFR
Malignant Pleural Mesothelioma	4/260	7.397845489592043E-5	4.255820690337694E-4	0	0	22.015625	209.40682734383697	JUN;STAT1;EGFR;VEGFA
Osteoarthritis, Knee	3/93	7.550237601954301E-5	4.324226990210191E-4	0	0	44.20444444444445	419.5596960451344	AR;EPAS1;ESR1
Mucinous Adenocarcinoma	3/93	7.550237601954301E-5	4.324226990210191E-4	0	0	44.20444444444445	419.5596960451344	ESR1;EGFR;VEGFA
Traditional Serrated Adenoma	3/94	7.794760240599194E-5	4.4445619650039113E-4	0	0	43.716483516483514	413.53492700023463	AR;JUN;EGFR
airway disease	3/94	7.794760240599194E-5	4.4445619650039113E-4	0	0	43.716483516483514	413.53492700023463	EZR;EGFR;VEGFA
Brain Ischemia	4/264	7.848800291352012E-5	4.465517875013711E-4	0	0	21.672527472527474	204.86096974998347	JUN;EPAS1;CAV1;VEGFA
Stage 0 Breast Carcinoma	2/15	7.977048122143578E-5	4.5086904375266654E-4	0	0	192.0096153846154	1811.8712842401887	EGFR;VEGFA
Sudden sensorineural hearing loss	2/15	7.977048122143578E-5	4.5086904375266654E-4	0	0	192.0096153846154	1811.8712842401887	CAV1;ESR1
Uterine Corpus Carcinosarcoma	2/15	7.977048122143578E-5	4.5086904375266654E-4	0	0	192.0096153846154	1811.8712842401887	EGFR;VEGFA
Limb ischemia	3/95	8.044410386146925E-5	4.5368366872090626E-4	0	0	43.23913043478261	407.6562722964439	AR;EZR;VEGFA
Idiopathic pulmonary hypertension	3/96	8.299237239090204E-5	4.660202127949999E-4	0	0	42.77204301075269	401.91870215095247	AR;CAV1;VEGFA
IMMUNE SUPPRESSION	3/96	8.299237239090204E-5	4.660202127949999E-4	0	0	42.77204301075269	401.91870215095247	STAT1;EGFR;VEGFA
Neoplasms, Intracranial	3/97	8.559289873755705E-5	4.7854211566906893E-4	0	0	42.314893617021276	396.31741067252864	ESR1;EGFR;VEGFA
Ductal Breast Carcinoma	3/97	8.559289873755705E-5	4.7854211566906893E-4	0	0	42.314893617021276	396.31741067252864	ESR1;EGFR;VEGFA
Congestive heart failure	6/884	8.611246479917883E-5	4.804071200351597E-4	0	0	10.879271070615035	101.82841480338664	NR4A1;CDKN1A;PIM1;ESR1;EGFR;VEGFA
Hypercalcemia	3/98	8.824617249269276E-5	4.912497059237616E-4	0	0	41.86736842105263	390.8478036191733	CDKN1A;ESR1;EGFR
Retinoblastoma	5/539	8.937137695561971E-5	4.964435842502488E-4	0	0	14.00749063670412	130.58777436905973	CDKN1A;CAV1;ESR1;EGFR;VEGFA
Serous cystadenocarcinoma ovary	2/16	9.11177629974979E-5	4.996967766932847E-4	0	0	178.28571428571428	1658.6557887027404	ESR1;VEGFA
Skin Manifestations	2/16	9.11177629974979E-5	4.996967766932847E-4	0	0	178.28571428571428	1658.6557887027404	EGFR;VEGFA
Growth hormone excess	2/16	9.11177629974979E-5	4.996967766932847E-4	0	0	178.28571428571428	1658.6557887027404	CDKN1A;CAV1
BREAST CANCER 3	2/16	9.11177629974979E-5	4.996967766932847E-4	0	0	178.28571428571428	1658.6557887027404	ESR1;VEGFA
Myxoma of the Endocardium	2/16	9.11177629974979E-5	4.996967766932847E-4	0	0	178.28571428571428	1658.6557887027404	EGFR;VEGFA
Choroidal Neovascularization	2/16	9.11177629974979E-5	4.996967766932847E-4	0	0	178.28571428571428	1658.6557887027404	EPAS1;VEGFA
Rectal Carcinoma	4/276	9.322316201581096E-5	5.101598039975418E-4	0	0	20.70378151260504	192.1417413786655	AR;CDKN1A;EGFR;VEGFA
Rhinitis	3/100	9.371291441807692E-5	5.106760716073685E-4	0	0	41.0	380.2862565875762	AR;EGFR;VEGFA
Rash and Dermatitis Adverse Event Associated with Chemoradiation	3/100	9.371291441807692E-5	5.106760716073685E-4	0	0	41.0	380.2862565875762	ESR1;EGFR;VEGFA
Fibrosis, Liver	5/545	9.41659562207402E-5	5.120645577224672E-4	0	0	13.847578347578347	128.3733081806154	CDKN1A;STAT1;HBB;EGFR;VEGFA
Metabolic Syndrome X	5/548	9.663662971716418E-5	5.243958289063762E-4	0	0	13.768947442980592	127.28776024641381	AR;CAV1;PIK3R1;ESR1;VEGFA
Acute lymphocytic leukemia	6/907	9.928714630562438E-5	5.37115346087481E-4	0	0	10.588790233074361	97.60211508207682	JUN;CDKN1A;STAT1;PIM1;ESR1;VEGFA
Adult Acute Myeloblastic Leukemia	3/102	9.939649068130696E-5	5.37115346087481E-4	0	0	40.16767676767677	370.2011251113072	ESR1;EGFR;VEGFA
Inflammatory Bowel Diseases	6/911	1.0173507208509819E-4	5.486047832897883E-4	0	0	10.539779005524862	96.89364769447707	NR4A1;CDKN1A;EZR;ESR1;EGFR;VEGFA
Hypopharyngeal Carcinoma	2/17	1.0321185160705684E-4	5.554087764604747E-4	0	0	166.39166666666668	1527.2636618368022	CAV1;EGFR
Malignant Testicular Germ Cell Tumor	3/106	1.1142962034774952E-4	5.983840111397859E-4	0	0	38.6	351.34173063651644	AR;CDKN1A;ESR1
Dermatitis, Allergic Contact	3/107	1.1457945316762028E-4	6.1402225629038E-4	0	0	38.22692307692308	346.88035326593445	PIM1;EGFR;VEGFA
Venous malformation	2/18	1.1605154390748581E-4	6.155259505401146E-4	0	0	155.984375	1413.4486893926328	STAT1;VEGFA
Malignant neoplasm tonsil	2/18	1.1605154390748581E-4	6.155259505401146E-4	0	0	155.984375	1413.4486893926328	CDH1;EGFR
Nongerminomatous Germ Cell Tumor	2/18	1.1605154390748581E-4	6.155259505401146E-4	0	0	155.984375	1413.4486893926328	ESR1;EGFR
Papillomatosis	2/18	1.1605154390748581E-4	6.155259505401146E-4	0	0	155.984375	1413.4486893926328	CDKN1A;EGFR
Disease due to Papilloma virus	2/18	1.1605154390748581E-4	6.155259505401146E-4	0	0	155.984375	1413.4486893926328	CDKN1A;ESR1
Secondary Neoplasm	3/108	1.1778686314595221E-4	6.209050357265196E-4	0	0	37.860952380952384	342.5141719356897	AR;ESR1;EGFR
Severe myopia	3/108	1.1778686314595221E-4	6.209050357265196E-4	0	0	37.860952380952384	342.5141719356897	JUN;ESR1;VEGFA
Tumor Promotion	3/108	1.1778686314595221E-4	6.209050357265196E-4	0	0	37.860952380952384	342.5141719356897	JUN;STAT1;ESR1
Pituitary Adenoma	4/294	1.1897589910749935E-4	6.258956158750933E-4	0	0	19.400985221674876	175.3187415530873	CDH1;ESR1;EGFR;VEGFA
Mental Depression	5/575	1.2120015027435969E-4	6.363007889403884E-4	0	0	13.098515519568151	118.1232937578376	AR;JUN;ESR1;EGFR;VEGFA
Kidney Failure	4/297	1.2372348156650554E-4	6.482307360776548E-4	0	0	19.199414919551437	172.745995982339	CAV1;HBB;EGFR;VEGFA
Reperfusion Injury	3/110	1.2437631910306414E-4	6.490182469559892E-4	0	0	37.149532710280376	334.0559818489225	JUN;CDKN1A;CAV1
Luminal A Breast Carcinoma	3/110	1.2437631910306414E-4	6.490182469559892E-4	0	0	37.149532710280376	334.0559818489225	AR;ESR1;EGFR
Arteriovenous Malformations, Cerebral	2/19	1.2963563814508892E-4	6.670295883043121E-4	0	0	146.8014705882353	1313.9880817962558	EGFR;VEGFA
Melanoma, Amelanotic	2/19	1.2963563814508892E-4	6.670295883043121E-4	0	0	146.8014705882353	1313.9880817962558	CAV1;VEGFA
Papilloma, Squamous Cell	2/19	1.2963563814508892E-4	6.670295883043121E-4	0	0	146.8014705882353	1313.9880817962558	CDKN1A;EGFR
ABLEPHARON-MACROSTOMIA SYNDROME	2/19	1.2963563814508892E-4	6.670295883043121E-4	0	0	146.8014705882353	1313.9880817962558	EPAS1;VEGFA
Angiolymphoid hyperplasia	2/19	1.2963563814508892E-4	6.670295883043121E-4	0	0	146.8014705882353	1313.9880817962558	AR;VEGFA
Lobular Neoplasia	2/19	1.2963563814508892E-4	6.670295883043121E-4	0	0	146.8014705882353	1313.9880817962558	CDH1;ESR1
Parathyroid hyperplasia	2/19	1.2963563814508892E-4	6.670295883043121E-4	0	0	146.8014705882353	1313.9880817962558	CDKN1A;EGFR
Lipodystrophy	3/113	1.347042039591539E-4	6.917315284820965E-4	0	0	36.13090909090909	322.0141715616055	CAV1;PIK3R1;ESR1
Testicular Germ Cell Tumor	3/114	1.3826704047066986E-4	7.072153772984956E-4	0	0	35.803603603603605	318.1624100587182	AR;CDKN1A;ESR1
leiomyosarcoma	3/114	1.3826704047066986E-4	7.072153772984956E-4	0	0	35.803603603603605	318.1624100587182	CDH1;ESR1;VEGFA
Malignant neoplasm of skin	4/307	1.4054723463566908E-4	7.16273622627584E-4	0	0	18.556341348420556	164.5941342156948	AR;JUN;EGFR;VEGFA
Myocardial Infarction	6/966	1.4059261582353275E-4	7.16273622627584E-4	0	0	9.907291666666667	87.87415106835084	AR;CDKN1A;EPAS1;CAV1;ESR1;VEGFA
Carcinoma, Cribriform	3/115	1.4189076431477682E-4	7.186349886766049E-4	0	0	35.482142857142854	314.38786131738334	ESR1;EGFR;VEGFA
Carcinoma, Granular Cell	3/115	1.4189076431477682E-4	7.186349886766049E-4	0	0	35.482142857142854	314.38786131738334	ESR1;EGFR;VEGFA
Pancreatic intraepithelial neoplasia	3/115	1.4189076431477682E-4	7.186349886766049E-4	0	0	35.482142857142854	314.38786131738334	CDKN1A;EPAS1;EGFR
Adenocarcinoma of lung, stage I	2/20	1.4396293387323563E-4	7.227466605403601E-4	0	0	138.63888888888889	1226.393330101256	EGFR;VEGFA
Carcinoma ex pleomorphic adenoma	2/20	1.4396293387323563E-4	7.227466605403601E-4	0	0	138.63888888888889	1226.393330101256	AR;EGFR
Congenital abnormality of vein	2/20	1.4396293387323563E-4	7.227466605403601E-4	0	0	138.63888888888889	1226.393330101256	STAT1;VEGFA
Endometrial Endometrioid Adenocarcinoma	2/20	1.4396293387323563E-4	7.227466605403601E-4	0	0	138.63888888888889	1226.393330101256	ESR1;VEGFA
Peripheral Neuropathy	4/309	1.4410163769968464E-4	7.227466605403601E-4	0	0	18.432786885245903	163.0378468235646	AR;JUN;EGFR;VEGFA
Familial (FPAH)	3/116	1.455758436490831E-4	7.273160621771406E-4	0	0	35.16637168141593	310.68832982513663	CDH1;ESR1;EGFR
Condition, Preneoplastic	3/116	1.455758436490831E-4	7.273160621771406E-4	0	0	35.16637168141593	310.68832982513663	CDH1;PIM1;VEGFA
Kidney Failure, Acute	4/310	1.4590312594336244E-4	7.275439658527128E-4	0	0	18.371615312791782	162.26853559374524	AR;EPAS1;EGFR;VEGFA
Adenocarcinoma, Basal Cell	3/117	1.4932274552258693E-4	7.417320224708501E-4	0	0	34.85614035087719	307.0617008363335	ESR1;EGFR;VEGFA
Leukemia, B-Cell	3/117	1.4932274552258693E-4	7.417320224708501E-4	0	0	34.85614035087719	307.0617008363335	NR4A1;CDKN1A;PIM1
Fibrolamellar Hepatocellular Carcinoma	2/21	1.590322318968525E-4	7.884457869281574E-4	0	0	131.33552631578948	1148.7135280506445	CDH1;EGFR
Hypodontia	3/121	1.6493787707205012E-4	8.161581158565238E-4	0	0	33.66779661016949	293.24454421291085	CDH1;PIK3R1;EGFR
Adenocarcinoma, Oxyphilic	3/122	1.6900085555594712E-4	8.330710112614721E-4	0	0	33.38319327731092	289.95328988725134	ESR1;EGFR;VEGFA
Gastrointestinal Neoplasms	3/122	1.6900085555594712E-4	8.330710112614721E-4	0	0	33.38319327731092	289.95328988725134	CDH1;EGFR;VEGFA
Barrett Esophagus	4/323	1.7083966412402885E-4	8.405311474902219E-4	0	0	17.61128526645768	152.77411463421114	CAV1;ESR1;EGFR;VEGFA
T-Cell Lymphoma	4/324	1.7287774664634007E-4	8.489414821055065E-4	0	0	17.555357142857144	152.08075772650633	CAV1;PIM1;EGFR;VEGFA
Breast cancer, lobular	2/22	1.7484233445803956E-4	8.537197540739437E-4	0	0	124.7625	1079.398480851498	CDH1;EGFR
Squamous cell carcinoma of tonsil	2/22	1.7484233445803956E-4	8.537197540739437E-4	0	0	124.7625	1079.398480851498	EGFR;VEGFA
Basal-Like Breast Carcinoma	2/22	1.7484233445803956E-4	8.537197540739437E-4	0	0	124.7625	1079.398480851498	ESR1;EGFR
Hypertrophic Cardiomyopathy	4/328	1.8120683722782065E-4	8.816149220978158E-4	0	0	17.335097001763668	149.3569670288241	AR;CAV1;ESR1;VEGFA
Adenocarcinoma, Tubular	3/125	1.8157922514751762E-4	8.816149220978158E-4	0	0	32.557377049180324	280.4433366500785	ESR1;EGFR;VEGFA
Familial M??ni??re disease	3/125	1.8157922514751762E-4	8.816149220978158E-4	0	0	32.557377049180324	280.4433366500785	AR;CAV1;ESR1
Laryngeal Squamous Cell Carcinoma	3/126	1.8590335200614834E-4	9.00916244337488E-4	0	0	32.291056910569104	277.3893376442282	CDKN1A;EZR;EGFR
Renal glomerular disease	3/127	1.9029390727843949E-4	9.187460981312321E-4	0	0	32.02903225806452	274.39082325464415	EPAS1;HBB;VEGFA
Gastritis, Atrophic	3/127	1.9029390727843949E-4	9.187460981312321E-4	0	0	32.02903225806452	274.39082325464415	CDH1;EGFR;VEGFA
Granuloma	2/23	1.91392045018297E-4	9.188952644651695E-4	0	0	118.81547619047619	1017.2014676113489	CDKN1A;VEGFA
Varicocele	2/23	1.91392045018297E-4	9.188952644651695E-4	0	0	118.81547619047619	1017.2014676113489	AR;STAT1
Cholesteatoma	2/23	1.91392045018297E-4	9.188952644651695E-4	0	0	118.81547619047619	1017.2014676113489	CDKN1A;VEGFA
Ependymoma	3/128	1.947513451571266E-4	9.332889138049314E-4	0	0	31.7712	271.4463644586381	CAV1;EGFR;VEGFA
Mood Disorders	4/336	1.9873270077537829E-4	9.506047520422261E-4	0	0	16.910499139414803	144.13748237514534	AR;PIK3R1;ESR1;VEGFA
Familial primary pulmonary hypertension	2/24	2.0868016842799032E-4	9.89029128531191E-4	0	0	113.4090909090909	961.1089042220101	CAV1;HBB
Stage III Colon Cancer	2/24	2.0868016842799032E-4	9.89029128531191E-4	0	0	113.4090909090909	961.1089042220101	EGFR;VEGFA
Uterine Neoplasms	2/24	2.0868016842799032E-4	9.89029128531191E-4	0	0	113.4090909090909	961.1089042220101	ESR1;EGFR
bilateral breast cancer	2/24	2.0868016842799032E-4	9.89029128531191E-4	0	0	113.4090909090909	961.1089042220101	AR;ESR1
Bronchitis	2/24	2.0868016842799032E-4	9.89029128531191E-4	0	0	113.4090909090909	961.1089042220101	EGFR;VEGFA
Mouth Neoplasms	3/132	2.1325896706951106E-4	0.0010088789595980715	0	0	30.77984496124031	260.182131736099	CDKN1A;CAV1;EGFR
Enterocolitis	2/25	2.267055108576553E-4	0.0010666308461663456	0	0	108.47282608695652	910.288628412586	STAT1;VEGFA
Non-infiltrating lobular carcinoma	2/25	2.267055108576553E-4	0.0010666308461663456	0	0	108.47282608695652	910.288628412586	CDH1;ESR1
Pulmonary Sclerosing Hemangioma	2/25	2.267055108576553E-4	0.0010666308461663456	0	0	108.47282608695652	910.288628412586	AR;EGFR
Neurilemmoma	3/135	2.2786403679955853E-4	0.001070132376460472	0	0	30.075757575757574	252.2382038162528	EZR;EGFR;VEGFA
Ewings sarcoma	4/352	2.374225890893037E-4	0.00111299917897944	0	0	16.119868637110017	134.53108681294873	STAT1;CAV1;EZR;VEGFA
Adenocarcinoma of pancreas	4/354	2.4261462999688627E-4	0.001135278241452821	0	0	16.026122448979592	133.40202434456586	NR4A1;CDKN1A;EGFR;VEGFA
Metastatic osteosarcoma	2/26	2.4546687981125164E-4	0.0011444782500946984	0	0	103.94791666666667	864.0513121915725	EZR;EGFR
Carotid Artery Plaque	2/26	2.4546687981125164E-4	0.0011444782500946984	0	0	103.94791666666667	864.0513121915725	STAT1;VEGFA
Chronic Obstructive Airway Disease	5/669	2.459645668010795E-4	0.0011447323892742132	0	0	11.189759036144578	92.99051266357843	EPAS1;STAT1;CAV1;EGFR;VEGFA
Differentiated Thyroid Gland Carcinoma	3/139	2.483261720567274E-4	0.0011536447885297247	0	0	29.185294117647057	242.26033989810892	CAV1;EGFR;VEGFA
Presenile dementia	4/362	2.642065643563404E-4	0.0012156299221651294	0	0	15.661612130885874	129.03256614213922	CDKN1A;STAT1;ESR1;VEGFA
Episodic abdominal pain	2/27	2.649630840801269E-4	0.0012156299221651294	0	0	99.785	821.821281893882	CDKN1A;ESR1
Intermittent abdominal pain	2/27	2.649630840801269E-4	0.0012156299221651294	0	0	99.785	821.821281893882	CDKN1A;ESR1
Intracranial Astrocytoma	2/27	2.649630840801269E-4	0.0012156299221651294	0	0	99.785	821.821281893882	AR;ESR1
Lobular carcinoma in situ of breast	2/27	2.649630840801269E-4	0.0012156299221651294	0	0	99.785	821.821281893882	CDH1;ESR1
Cervical dysplasia	2/27	2.649630840801269E-4	0.0012156299221651294	0	0	99.785	821.821281893882	ESR1;EGFR
Childhood Cerebral Astrocytoma	2/27	2.649630840801269E-4	0.0012156299221651294	0	0	99.785	821.821281893882	AR;ESR1
Thrombocythemia, Essential	3/145	2.8119541352467596E-4	0.0012878151651316277	0	0	27.943661971830984	228.48025416507025	AR;STAT1;VEGFA
Liposarcoma, well differentiated	2/28	2.851929338387316E-4	0.0012992122541542216	0	0	95.9423076923077	783.1141815068878	JUN;EGFR
Cerebral Astrocytoma	2/28	2.851929338387316E-4	0.0012992122541542216	0	0	95.9423076923077	783.1141815068878	AR;ESR1
Condylomata Acuminata	2/28	2.851929338387316E-4	0.0012992122541542216	0	0	95.9423076923077	783.1141815068878	JUN;STAT1
Depressive Symptoms	3/147	2.927460921358749E-4	0.001331273161948882	0	0	27.552777777777777	224.17504568500033	AR;ESR1;EGFR
Female sterility	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	AR;ESR1
Head Neoplasms	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	EGFR;VEGFA
Hereditary hemorrhagic telangiectasia	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	EGFR;VEGFA
Sterility, Postpartum	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	AR;ESR1
Subfertility, Female	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	AR;ESR1
Upper Aerodigestive Tract Neoplasms	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	EGFR;VEGFA
Infection of bone	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	HBB;PIK3R1
Intermittent Claudication	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	EPAS1;VEGFA
Angiofibroma	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	CDKN1A;ESR1
Breast cancer recurrent	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	ESR1;EGFR
Paget Disease Extramammary	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	AR;CDH1
Primary peritoneal carcinoma	2/29	3.0615524060429166E-4	0.0013634465284153197	0	0	92.38425925925925	747.5196825305202	EGFR;VEGFA
Hyperinsulinism	4/377	3.0838291060588876E-4	0.0013710035423322043	0	0	15.02029873611643	121.4266233630381	STAT1;CAV1;ESR1;VEGFA
Idiopathic Pulmonary Fibrosis	4/379	3.1465068820118975E-4	0.00139646516773827	0	0	14.938666666666666	120.46611700103841	CDKN1A;CAV1;EGFR;VEGFA
Glaucoma	4/381	3.2100979878349543E-4	0.0014222440999275621	0	0	14.857900719969685	119.51753150484814	CDKN1A;CAV1;PIK3R1;VEGFA
Osteochondrodysplasias	3/152	3.229555286257611E-4	0.001428414606918392	0	0	26.621476510067115	213.9833197451719	STAT1;EGFR;VEGFA
Carcinoma, Signet Ring Cell	2/30	3.2784881716921787E-4	0.0014353110080476098	0	0	89.08035714285714	714.6879621205851	CDH1;ESR1
Optic Atrophy, Autosomal Dominant	2/30	3.2784881716921787E-4	0.0014353110080476098	0	0	89.08035714285714	714.6879621205851	CDKN1A;CDH1
Cancer of Head	2/30	3.2784881716921787E-4	0.0014353110080476098	0	0	89.08035714285714	714.6879621205851	EGFR;VEGFA
Cancer of Neck	2/30	3.2784881716921787E-4	0.0014353110080476098	0	0	89.08035714285714	714.6879621205851	EGFR;VEGFA
Prostatic Hypertrophy	2/30	3.2784881716921787E-4	0.0014353110080476098	0	0	89.08035714285714	714.6879621205851	AR;ESR1
Protoplasmic astrocytoma	2/30	3.2784881716921787E-4	0.0014353110080476098	0	0	89.08035714285714	714.6879621205851	AR;ESR1
Cervical Squamous Cell Carcinoma	3/153	3.2922931303196065E-4	0.0014389159315762342	0	0	26.442666666666668	212.03729330865093	CDH1;EGFR;VEGFA
Hepatitis C, Chronic	4/386	3.373123424939487E-4	0.0014717530078747795	0	0	14.659685863874346	117.19687658996172	STAT1;HBB;EGFR;VEGFA
Sebaceous Adenocarcinoma	2/31	3.5027247768592E-4	0.001515500519033051	0	0	86.00431034482759	684.3190276353239	CDKN1A;CDH1
Adenocarcinoma in Situ	2/31	3.5027247768592E-4	0.001515500519033051	0	0	86.00431034482759	684.3190276353239	CAV1;EGFR
Myxoma	2/31	3.5027247768592E-4	0.001515500519033051	0	0	86.00431034482759	684.3190276353239	STAT1;VEGFA
Pericardial effusion	2/31	3.5027247768592E-4	0.001515500519033051	0	0	86.00431034482759	684.3190276353239	EGFR;VEGFA
Endocrine Gland Neoplasms	2/31	3.5027247768592E-4	0.001515500519033051	0	0	86.00431034482759	684.3190276353239	ESR1;EGFR
Intestinal Neoplasms	3/158	3.617810855349489E-4	0.0015626764948775467	0	0	25.583225806451612	202.73353777323413	CDKN1A;EGFR;VEGFA
Gastrinoma	2/32	3.734250375722719E-4	0.0016049199202149388	0	0	83.13333333333334	656.1542143574874	CDH1;EGFR
Verrucous carcinoma	2/32	3.734250375722719E-4	0.0016049199202149388	0	0	83.13333333333334	656.1542143574874	CDH1;EGFR
Oropharyngeal disorders	2/32	3.734250375722719E-4	0.0016049199202149388	0	0	83.13333333333334	656.1542143574874	JUN;EGFR
Nephritis	3/162	3.892671636350549E-4	0.0016702277137364563	0	0	24.934591194968554	195.76757582179673	CAV1;ESR1;VEGFA
Depressive disorder	5/741	3.9464273262414473E-4	0.0016904845412407392	0	0	10.057483277591974	78.82582366120359	AR;HBB;ESR1;EGFR;VEGFA
Fibrillary Astrocytoma	2/33	3.973053137316762E-4	0.0016906748358631297	0	0	80.4475806451613	629.9693586370835	AR;ESR1
Trigeminal Neuralgia	2/33	3.973053137316762E-4	0.0016906748358631297	0	0	80.4475806451613	629.9693586370835	ESR1;EGFR
Meniere Disease	2/33	3.973053137316762E-4	0.0016906748358631297	0	0	80.4475806451613	629.9693586370835	CAV1;ESR1
Metabolic Bone Disorder	2/33	3.973053137316762E-4	0.0016906748358631297	0	0	80.4475806451613	629.9693586370835	ESR1;VEGFA
Bone Diseases	3/165	4.107419582330657E-4	0.0017449777600592247	0	0	24.469135802469136	190.7991968166656	CDKN1A;ESR1;EGFR
invasive cancer	3/166	4.1806628300213646E-4	0.001773177683078027	0	0	24.317791411042943	189.1892696346213	CDKN1A;ESR1;EGFR
Female infertility	2/34	4.219121242602919E-4	0.0017778124257166951	0	0	77.9296875	605.5692748599668	AR;ESR1
Sarcoma, Spindle Cell	2/34	4.219121242602919E-4	0.0017778124257166951	0	0	77.9296875	605.5692748599668	CDH1;VEGFA
Metastatic Carcinoma	2/34	4.219121242602919E-4	0.0017778124257166951	0	0	77.9296875	605.5692748599668	AR;EGFR
prostatitis	2/34	4.219121242602919E-4	0.0017778124257166951	0	0	77.9296875	605.5692748599668	AR;VEGFA
Papillary Renal Cell Carcinoma	3/169	4.405431845776743E-4	0.0018532948628080337	0	0	23.874698795180723	184.49178464758796	EPAS1;CDH1;VEGFA
Varicose Ulcer	2/35	4.472442885735218E-4	0.0018693074391349623	0	0	75.56439393939394	582.7832554136846	ESR1;VEGFA
Acanthosis Nigricans	2/35	4.472442885735218E-4	0.0018693074391349623	0	0	75.56439393939394	582.7832554136846	CAV1;ESR1
Neoplasm of uncertain or unknown behavior of ovary	2/35	4.472442885735218E-4	0.0018693074391349623	0	0	75.56439393939394	582.7832554136846	PIK3R1;ESR1
PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA	2/35	4.472442885735218E-4	0.0018693074391349623	0	0	75.56439393939394	582.7832554136846	EGFR;VEGFA
Cardiomyopathy, Dilated	4/419	4.602454948237358E-4	0.0019205397627297409	0	0	13.471256454388984	103.5097738732274	AR;ESR1;EGFR;VEGFA
Familial medullary thyroid carcinoma	2/36	4.7330062752558495E-4	0.001962336309628549	0	0	73.33823529411765	561.461379980425	EGFR;VEGFA
Germ Cell Cancer	2/36	4.7330062752558495E-4	0.001962336309628549	0	0	73.33823529411765	561.461379980425	ESR1;EGFR
Large cell neuroendocrine carcinoma	2/36	4.7330062752558495E-4	0.001962336309628549	0	0	73.33823529411765	561.461379980425	AR;EGFR
Ocular Hypertension	2/36	4.7330062752558495E-4	0.001962336309628549	0	0	73.33823529411765	561.461379980425	JUN;CDKN1A
ACTH-Secreting Pituitary Adenoma	2/37	5.000799632796284E-4	0.002066730472242048	0	0	71.23928571428571	541.471469858816	CDH1;EGFR
Atypical Lipoma	2/37	5.000799632796284E-4	0.002066730472242048	0	0	71.23928571428571	541.471469858816	JUN;EGFR
Hepatitis C	5/783	5.083385036208977E-4	0.002097505359189742	0	0	9.493771010480522	72.00420545500303	CDKN1A;STAT1;ESR1;EGFR;VEGFA
Cardiovascular Diseases	5/787	5.203375440397965E-4	0.0021435915091783	0	0	9.44324217981507	71.40066417933963	JUN;CAV1;HBB;ESR1;VEGFA
Lipoid nephrosis	2/38	5.275811191520497E-4	0.002166521511557622	0	0	69.25694444444444	522.6965599068795	CDKN1A;VEGFA
Comedone	2/38	5.275811191520497E-4	0.002166521511557622	0	0	69.25694444444444	522.6965599068795	ESR1;EGFR
Hepatitis, Chronic	3/183	5.557190013803392E-4	0.0022644147354368934	0	0	22.002222222222223	164.9121073688998	STAT1;CDH1;HBB
Neoplasm Invasiveness	3/183	5.557190013803392E-4	0.0022644147354368934	0	0	22.002222222222223	164.9121073688998	CDH1;ESR1;EGFR
Delayed bone age	3/183	5.557190013803392E-4	0.0022644147354368934	0	0	22.002222222222223	164.9121073688998	STAT1;PIK3R1;ESR1
Stage IV Ovarian Carcinoma	2/39	5.558029199639917E-4	0.0022644147354368934	0	0	67.38175675675676	505.03278857308806	EGFR;VEGFA
Adenocarcinoma of rectum	2/39	5.558029199639917E-4	0.0022644147354368934	0	0	67.38175675675676	505.03278857308806	CDKN1A;EGFR
Osteoporosis	4/441	5.58222975021381E-4	0.002270692825953114	0	0	12.7786858450474	95.72196755541182	AR;STAT1;HBB;ESR1
Ulcer	3/184	5.646119598089839E-4	0.0022930702707336563	0	0	21.879558011049724	163.64535048765396	CDKN1A;CDH1;VEGFA
Fatty Liver	4/443	5.678122897216093E-4	0.0023024476363436687	0	0	12.719166937845753	95.0594881256334	AR;EPAS1;EGFR;VEGFA
Malignant neoplasm of testis	3/185	5.735958383276149E-4	0.0023222539974925224	0	0	21.75824175824176	162.39449821584373	AR;CDKN1A;ESR1
HIV Infections	5/806	5.802982038613186E-4	0.00234571245786195	0	0	9.210121962930952	68.63353821438598	JUN;CDKN1A;STAT1;PIK3R1;EGFR
Chronic rejection of renal transplant	2/40	5.847441918510701E-4	0.002356309278551192	0	0	65.60526315789474	488.3876279088855	EGFR;VEGFA
Prostate cancer recurrent	2/40	5.847441918510701E-4	0.002356309278551192	0	0	65.60526315789474	488.3876279088855	AR;EGFR
Childhood Glioblastoma	3/187	5.918379149715654E-4	0.0023811796485538215	0	0	21.519565217391303	159.93938581613548	STAT1;EGFR;VEGFA
Familial Alzheimer Disease (FAD)	3/188	6.010968901257477E-4	0.0024071833599919475	0	0	21.402162162162163	158.73458084740201	NFIB;ESR1;VEGFA
Malignant Peripheral Nerve Sheath Tumor	3/188	6.010968901257477E-4	0.0024071833599919475	0	0	21.402162162162163	158.73458084740201	ESR1;EGFR;VEGFA
Dyspnea	3/188	6.010968901257477E-4	0.0024071833599919475	0	0	21.402162162162163	158.73458084740201	CAV1;HBB;EGFR
Adult Glioblastoma	3/189	6.104483395915748E-4	0.002437138818932271	0	0	21.286021505376343	157.5445904424033	STAT1;EGFR;VEGFA
Heart failure	5/815	6.104641176342158E-4	0.002437138818932271	0	0	9.103513770180436	67.37775491354294	NR4A1;CDKN1A;PIM1;EGFR;VEGFA
Schwartz-Jampel Syndrome	2/41	6.144037622474869E-4	0.002445308039884836	0	0	63.919871794871796	472.6783914538256	EGFR;VEGFA
Malabsorption Syndrome	2/41	6.144037622474869E-4	0.002445308039884836	0	0	63.919871794871796	472.6783914538256	EZR;EGFR
Oligoarticular Juvenile Idiopathic Arthritis	2/42	6.44780459847493E-4	0.002558322469717472	0	0	62.31875	457.8309705931631	STAT1;ESR1
Diffuse Scleroderma	2/42	6.44780459847493E-4	0.002558322469717472	0	0	62.31875	457.8309705931631	CAV1;EGFR
Mean Corpuscular Volume (result)	3/194	6.586061700926524E-4	0.0026091713763026396	0	0	20.723560209424083	151.80805336552052	CDH1;HBB;PIK3R1
CATARACT, ANTERIOR POLAR	2/43	6.758731147824064E-4	0.0026531614824968934	0	0	60.795731707317074	443.7787597089313	AR;EGFR
Gemistocytic astrocytoma	2/43	6.758731147824064E-4	0.0026531614824968934	0	0	60.795731707317074	443.7787597089313	AR;ESR1
Yolk Sac Tumor	2/43	6.758731147824064E-4	0.0026531614824968934	0	0	60.795731707317074	443.7787597089313	ESR1;EGFR
Chloracne	2/43	6.758731147824064E-4	0.0026531614824968934	0	0	60.795731707317074	443.7787597089313	HBB;EGFR
Non-small cell lung cancer metastatic	2/43	6.758731147824064E-4	0.0026531614824968934	0	0	60.795731707317074	443.7787597089313	ESR1;EGFR
Pyruvate Carboxylase Deficiency Disease	2/43	6.758731147824064E-4	0.0026531614824968934	0	0	60.795731707317074	443.7787597089313	AR;EGFR
Carcinoma, Papillary	3/196	6.78530047992475E-4	0.0026595494900827966	0	0	20.506735751295338	149.6085679965196	CDH1;ESR1;VEGFA
Endometriosis of uterus	2/44	7.076805583778768E-4	0.0027612369823112625	0	0	59.345238095238095	430.46173818774844	ESR1;VEGFA
Split hand foot deformity 1	2/44	7.076805583778768E-4	0.0027612369823112625	0	0	59.345238095238095	430.46173818774844	AR;EGFR
Thyroiditis	2/44	7.076805583778768E-4	0.0027612369823112625	0	0	59.345238095238095	430.46173818774844	STAT1;VEGFA
Acute Promyelocytic Leukemia	4/475	7.377613226860498E-4	0.0028579085098571896	0	0	11.83560812860176	85.35710623425443	CDKN1A;STAT1;EGFR;VEGFA
gallbladder neoplasm	2/45	7.40201623342803E-4	0.0028579085098571896	0	0	57.96220930232558	417.82568323656506	CDH1;EGFR
Liposarcoma, Dedifferentiated	2/45	7.40201623342803E-4	0.0028579085098571896	0	0	57.96220930232558	417.82568323656506	JUN;EPAS1
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	2/45	7.40201623342803E-4	0.0028579085098571896	0	0	57.96220930232558	417.82568323656506	EGFR;VEGFA
Bronchogenic Carcinoma	2/45	7.40201623342803E-4	0.0028579085098571896	0	0	57.96220930232558	417.82568323656506	CDKN1A;EGFR
Chondrodysplasia	2/45	7.40201623342803E-4	0.0028579085098571896	0	0	57.96220930232558	417.82568323656506	CDKN1A;STAT1
Endometrial Stromal Sarcoma	2/45	7.40201623342803E-4	0.0028579085098571896	0	0	57.96220930232558	417.82568323656506	CAV1;ESR1
Left Ventricular Hypertrophy	3/203	7.512926283343531E-4	0.0028964012820710955	0	0	19.782	142.3060766682985	AR;ESR1;VEGFA
Infiltrating Cervical Carcinoma	2/46	7.734351437291583E-4	0.002972891333708952	0	0	56.64204545454545	405.82149239611823	EGFR;VEGFA
Peptic Esophagitis	2/46	7.734351437291583E-4	0.002972891333708952	0	0	56.64204545454545	405.82149239611823	ESR1;EGFR
Childhood Osteosarcoma	3/206	7.839414267730682E-4	0.003008797481953693	0	0	19.48669950738916	139.3528227306058	EPAS1;ESR1;VEGFA
Dermatitis, Atopic	4/484	7.914395802828511E-4	0.0030330688959504513	0	0	11.608333333333333	82.90273520881293	JUN;CDKN1A;EGFR;VEGFA
Colorectal cancer metastatic	3/208	8.062029821222961E-4	0.0030759032797856964	0	0	19.294634146341462	137.43905574555606	CDH1;EGFR;VEGFA
Hyperparathyroidism	2/47	8.073799549727844E-4	0.0030759032797856964	0	0	55.38055555555555	394.40459836307184	CDKN1A;EGFR
Male sterility	2/47	8.073799549727844E-4	0.0030759032797856964	0	0	55.38055555555555	394.40459836307184	AR;ESR1
Colonic Polyps	2/47	8.073799549727844E-4	0.0030759032797856964	0	0	55.38055555555555	394.40459836307184	EGFR;VEGFA
Trisomy	3/209	8.174835684366543E-4	0.003105235378340997	0	0	19.2	136.49817129919765	AR;PIM1;EGFR
Nonalcoholic Steatohepatitis	3/209	8.174835684366543E-4	0.003105235378340997	0	0	19.2	136.49817129919765	CDKN1A;PIK3R1;VEGFA
Female Breast Carcinoma	2/49	8.773987974909651E-4	0.0033230514573594767	0	0	53.0186170212766	373.1741306231756	AR;ESR1
Thromboangiitis Obliterans	2/49	8.773987974909651E-4	0.0033230514573594767	0	0	53.0186170212766	373.1741306231756	STAT1;VEGFA
Adult T-Cell Lymphoma/Leukemia	4/500	8.936428005945616E-4	0.003379618380579433	0	0	11.224654377880185	78.7993682152863	JUN;CDKN1A;STAT1;VEGFA
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	3/216	8.992780652935855E-4	0.003386057205034011	0	0	18.56244131455399	130.19544620156347	STAT1;EGFR;VEGFA
Alopecia	3/216	8.992780652935855E-4	0.003386057205034011	0	0	18.56244131455399	130.19544620156347	AR;PIK3R1;EGFR
Dyslipidemias	3/216	8.992780652935855E-4	0.003386057205034011	0	0	18.56244131455399	130.19544620156347	AR;CAV1;ESR1
Giant Cell Tumors	2/50	9.134705062420161E-4	0.0033998477199180515	0	0	51.911458333333336	363.2898548418271	AR;VEGFA
stage, prostate cancer	2/50	9.134705062420161E-4	0.0033998477199180515	0	0	51.911458333333336	363.2898548418271	AR;VEGFA
Microscopic Polyarteritis	2/50	9.134705062420161E-4	0.0033998477199180515	0	0	51.911458333333336	363.2898548418271	ESR1;EGFR
Candidiasis	2/50	9.134705062420161E-4	0.0033998477199180515	0	0	51.911458333333336	363.2898548418271	STAT1;EGFR
Carcinosarcoma	2/50	9.134705062420161E-4	0.0033998477199180515	0	0	51.911458333333336	363.2898548418271	EGFR;VEGFA
Muscular fasciculation	2/50	9.134705062420161E-4	0.0033998477199180515	0	0	51.911458333333336	363.2898548418271	AR;EGFR
Cervical Squamous Intraepithelial Neoplasia	2/50	9.134705062420161E-4	0.0033998477199180515	0	0	51.911458333333336	363.2898548418271	EGFR;VEGFA
Endocardial Cushion Defects	2/50	9.134705062420161E-4	0.0033998477199180515	0	0	51.911458333333336	363.2898548418271	AR;EGFR
Nasal Polyps	3/219	9.358689648286442E-4	0.0034782007714422854	0	0	18.30185185185185	127.63775695593273	JUN;EGFR;VEGFA
Cockayne Syndrome, Type I	2/51	9.502488602876735E-4	0.0035114346296467244	0	0	50.849489795918366	353.85075072456357	CDKN1A;STAT1
Bicuspid aortic valve	2/51	9.502488602876735E-4	0.0035114346296467244	0	0	50.849489795918366	353.85075072456357	EGFR;VEGFA
Breast Diseases	2/51	9.502488602876735E-4	0.0035114346296467244	0	0	50.849489795918366	353.85075072456357	ESR1;EGFR
NONAKA MYOPATHY	2/51	9.502488602876735E-4	0.0035114346296467244	0	0	50.849489795918366	353.85075072456357	ESR1;EGFR
Major Depressive Disorder	4/513	9.833222888943121E-4	0.0036284592460200118	0	0	10.930676396295256	75.69027352085872	JUN;ESR1;EGFR;VEGFA
Malignant ascites	2/52	9.877327017010398E-4	0.0036343498126692104	0	0	49.83	344.82850534778163	EGFR;VEGFA
Carcinomatosis of peritoneal cavity	2/52	9.877327017010398E-4	0.0036343498126692104	0	0	49.83	344.82850534778163	EGFR;VEGFA
Coronary heart disease	5/913	0.0010214293568430622	0.003742872339118894	0	0	8.079464588275162	55.63965546250168	AR;CAV1;ESR1;EGFR;VEGFA
Stevens-Johnson Syndrome	2/53	0.0010259208734402544	0.003742872339118894	0	0	48.85049019607843	336.19711708556474	CAV1;EGFR
Prostate cancer, familial	2/53	0.0010259208734402544	0.003742872339118894	0	0	48.85049019607843	336.19711708556474	AR;CDH1
Thrombocytosis	2/53	0.0010259208734402544	0.003742872339118894	0	0	48.85049019607843	336.19711708556474	AR;HBB
Tumor-Associated Vasculature	2/53	0.0010259208734402544	0.003742872339118894	0	0	48.85049019607843	336.19711708556474	EGFR;VEGFA
Nodular glomerulosclerosis	2/53	0.0010259208734402544	0.003742872339118894	0	0	48.85049019607843	336.19711708556474	CDKN1A;VEGFA
Ki-1+ Anaplastic Large Cell Lymphoma	3/228	0.0010512932800764577	0.003830028973818745	0	0	17.561777777777777	120.43400368285464	JUN;CDKN1A;VEGFA
Seminoma	3/229	0.0010646490969781562	0.003857517482783183	0	0	17.483185840707964	119.67433058882263	AR;ESR1;EGFR
Rotavirus Infections	2/54	0.001064812220373368	0.003857517482783183	0	0	47.90865384615385	327.93266660649385	JUN;STAT1
Malignant neoplasm of nasopharynx	2/54	0.001064812220373368	0.003857517482783183	0	0	47.90865384615385	327.93266660649385	CDH1;VEGFA
Cerebral Aneurysm	2/54	0.001064812220373368	0.003857517482783183	0	0	47.90865384615385	327.93266660649385	STAT1;ESR1
Sepsis	4/529	0.00110223988897793	0.003973091411912802	0	0	10.588843537414967	72.11437551806952	JUN;CAV1;HBB;VEGFA
Gingivitis	2/55	0.0011044055879804073	0.003973091411912802	0	0	47.00235849056604	320.01311451477966	ESR1;VEGFA
Osteoporosis, Postmenopausal	2/55	0.0011044055879804073	0.003973091411912802	0	0	47.00235849056604	320.01311451477966	ESR1;VEGFA
Atherogenesis	2/55	0.0011044055879804073	0.003973091411912802	0	0	47.00235849056604	320.01311451477966	ESR1;VEGFA
Primary central nervous system lymphoma	2/55	0.0011044055879804073	0.003973091411912802	0	0	47.00235849056604	320.01311451477966	CDKN1A;PIM1
Gallbladder Carcinoma	3/233	0.0011191503122036696	0.004014951745030665	0	0	17.175652173913043	116.711743144768	ESR1;EGFR;VEGFA
Chronic myeloproliferative disorder	3/233	0.0011191503122036696	0.004014951745030665	0	0	17.175652173913043	116.711743144768	AR;PIM1;VEGFA
Epstein-Barr Virus Infections	3/234	0.0011330468158891906	0.004059167719059334	0	0	17.1004329004329	115.98958541176644	CDH1;PIK3R1;EGFR
HER2 gene amplification	2/56	0.0011446998237224415	0.004083922161153407	0	0	46.129629629629626	312.4181218895314	ESR1;EGFR
Adenoviral infections	2/56	0.0011446998237224415	0.004083922161153407	0	0	46.129629629629626	312.4181218895314	CDKN1A;VEGFA
Laryngeal Diseases	2/56	0.0011446998237224415	0.004083922161153407	0	0	46.129629629629626	312.4181218895314	CDKN1A;EGFR
Sarcoidosis	3/236	0.001161167647257525	0.004136960045332672	0	0	16.951931330472103	114.56673229819124	CDKN1A;STAT1;VEGFA
IGA Glomerulonephritis	3/237	0.001175392652351777	0.004181872205268099	0	0	16.87863247863248	113.86583738471624	STAT1;EZR;VEGFA
Sentinel node (disorder)	2/57	0.001185693776183296	0.004212719427622357	0	0	45.288636363636364	305.12889096639515	ESR1;VEGFA
Hepatitis B, Chronic	3/238	0.0011897278337605463	0.004215455410978726	0	0	16.80595744680851	113.17183354335343	STAT1;CDH1;ESR1
Overweight	3/238	0.0011897278337605463	0.004215455410978726	0	0	16.80595744680851	113.17183354335343	AR;ESR1;VEGFA
Pituitary Diseases	3/240	0.0012187300690822299	0.004307525542605691	0	0	16.662447257383967	111.8041194813529	AR;ESR1;VEGFA
Recurrent bacterial infection	2/58	0.0012273862947571772	0.004307525542605691	0	0	44.47767857142857	298.12802327286596	HBB;PIK3R1
Hepatosplenomegaly	2/58	0.0012273862947571772	0.004307525542605691	0	0	44.47767857142857	298.12802327286596	STAT1;CAV1
Increased susceptibility to bacterial infections	2/58	0.0012273862947571772	0.004307525542605691	0	0	44.47767857142857	298.12802327286596	HBB;PIK3R1
Large cell carcinoma of lung	2/58	0.0012273862947571772	0.004307525542605691	0	0	44.47767857142857	298.12802327286596	EGFR;VEGFA
Oncocytic Neoplasm	2/58	0.0012273862947571772	0.004307525542605691	0	0	44.47767857142857	298.12802327286596	CDH1;ESR1
Prone to bacterial infection	2/58	0.0012273862947571772	0.004307525542605691	0	0	44.47767857142857	298.12802327286596	HBB;PIK3R1
Meningioma, benign, no ICD-O subtype	3/241	0.0012333977923819053	0.004322749657696691	0	0	16.591596638655464	111.13022368841791	CDH1;ESR1;VEGFA
Diabetes Mellitus, Insulin-Dependent	5/956	0.0012559974164307866	0.004395990957507753	0	0	7.696756450699668	51.412988220410696	AR;STAT1;ESR1;EGFR;VEGFA
Sleep Apnea Syndromes	2/59	0.0012697762309429347	0.004426224027699866	0	0	43.69517543859649	291.39939300135444	AR;VEGFA
SVEINSSON CHORIORETINAL ATROPHY	2/59	0.0012697762309429347	0.004426224027699866	0	0	43.69517543859649	291.39939300135444	EGFR;VEGFA
Anaplastic Oligodendroglioma	2/59	0.0012697762309429347	0.004426224027699866	0	0	43.69517543859649	291.39939300135444	EGFR;VEGFA
Subfertility, Male	2/60	0.0013128624367881993	0.004570247539385335	0	0	42.939655172413794	284.92803390338764	AR;ESR1
Cholestasis, Extrahepatic	2/61	0.0013566437662336027	0.0046973335766506644	0	0	42.20974576271186	278.70003786815613	JUN;CDKN1A
Ganglioglioma	2/61	0.0013566437662336027	0.0046973335766506644	0	0	42.20974576271186	278.70003786815613	AR;EGFR
Leukoplakia	2/61	0.0013566437662336027	0.0046973335766506644	0	0	42.20974576271186	278.70003786815613	PRKDC;EGFR
Bile duct carcinoma	2/61	0.0013566437662336027	0.0046973335766506644	0	0	42.20974576271186	278.70003786815613	ESR1;EGFR
Immune System Diseases	3/250	0.001370465163711232	0.004738837373314742	0	0	15.979757085020243	105.34822743570048	STAT1;ESR1;EGFR
Systemic Scleroderma	4/562	0.0013790688376810424	0.004762212309799643	0	0	9.945724526369688	65.50599053861627	JUN;CAV1;EGFR;VEGFA
Hereditary Malignant Neoplasm	2/62	0.001401119074102026	0.004812620436709486	0	0	41.50416666666667	272.7024639719935	AR;CDH1
Marijuana Abuse	2/62	0.001401119074102026	0.004812620436709486	0	0	41.50416666666667	272.7024639719935	ESR1;EGFR
Nijmegen Breakage Syndrome	2/62	0.001401119074102026	0.004812620436709486	0	0	41.50416666666667	272.7024639719935	CDKN1A;VEGFA
Pemphigus Vulgaris	2/62	0.001401119074102026	0.004812620436709486	0	0	41.50416666666667	272.7024639719935	CDH1;EGFR
Coronary Artery Disease	5/981	0.0014096989374270984	0.004835660498504908	0	0	7.489754098360656	49.16558539433832	AR;STAT1;CAV1;ESR1;VEGFA
Alzheimer Disease, Late Onset	3/253	0.0014182030134256716	0.004858379819202268	0	0	15.7856	103.52772168633585	PIK3R1;ESR1;VEGFA
Kidney Calculi	2/63	0.0014462872168013686	0.004941481324071343	0	0	40.82172131147541	266.9232566421176	AR;CDH1
Necrotizing Enterocolitis	2/63	0.0014462872168013686	0.004941481324071343	0	0	40.82172131147541	266.9232566421176	EGFR;VEGFA
Neuroendocrine Tumors	3/257	0.0014834711166307698	0.00506183077180618	0	0	15.533858267716536	101.17777556174062	ESR1;EGFR;VEGFA
Adenocarcinoma, Endometrioid	2/64	0.0014921470517396229	0.005064672581660244	0	0	40.16129032258065	261.35117197671207	ESR1;EGFR
Retinopathy of Prematurity	2/64	0.0014921470517396229	0.005064672581660244	0	0	40.16129032258065	261.35117197671207	EPAS1;VEGFA
Uterine Cancer	2/64	0.0014921470517396229	0.005064672581660244	0	0	40.16129032258065	261.35117197671207	ESR1;EGFR
Multiple Endocrine Neoplasia Type 2a	2/64	0.0014921470517396229	0.005064672581660244	0	0	40.16129032258065	261.35117197671207	AR;VEGFA
Sjogren's Syndrome	3/260	0.0015336465990394188	0.005198699692019447	0	0	15.350194552529183	99.47090288417294	STAT1;ESR1;EGFR
FRIEDREICH ATAXIA 1	2/65	0.0015386974380497008	0.005202166861887928	0	0	39.5218253968254	255.97571122223422	AR;ESR1
Lymphocytosis	2/65	0.0015386974380497008	0.005202166861887928	0	0	39.5218253968254	255.97571122223422	AR;PIM1
Hepatitis A	3/261	0.0015506066688237578	0.0052355778112049235	0	0	15.289922480620156	98.91217551684056	JUN;CDKN1A;ESR1
Endothelial dysfunction	3/262	0.001567684717988901	0.005286331105176673	0	0	15.23011583011583	98.35845555213352	STAT1;CAV1;VEGFA
Malignant neoplasm of gastrointestinal tract	3/263	0.0015848810590343026	0.005320098544967462	0	0	15.170769230769231	97.80967996698121	CDH1;EGFR;VEGFA
Skeletal dysplasia	2/66	0.0015859372356271568	0.005320098544967462	0	0	38.90234375	250.7870606899547	STAT1;EGFR
stage, non-small cell lung cancer	2/66	0.0015859372356271568	0.005320098544967462	0	0	38.90234375	250.7870606899547	EGFR;VEGFA
Thyroid Nodule	2/66	0.0015859372356271568	0.005320098544967462	0	0	38.90234375	250.7870606899547	AR;VEGFA
Myeloproliferative disease	3/264	0.001602196004646699	0.005367668326851392	0	0	15.111877394636016	97.26578675291698	NR4A1;AR;VEGFA
Schistosomiasis	2/67	0.0016338653066189622	0.005424516821332622	0	0	38.301923076923075	245.7760372982144	EGFR;VEGFA
Gestational Diabetes	2/67	0.0016338653066189622	0.005424516821332622	0	0	38.301923076923075	245.7760372982144	AR;VEGFA
Tongue Carcinoma	2/67	0.0016338653066189622	0.005424516821332622	0	0	38.301923076923075	245.7760372982144	CAV1;VEGFA
Metastatic Renal Cell Cancer	2/67	0.0016338653066189622	0.005424516821332622	0	0	38.301923076923075	245.7760372982144	EZR;VEGFA
Multiple Chronic Conditions	2/67	0.0016338653066189622	0.005424516821332622	0	0	38.301923076923075	245.7760372982144	AR;EGFR
Cerebral Hemorrhage	2/67	0.0016338653066189622	0.005424516821332622	0	0	38.301923076923075	245.7760372982144	ESR1;VEGFA
Cervical Adenocarcinoma	2/67	0.0016338653066189622	0.005424516821332622	0	0	38.301923076923075	245.7760372982144	CDH1;EGFR
Hypothyroidism	3/268	0.0016726480430608824	0.005546148774359768	0	0	14.880754716981132	95.1378323050086	STAT1;CAV1;VEGFA
Alveolar rhabdomyosarcoma	2/68	0.0016824805132125557	0.005564465000804137	0	0	37.71969696969697	240.93403928127228	CAV1;EGFR
Osteoarthritis of hip	2/68	0.0016824805132125557	0.005564465000804137	0	0	37.71969696969697	240.93403928127228	ESR1;VEGFA
Myopia	3/269	0.0016905606615734382	0.005584038604660091	0	0	14.82406015037594	94.61745538205723	PIK3R1;ESR1;VEGFA
Histiocytosis, Langerhans-Cell	2/69	0.0017317817196253697	0.005662268584547253	0	0	37.15485074626866	236.25300132720042	AR;CDKN1A
Simple Partial Status Epilepticus	2/69	0.0017317817196253697	0.005662268584547253	0	0	37.15485074626866	236.25300132720042	JUN;VEGFA
Grand Mal Status Epilepticus	2/69	0.0017317817196253697	0.005662268584547253	0	0	37.15485074626866	236.25300132720042	JUN;VEGFA
Status Epilepticus, Subclinical	2/69	0.0017317817196253697	0.005662268584547253	0	0	37.15485074626866	236.25300132720042	JUN;VEGFA
Non-Convulsive Status Epilepticus	2/69	0.0017317817196253697	0.005662268584547253	0	0	37.15485074626866	236.25300132720042	JUN;VEGFA
Chronic otitis media	2/69	0.0017317817196253697	0.005662268584547253	0	0	37.15485074626866	236.25300132720042	PIK3R1;VEGFA
Complex Partial Status Epilepticus	2/69	0.0017317817196253697	0.005662268584547253	0	0	37.15485074626866	236.25300132720042	JUN;VEGFA
Diphtheria	2/69	0.0017317817196253697	0.005662268584547253	0	0	37.15485074626866	236.25300132720042	EGFR;VEGFA
Brain Injuries, Focal	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	JUN;VEGFA
Injuries, Acute Brain	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	JUN;VEGFA
Stromal Neoplasm	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	CAV1;VEGFA
Brain Injuries	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	JUN;VEGFA
Brain Lacerations	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	JUN;VEGFA
Neck Neoplasms	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	EGFR;VEGFA
Neurofibromatosis 2	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	EZR;VEGFA
Ovarian adenocarcinoma	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	CDH1;ESR1
Pulmonary arterial hypertension	2/70	0.0017817677909702713	0.0057600828586685995	0	0	36.606617647058826	231.72535384837516	CAV1;VEGFA
Bacterial Infections	3/276	0.0018193388766530466	0.005874190397993524	0	0	14.438827838827839	91.0986380064443	STAT1;EGFR;VEGFA
Congenital Abnormality	4/607	0.0018309813720379486	0.005894378962823625	0	0	9.182184316512675	57.87441879213589	AR;STAT1;ESR1;VEGFA
Rhabdoid Tumor	2/71	0.0018324375947144293	0.005894378962823625	0	0	36.07427536231884	227.34398583074542	CDKN1A;EGFR
Pterygium	2/71	0.0018324375947144293	0.005894378962823625	0	0	36.07427536231884	227.34398583074542	EGFR;VEGFA
Benign melanocytic nevus	2/72	0.0018837899979258688	0.006052026821694675	0	0	35.55714285714286	223.10221103497707	CDKN1A;EGFR
Bone neoplasms	2/73	0.0019358238702516727	0.00621146963585102	0	0	35.054577464788736	218.99373701664894	CAV1;EGFR
Low density lipoprotein cholesterol measurement	3/283	0.0019541232671475904	0.006254647334624815	0	0	14.072857142857142	87.78386027936239	AR;PRKDC;ESR1
Cerebral Infarction	3/283	0.0019541232671475904	0.006254647334624815	0	0	14.072857142857142	87.78386027936239	JUN;ESR1;VEGFA
Marginal Zone B-Cell Lymphoma	2/74	0.0019885380825574606	0.006349065348882473	0	0	34.56597222222222	215.01263688059672	CDH1;PIM1
Necrotizing enterocolitis in fetus OR newborn	2/74	0.0019885380825574606	0.006349065348882473	0	0	34.56597222222222	215.01263688059672	EGFR;VEGFA
Angiogenic Switch	2/75	0.0020419315060168624	0.006495454532070881	0	0	34.090753424657535	211.1533234069638	EPAS1;VEGFA
Central Nervous System Neoplasms	2/75	0.0020419315060168624	0.006495454532070881	0	0	34.090753424657535	211.1533234069638	EGFR;VEGFA
Endometrial Hyperplasia	2/75	0.0020419315060168624	0.006495454532070881	0	0	34.090753424657535	211.1533234069638	AR;ESR1
Huntington Disease	4/627	0.002061675184638764	0.0065501931142951135	0	0	8.878238936023848	54.905128664348645	AR;CDKN1A;CAV1;VEGFA
Stable angina	2/76	0.0020960030142903557	0.006634774247441163	0	0	33.62837837837838	207.41052527927258	STAT1;VEGFA
Chest Pain	2/76	0.0020960030142903557	0.006634774247441163	0	0	33.62837837837838	207.41052527927258	HBB;VEGFA
Petit mal status	2/76	0.0020960030142903557	0.006634774247441163	0	0	33.62837837837838	207.41052527927258	JUN;VEGFA
aggressive cancer	2/77	0.002150751481238128	0.006799744279116383	0	0	33.178333333333335	203.77926533955574	EZR;EGFR
Marinesco-Sjogren syndrome	2/78	0.00220617578300177	0.006949453716455576	0	0	32.74013157894737	200.25484053611478	EGFR;VEGFA
Bronchial Hyperreactivity	2/78	0.00220617578300177	0.006949453716455576	0	0	32.74013157894737	200.25484053611478	ESR1;VEGFA
Pulmonary Edema	2/78	0.00220617578300177	0.006949453716455576	0	0	32.74013157894737	200.25484053611478	EPAS1;VEGFA
Spinocerebellar Ataxia Type 1	2/79	0.0022622747962299803	0.007117485747456808	0	0	32.313311688311686	196.83280353584135	AR;VEGFA
Dementia, Vascular	2/80	0.002319047399578581	0.0072872255877268555	0	0	31.897435897435898	193.50894574053115	ESR1;VEGFA
Cutaneous Melanoma	3/301	0.0023289966273789932	0.007309596948383888	0	0	13.210738255033558	80.08769283151244	CDH1;PIK3R1;VEGFA
Pancreatitis, Chronic	3/302	0.0023510407661566654	0.0073698280327459545	0	0	13.165886287625417	79.69175584633483	NR4A1;EGFR;VEGFA
Sensory neuropathy	2/81	0.0023764924719155735	0.007440581884797486	0	0	31.492088607594937	190.2792816750188	AR;VEGFA
Cholecystolithiasis	2/82	0.0024346088945992775	0.0076133108653146896	0	0	31.096875	187.14003452280946	AR;ESR1
Lymphoma, Large-Cell, Follicular	2/83	0.002493395549670354	0.00775956711421509	0	0	30.71141975308642	184.08762281714473	PIM1;VEGFA
Hay fever	2/83	0.002493395549670354	0.00775956711421509	0	0	30.71141975308642	184.08762281714473	EGFR;VEGFA
Testicular Neoplasms	2/83	0.002493395549670354	0.00775956711421509	0	0	30.71141975308642	184.08762281714473	AR;VEGFA
Paraganglioma	2/83	0.002493395549670354	0.00775956711421509	0	0	30.71141975308642	184.08762281714473	EPAS1;VEGFA
Soft Tissue Neoplasms	2/84	0.002552851320063413	0.007925498749668023	0	0	30.335365853658537	181.11864810557336	CDKN1A;EGFR
Thrombophilia	2/84	0.002552851320063413	0.007925498749668023	0	0	30.335365853658537	181.11864810557336	ESR1;EGFR
Alzheimer's Disease, Focal Onset	2/85	0.0026129750907771514	0.0080733428941117	0	0	29.968373493975903	178.2298835204112	ESR1;VEGFA
Acute Confusional Senile Dementia	2/85	0.0026129750907771514	0.0080733428941117	0	0	29.968373493975903	178.2298835204112	ESR1;VEGFA
Lesion of brain	2/85	0.0026129750907771514	0.0080733428941117	0	0	29.968373493975903	178.2298835204112	EGFR;VEGFA
Primary physiologic amenorrhea	2/85	0.0026129750907771514	0.0080733428941117	0	0	29.968373493975903	178.2298835204112	AR;ESR1
Impaired cognition	4/671	0.002639319734994315	0.00814499746175665	0	0	8.273720282715784	49.12301395784255	PRKDC;NFIB;ESR1;VEGFA
Curvature of digit	2/86	0.0026737657475791204	0.008241452178993877	0	0	29.610119047619047	175.4182632174737	CDH1;PIK3R1
Hepatitis	3/317	0.0026974632863467412	0.008304586017441756	0	0	12.527388535031847	74.10505872043977	JUN;STAT1;ESR1
Gynecomastia	2/87	0.0027352221778139145	0.008370946546556091	0	0	29.26029411764706	172.6808725566614	AR;VEGFA
Hemangiosarcoma	2/87	0.0027352221778139145	0.008370946546556091	0	0	29.26029411764706	172.6808725566614	JUN;VEGFA
Actinic keratosis	2/87	0.0027352221778139145	0.008370946546556091	0	0	29.26029411764706	172.6808725566614	CDKN1A;EGFR
Lipoma	2/87	0.0027352221778139145	0.008370946546556091	0	0	29.26029411764706	172.6808725566614	NFIB;CAV1
Nevus	2/87	0.0027352221778139145	0.008370946546556091	0	0	29.26029411764706	172.6808725566614	CDKN1A;EGFR
Brain Tumor, Primary	2/88	0.0027973432696242373	0.008550932148449	0	0	28.91860465116279	170.0149390044448	EGFR;VEGFA
Kaposi Sarcoma	3/323	0.002844430591419839	0.008684591273803126	0	0	12.28875	72.04147429887925	AR;CDKN1A;VEGFA
Acute Kidney Insufficiency	2/89	0.0028601279131244485	0.008701661248057067	0	0	28.58477011494253	167.41782366085732	EGFR;VEGFA
Nasopharyngeal Neoplasms	2/89	0.0028601279131244485	0.008701661248057067	0	0	28.58477011494253	167.41782366085732	CDH1;EGFR
Congenital clinodactyly	2/89	0.0028601279131244485	0.008701661248057067	0	0	28.58477011494253	167.41782366085732	CDH1;PIK3R1
Heart Diseases	3/325	0.002894502294542546	0.008795881678592231	0	0	12.211180124223603	71.37364081976732	AR;EGFR;VEGFA
Impaired glucose tolerance	3/326	0.002919742295458367	0.008852982675315065	0	0	12.172755417956656	71.04336458097555	CAV1;PIK3R1;ESR1
Motor neuron atrophy	2/90	0.002923574998855498	0.008852982675315065	0	0	28.258522727272727	164.88701340835084	AR;VEGFA
Degenerative disorder	2/90	0.002923574998855498	0.008852982675315065	0	0	28.258522727272727	164.88701340835084	AR;VEGFA
Acute kidney injury	2/92	0.0030524520685432928	0.009221618354441316	0	0	27.627777777777776	160.01484111581982	EGFR;VEGFA
Premature aging syndrome	2/92	0.0030524520685432928	0.009221618354441316	0	0	27.627777777777776	160.01484111581982	CDKN1A;CAV1
PARKINSON DISEASE, LATE-ONSET	2/93	0.0031178798401161494	0.00938634455363638	0	0	27.322802197802197	157.66901828082703	AR;VEGFA
Intraepithelial Neoplasia	2/93	0.0031178798401161494	0.00938634455363638	0	0	27.322802197802197	157.66901828082703	EGFR;VEGFA
Coughing	2/93	0.0031178798401161494	0.00938634455363638	0	0	27.322802197802197	157.66901828082703	PIK3R1;EGFR
Non-alcoholic Fatty Liver Disease	3/334	0.003126595487831373	0.009401625314398646	0	0	11.873716012084593	68.48534471940853	JUN;CAV1;VEGFA
Triglycerides measurement	3/336	0.0031796883466287166	0.009550156975979041	0	0	11.8012012012012	67.86837875071551	CDKN1A;PRKDC;ESR1
Rotting teeth	2/95	0.0032507083387279933	0.0097408116460956	0	0	26.732526881720432	153.14750158426136	CDH1;CAV1
Congenital diaphragmatic hernia	2/95	0.0032507083387279933	0.0097408116460956	0	0	26.732526881720432	153.14750158426136	PIM1;VEGFA
Muscle Weakness	3/339	0.003260370392276132	0.009747148985242187	0	0	11.69404761904762	66.959116507457	AR;CAV1;HBB
Pneumonitis	3/339	0.003260370392276132	0.009747148985242187	0	0	11.69404761904762	66.959116507457	JUN;CAV1;VEGFA
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE	2/96	0.003318106861531702	0.009896847602005066	0	0	26.4468085106383	150.96792713266765	ESR1;EGFR
Cardiac fibrosis	2/96	0.003318106861531702	0.009896847602005066	0	0	26.4468085106383	150.96792713266765	NR4A1;VEGFA
Adult Hepatocellular Carcinoma	2/97	0.003386160098682633	0.010088179394345146	0	0	26.167105263157893	148.84003110829175	CDKN1A;CDH1
Central Serous Chorioretinopathy	2/98	0.003454866951884673	0.010281015364882615	0	0	25.893229166666668	146.76208059313473	CDKN1A;EGFR
Nephrolithiasis	2/99	0.003524226323481464	0.010475347058173327	0	0	25.625	144.73241770614385	AR;CDH1
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	3/349	0.0035384270759147895	0.010505467973664254	0	0	11.35028901734104	64.06185955135255	CDKN1A;STAT1;PIM1
Childhood Neuroblastoma	2/100	0.0035942371173740815	0.01064669091075373	0	0	25.362244897959183	142.74945562505079	AR;VEGFA
Oral Cavity Carcinoma	2/100	0.0035942371173740815	0.01064669091075373	0	0	25.362244897959183	142.74945562505079	EGFR;VEGFA
Hypertension, Portal	2/101	0.0036648982381020144	0.010831158065237418	0	0	25.10479797979798	140.8116748697442	PIK3R1;VEGFA
Hematocrit procedure	2/101	0.0036648982381020144	0.010831158065237418	0	0	25.10479797979798	140.8116748697442	HBB;VEGFA
Retinal Diseases	3/355	0.0037120661478999583	0.010958019268600678	0	0	11.153409090909092	62.41633592367148	CAV1;HBB;VEGFA
Neurodegenerative Disorders	4/745	0.0038494428649296234	0.011350583242138376	0	0	7.418931945247735	41.247977039098686	AR;JUN;EGFR;VEGFA
Carcinoid tumor no ICD-O subtype	2/104	0.003880772627961155	0.01142991527710794	0	0	24.362745098039216	135.25516392567505	JUN;EGFR
Leukoencephalopathy, Progressive Multifocal	2/105	0.003954024129976149	0.011605959463327719	0	0	24.125	133.48414251930805	STAT1;HBB
M5b Acute differentiated monocytic leukemia	2/105	0.003954024129976149	0.011605959463327719	0	0	24.125	133.48414251930805	CDKN1A;VEGFA
Carotid Atherosclerosis	2/105	0.003954024129976149	0.011605959463327719	0	0	24.125	133.48414251930805	STAT1;ESR1
Teratocarcinoma	2/106	0.004027920502030799	0.011782693835498929	0	0	23.891826923076923	131.75159999784861	CDKN1A;HBB
Atrial Premature Complexes	2/106	0.004027920502030799	0.011782693835498929	0	0	23.891826923076923	131.75159999784861	CDH1;CAV1
Chronic graft-versus-host disease	2/106	0.004027920502030799	0.011782693835498929	0	0	23.891826923076923	131.75159999784861	CAV1;VEGFA
Basal cell carcinoma	2/107	0.0041024606560516284	0.011973622457154075	0	0	23.663095238095238	130.0563545257806	EGFR;VEGFA
Pleural effusion disorder	2/107	0.0041024606560516284	0.011973622457154075	0	0	23.663095238095238	130.0563545257806	EGFR;VEGFA
Coronary Arteriosclerosis	4/760	0.0041342956019756304	0.012052918216594868	0	0	7.266061980347694	39.87933297359457	AR;CAV1;ESR1;VEGFA
Carcinoma, Lewis Lung	2/108	0.0041776435065928345	0.01215186168640686	0	0	23.43867924528302	128.39727114514832	EGFR;VEGFA
Malabsorption	2/108	0.0041776435065928345	0.01215186168640686	0	0	23.43867924528302	128.39727114514832	CAV1;HBB
Oligospermia	2/109	0.004253467968046405	0.012358501418969476	0	0	23.218457943925234	126.77325951701553	AR;ESR1
Borderline Personality Disorder	2/110	0.004329932956858972	0.012566535761310926	0	0	23.002314814814813	125.18327176395607	EGFR;VEGFA
Multiple Endocrine Neoplasia Type 1	2/111	0.0044070373895657615	0.012775956876821955	0	0	22.790137614678898	123.62630045779481	CDKN1A;VEGFA
Skin Erosion	2/112	0.00448478018606296	0.012936000073332263	0	0	22.581818181818182	122.10137669299964	CDKN1A;VEGFA
Muscular Dystrophy, Facioscapulohumeral	2/112	0.00448478018606296	0.012936000073332263	0	0	22.581818181818182	122.10137669299964	CDKN1A;PIM1
Synovitis	2/112	0.00448478018606296	0.012936000073332263	0	0	22.581818181818182	122.10137669299964	STAT1;VEGFA
Merkel cell carcinoma	2/112	0.00448478018606296	0.012936000073332263	0	0	22.581818181818182	122.10137669299964	EGFR;VEGFA
Chronic Kidney Diseases	3/380	0.004491720469842855	0.012936000073332263	0	0	10.40053050397878	56.22027016341332	ESR1;EGFR;VEGFA
delta-Thalassemia	1/5	0.0044922927083929694	0.012936000073332263	0	0	293.79411764705884	1588.072397289777	HBB
Age related macular degeneration	3/382	0.004558071704136307	0.013067231668979887	0	0	10.344591029023746	55.766196652221666	EZR;ESR1;VEGFA
Adenocarcinoma, Clear Cell	2/113	0.004563160265358056	0.013067231668979887	0	0	22.37725225225225	120.60756830597164	EGFR;VEGFA
Diabetes Mellitus, Experimental	2/113	0.004563160265358056	0.013067231668979887	0	0	22.37725225225225	120.60756830597164	CAV1;VEGFA
Streptozotocin Diabetes	2/113	0.004563160265358056	0.013067231668979887	0	0	22.37725225225225	120.60756830597164	CAV1;VEGFA
Alloxan Diabetes	2/113	0.004563160265358056	0.013067231668979887	0	0	22.37725225225225	120.60756830597164	CAV1;VEGFA
Gingival Diseases	2/114	0.004642176548654469	0.01322022273999393	0	0	22.176339285714285	119.143978155454	STAT1;VEGFA
Head and Neck Carcinoma	2/114	0.004642176548654469	0.01322022273999393	0	0	22.176339285714285	119.143978155454	PIM1;EGFR
Urticaria	2/114	0.004642176548654469	0.01322022273999393	0	0	22.176339285714285	119.143978155454	ESR1;VEGFA
Intracranial Aneurysm	2/114	0.004642176548654469	0.01322022273999393	0	0	22.176339285714285	119.143978155454	STAT1;VEGFA
Dermatomyositis	2/114	0.004642176548654469	0.01322022273999393	0	0	22.176339285714285	119.143978155454	STAT1;VEGFA
Chronic kidney disease stage 5	3/388	0.004760718761468268	0.013542881674969755	0	0	10.180259740259741	54.437479334024715	CAV1;ESR1;VEGFA
Alzheimer Disease, Early Onset	2/116	0.0048021134180562626	0.013630614240482777	0	0	21.785087719298247	116.30402956291051	ESR1;VEGFA
Ischemic cardiomyopathy	2/116	0.0048021134180562626	0.013630614240482777	0	0	21.785087719298247	116.30402956291051	ESR1;VEGFA
Carcinoma, Small Cell	2/117	0.0048830318531226085	0.013814754957958048	0	0	21.594565217391306	114.9260379130439	AR;EGFR
Teratoma	2/117	0.0048830318531226085	0.013814754957958048	0	0	21.594565217391306	114.9260379130439	AR;ESR1
Hyperhomocysteinemia	2/117	0.0048830318531226085	0.013814754957958048	0	0	21.594565217391306	114.9260379130439	CDKN1A;VEGFA
Erectile dysfunction	2/118	0.004964582188685505	0.014026651386975258	0	0	21.407327586206897	113.57499528522725	AR;VEGFA
Ischemic stroke	3/394	0.0049687905610074955	0.014026651386975258	0	0	10.020971867007672	53.15703508520186	AR;ESR1;VEGFA
Liver Cirrhosis, Experimental	4/801	0.004985971947962247	0.014059787709155553	0	0	6.877576626635598	36.45890660021552	CDKN1A;CAV1;EZR;VEGFA
Juvenile Myelomonocytic Leukemia	2/121	0.005213013881359714	0.014423220228400636	0	0	20.86449579831933	109.67624832265865	AR;PIK3R1
Schizophrenia	6/1923	0.005264062049610329	0.014423220228400636	0	0	4.711789254042775	24.722062272856608	AR;JUN;CAV1;ESR1;EGFR;VEGFA
Peripheral T-Cell Lymphoma	2/123	0.005381774881042169	0.014423220228400636	0	0	20.517561983471076	107.1988663871544	CAV1;PIM1
Anoxia-Ischemia, Brain	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Anoxia-Ischemia, Cerebral	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Renal cancer metastatic	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Erythrocytosis due to low atmospheric pressure	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Exudative age-related macular degeneration	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
RIPPLING MUSCLE DISEASE 1	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Corneal dystrophy, Fuchs' endothelial, 1	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	JUN
Scleritis	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	STAT1
Fibrous histiocytoma of tendon sheath	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	AR
Serrated polyp	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Hypospadias, perineal	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	AR
Germ cell neoplasia	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	AR
Giant cell carcinoma of lung	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Somatostatinoma	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EPAS1
Splenic Neoplasms	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Hematocrit increased	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EPAS1
Squamous cell carcinoma of pharynx	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Squamous Lung Dysplasia	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Hemoglobin E disease	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	HBB
Tension Headache	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	ESR1
Troyer syndrome	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Immune dysregulation	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	STAT1
Uterus absent (finding)	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	AR
Virchow's node (disorder)	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	ESR1
Vitreoretinopathy	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Intestinal-Type Sinonasal Adenocarcinoma	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Kaposi's sarcoma-associated herpesvirus infection	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Anoxic-Ischemic Encephalopathy	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Aromatase deficiency	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	ESR1
Beta thalassemia minor	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	HBB
Bulbospinal Neuronopathy	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	AR
Carcinomatous ascites	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Central blindness	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Cerebral Hypoxia-Ischemia	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Non-Metastatic Childhood Soft Tissue Sarcoma	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Osteoblastic Osteosarcoma	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	ESR1
Ovarian papillary adenocarcinoma	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	CDH1
Papillary transitional cell carcinoma	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Papillary urothelial carcinoma	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	ESR1
Pleomorphic carcinoma	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
Pleural Neoplasms	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EGFR
prenatal alcohol exposure	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	VEGFA
Primary Hypothyroidism	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	STAT1
Disseminated Bacillus Calmette-Guerin infection	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	STAT1
Dominant beta-thalassemia	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	HBB
Endometrial neoplasm malignant metastatic	1/6	0.0053884659389882355	0.014423220228400636	0	0	235.0235294117647	1227.644124299904	EZR
Dermatologic disorders	3/406	0.005401382602665415	0.014442827394083608	0	0	9.716625310173697	50.73147552261577	JUN;EGFR;VEGFA
Hernia, Inguinal	2/124	0.005467094139624529	0.01458833074653942	0	0	20.348360655737704	105.99477424850924	AR;PIK3R1
Polycystic Kidney Diseases	2/124	0.005467094139624529	0.01458833074653942	0	0	20.348360655737704	105.99477424850924	JUN;CDKN1A
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3/408	0.005475631837886898	0.014596034094181483	0	0	9.667654320987655	50.34380334712186	CDKN1A;STAT1;PIM1
Congenital hypoplasia of lung	2/125	0.005553037815703366	0.014787109977280201	0	0	20.181910569105693	104.81293913113458	NFIB;EGFR
Memory Loss	2/126	0.005639604845823604	0.015002162015203265	0	0	20.018145161290324	103.65278015413259	EGFR;VEGFA
Childhood asthma	2/127	0.005726794167239465	0.01521842524071969	0	0	19.857	102.51373602728555	CDH1;VEGFA
Hereditary Nonpolyposis Colorectal Cancer	2/128	0.0058146047177470165	0.015420045160103228	0	0	19.6984126984127	101.3952642428178	CDH1;EGFR
Peritonitis	2/128	0.0058146047177470165	0.015420045160103228	0	0	19.6984126984127	101.3952642428178	AR;VEGFA
Bipolar Disorder	4/837	0.005826205038406512	0.015434961655593864	0	0	6.567998628022638	33.79491069967121	CAV1;ESR1;EGFR;VEGFA
liposarcoma	2/129	0.00590303543685089	0.015606489798757265	0	0	19.54232283464567	100.29684030209523	JUN;CAV1
Chronic liver disease	2/129	0.00590303543685089	0.015606489798757265	0	0	19.54232283464567	100.29684030209523	ESR1;VEGFA
Uveitis	2/130	0.00599208526644116	0.01566723580147316	0	0	19.388671875	99.21795698165909	STAT1;CAV1
Aortic Valve Stenosis	2/130	0.00599208526644116	0.01566723580147316	0	0	19.388671875	99.21795698165909	JUN;ESR1
Lyme Disease	2/130	0.00599208526644116	0.01566723580147316	0	0	19.388671875	99.21795698165909	JUN;CDKN1A
Delayed Puberty	2/130	0.00599208526644116	0.01566723580147316	0	0	19.388671875	99.21795698165909	STAT1;HBB
Pseudohyperkalemia Cardiff	2/131	0.006081753147875876	0.01566723580147316	0	0	19.237403100775193	98.15812364603615	STAT1;HBB
Alcoholic Intoxication, Chronic	3/424	0.006092019262478582	0.01566723580147316	0	0	9.292636579572447	47.39965468697031	AR;PIK3R1;EGFR
Sleep Apnea, Obstructive	2/132	0.006172038024067215	0.01566723580147316	0	0	19.088461538461537	97.11686557699232	AR;VEGFA
Abortion, Habitual	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Chondromatosis, Synovial	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Rippling muscle disease	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Fat redistribution	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	AR
Fenestration (morphologic abnormality)	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Fibrosis of bile duct	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Hemangioma of retina	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Hemoglobin increased	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EPAS1
Hemoglobin M Disease	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	HBB
Hemoglobin SC Disease	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	HBB
Subacute Bacterial Endocarditis	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
PROSTATE CANCER, SOMATIC	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	AR
Synovial osteochondromatosis	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Squamous cell carcinoma, metastatic	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Hypopharyngeal Neoplasms	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	CDKN1A
Ulcer of esophagus	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Idiopathic osteoporosis	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	ESR1
Absent axillary hair	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	AR
ACTIVATED PI3K-DELTA SYNDROME	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	PIK3R1
Intermenstrual heavy bleeding	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Adenosarcoma	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Adnexal mass	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	ESR1
Intratubular malignant germ cells	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	AR
Adult Classical Hodgkin Lymphoma	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Labial hypoplasia	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	AR
LEPTIN DEFICIENCY OR DYSFUNCTION	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Angiodysplasia	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Angiodysplasia of colon	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Angiokeratoma	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Lupus-like syndrome	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	CDKN1A
Lymphangiectasis	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Ataxic cerebral palsy	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Malignant neoplasm of appendix	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Benign neoplasm of esophagus	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Meningeal Neoplasms	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Metastatic Endometrial Carcinoma	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Carcinoma in situ of esophagus	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Narrow foramen obturatorium	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	CAV1
Chromosome 17 trisomy	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Non-small cell lung cancer stage III	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Null Cell Pituitary Gland Adenoma	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	ESR1
Cohen syndrome	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
OTOFACIOCERVICAL SYNDROME 1	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	CDH1
Papillary adenocarcinoma	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Papillary cystic tumor	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	CDH1
Congenital malformation of genital organs	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	AR
Periampullary Adenocarcinoma	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	EGFR
Deficiency of butyryl-CoA dehydrogenase	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Primary cutaneous marginal zone B-cell lymphoma	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	PIM1
Primary malignant neoplasm of appendix	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	VEGFA
Dysplastic nodule	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	AR
Pupillary abnormality	1/7	0.006283877774032595	0.01566723580147316	0	0	195.84313725490196	992.8792720611536	PIK3R1
Inflammation	3/429	0.006292878471749314	0.01567454685875456	0	0	9.181220657276995	46.53351748210629	CDKN1A;CDH1;VEGFA
Motor Neuron Disease	2/135	0.0064465840748537725	0.01604193320361011	0	0	18.655075187969924	94.10002147267745	AR;VEGFA
Follicular adenoma	2/136	0.006539326388952067	0.0162258213858436	0	0	18.51492537313433	93.12861412231948	NR4A1;CDKN1A
Melanoma, B16	2/136	0.006539326388952067	0.0162258213858436	0	0	18.51492537313433	93.12861412231948	ESR1;VEGFA
Vasculitis	2/136	0.006539326388952067	0.0162258213858436	0	0	18.51492537313433	93.12861412231948	CAV1;VEGFA
Dementia	3/436	0.006580741625364385	0.01631291326133993	0	0	9.029561200923787	45.36097435922111	CDKN1A;STAT1;ESR1
Kidney Failure, Chronic	3/437	0.006622502236881999	0.016394462734104324	0	0	9.008294930875577	45.1971559987981	CAV1;ESR1;VEGFA
Periodontal Diseases	2/137	0.006632680432496716	0.016394462734104324	0	0	18.376851851851853	92.17362609399046	STAT1;VEGFA
Pruritus	2/137	0.006632680432496716	0.016394462734104324	0	0	18.376851851851853	92.17362609399046	EGFR;VEGFA
Measles	2/138	0.0067266451568714315	0.016610826424664348	0	0	18.240808823529413	91.23466588312017	STAT1;EGFR
Childhood Acute Lymphoblastic Leukemia	3/443	0.006876428340553285	0.016902588591449004	0	0	8.882727272727273	44.23292525735861	CDKN1A;ESR1;VEGFA
Myocardial Ischemia	3/448	0.007092454865068227	0.016902588591449004	0	0	8.780674157303372	43.45313078765736	NR4A1;ESR1;VEGFA
Vascular inflammations	2/142	0.007108589909223894	0.016902588591449004	0	0	17.71607142857143	87.63168596319518	NR4A1;VEGFA
Recurrent mycobacterial infections	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	STAT1
Erdheim-Chester Disease	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	AR
Retinal Neovascularization	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Fetal Hypoxia	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Secondary malignant neoplasm of ovary	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CDH1
Sensory denervation disorder	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	STAT1
Frontometaphyseal dysplasia	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	PIM1
Multiple Sclerosis, Secondary Progressive	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CAV1
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CAV1
Pulmonary Hypertension, Primary, Fenfluramine-Associated	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CAV1
Histoplasmosis	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	STAT1
Hot flushes	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	ESR1
Testicular dysgenesis syndrome	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	AR
Thanatophoric dysplasia, type 2	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	STAT1
Total Hypotrichosis, Mari type	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	ESR1
Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	ESR1
Hyperplasia of malar bones	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	HBB
Uterine carcinoma	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CAV1
Uterine Diseases	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	ESR1
Visually threatening diabetic retinopathy	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Intestinal adenocarcinoma	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CDH1
Adenofibroma	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	ESR1
Adenomyoma	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CDKN1A
Krukenberg Tumor	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CDH1
Macular Holes	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Malar prominence	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	HBB
Avascular retina	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Meningeal Carcinomatosis	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	EGFR
Metastases to adrenals	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	EGFR
Brenner Tumor	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	EGFR
Chronic mountain sickness	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	EPAS1
Claudication (finding)	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Cleft palate and bilateral cleft lip	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CDH1
Common wart	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CDKN1A
Congenital atresia of extrahepatic bile duct	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Pancreatic adenocarcinoma metastatic	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	EGFR
Craniofacial asymmetry	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	ESR1
Peritoneal Mesothelioma	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	EGFR
Persistence of hemoglobin F	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	HBB
Pleural Mesothelioma	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	EGFR
Deficiency of testosterone biosynthesis	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	AR
Polymorphous low grade adenocarcinoma	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	NFIB
delta beta^0^ Thalassemia	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	HBB
Poxviridae Infections	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Premenstrual Dysphoric Disorder	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	ESR1
Distichiasis	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	CDH1
Ectopic Pregnancy	1/8	0.007178528720410204	0.016902588591449004	0	0	167.85714285714286	828.6537822644398	VEGFA
Generalized osteopenia	2/145	0.007401409374967147	0.017395669167916416	0	0	17.341783216783217	85.08025975281727	STAT1;ESR1
Nerve Degeneration	2/145	0.007401409374967147	0.017395669167916416	0	0	17.341783216783217	85.08025975281727	CDH1;VEGFA
Anxiety	3/464	0.007810994140117291	0.01802165866712147	0	0	8.468980477223427	41.093382133912314	AR;HBB;ESR1
Crohn Disease	4/912	0.007874331950996042	0.01802165866712147	0	0	6.001887979861548	29.07402722877963	NR4A1;JUN;CDH1;VEGFA
Mild cognitive disorder	2/150	0.007901474565627706	0.01802165866712147	0	0	16.75168918918919	81.09000040913159	ESR1;VEGFA
Monoclonal Gammopathy of Undetermined Significance	2/150	0.007901474565627706	0.01802165866712147	0	0	16.75168918918919	81.09000040913159	CDH1;VEGFA
Septicemia	3/468	0.007997169971875946	0.01802165866712147	0	0	8.394408602150538	40.53380844721421	JUN;CAV1;VEGFA
Lung Diseases, Interstitial	2/151	0.008003283183497207	0.01802165866712147	0	0	16.638422818791945	80.32869848940709	EZR;EGFR
Malignant Squamous Cell Neoplasm	2/151	0.008003283183497207	0.01802165866712147	0	0	16.638422818791945	80.32869848940709	AR;EGFR
Primary Sj??gren's syndrome	2/151	0.008003283183497207	0.01802165866712147	0	0	16.638422818791945	80.32869848940709	STAT1;EGFR
Renal vascular disorder	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Familial pulmonary arterial hypertension	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	CAV1
Female Pseudohermaphroditism	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
Hypospadias, penoscrotal	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
Hypoxia-Ischemia, Brain	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Keratitis, Herpetic	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Skin Wrinkling	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	PIK3R1
Spinal Cord Contusion	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Spinal Cord Injuries	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Spinal Cord Laceration	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Spinal Cord transection injury	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Spinal Diseases	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
Hemorrhagic cystitis	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Thalassemia trait	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	HBB
Venous retinal branch occlusion	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Acquired porencephaly	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
West Nile Fever	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	STAT1
Adult Soft Tissue Sarcoma	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	EGFR
Low Grade Prostatic Intraepithelial Neoplasia	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	EGFR
Atresia	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	STAT1
Atypical polypoid adenomyoma	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	CDKN1A
Avascular Necrosis of Femur Head	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	STAT1
Mature Teratoma	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	EGFR
Medullary carcinoma of breast	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	ESR1
Birth length less than 3rd percentile	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	PIK3R1
Metaplastic breast carcinoma	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	EGFR
Microvillus inclusion disease	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	EZR
Capillary Leak Syndrome	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Carcinoid tumor of lung	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	EGFR
Carcinoma in situ of prostate	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	ESR1
Myocardial hypoxia	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Chronic acquired lymphedema	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Chronic anemia	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	HBB
Chronic periaortitis	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Obsessions	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	ESR1
Collagen-vascular disease	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Other emphysema	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	JUN
Other specified peritonitis	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	ESR1
Congenital porencephaly	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
Pericytic Neoplasm	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Peripheral Nervous System Neoplasms	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	EGFR
Pituitary growth hormone cell adenoma	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	CDKN1A
Deficiency of steroid 21-monooxygenase	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
Post-Traumatic Myelopathy	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	VEGFA
Dilatation of the cerebral artery	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	STAT1
Progression of prostate cancer	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
Progressive Muscular Atrophy	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
pseudohermaphrodite (non-specific)	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	AR
Psychoticism	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	ESR1
Endometrial Diseases	1/9	0.008072419310050151	0.01802165866712147	0	0	146.86764705882354	707.7995527019895	ESR1
Aneurysm	2/152	0.008105687918117133	0.018064703962464672	0	0	16.526666666666667	79.57902769854041	STAT1;VEGFA
Pre-Eclampsia	2/152	0.008105687918117133	0.018064703962464672	0	0	16.526666666666667	79.57902769854041	ESR1;VEGFA
Cachexia	2/153	0.008208687737135404	0.018262739384169464	0	0	16.41639072847682	78.84073766209582	EGFR;VEGFA
Primary Effusion Lymphoma	2/153	0.008208687737135404	0.018262739384169464	0	0	16.41639072847682	78.84073766209582	CDKN1A;VEGFA
Hypercholesterolemia, Familial	2/154	0.008312281608136166	0.018461413064329937	0	0	16.307565789473685	78.11358497219229	ESR1;EGFR
Premature Menopause	2/154	0.008312281608136166	0.018461413064329937	0	0	16.307565789473685	78.11358497219229	AR;ESR1
Abnormality of metabolism/homeostasis	2/155	0.008416468504225307	0.018660719438981947	0	0	16.200163398692812	77.39733293925609	CDH1;HBB
Other specified transient cerebral ischemias	2/155	0.008416468504225307	0.018660719438981947	0	0	16.200163398692812	77.39733293925609	CAV1;ESR1
Mucocutaneous Lymph Node Syndrome	2/156	0.008521247395824046	0.018876828493493578	0	0	16.094155844155843	76.69175138060437	STAT1;VEGFA
Cardiomyopathies	3/480	0.008571548763376957	0.018971988394004012	0	0	8.178197064989519	38.922549259057206	PIM1;EGFR;VEGFA
Cardiomegaly	2/159	0.008839125793675793	0.019013149335891807	0	0	15.784235668789808	74.63682062852904	CAV1;HBB
Turner Syndrome	2/160	0.00894626241966806	0.019013149335891807	0	0	15.683544303797468	73.9717416072873	AR;ESR1
46, XX Testicular Disorders of Sex Development	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	AR
Enlarged polycystic ovaries	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Agammaglobulinemia, non-Bruton type	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	PIK3R1
Congenital secretory diarrhea, sodium type (disorder)	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CAV1
Fasting hyperinsulinemia	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CDKN1A
Scimitar Syndrome	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	VEGFA
Severe beta thalassemia	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	HBB
Gangrene	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	VEGFA
Sick Headaches	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Generalized osteoporosis with pathologic fractures	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	STAT1
Meningitis, Cryptococcal	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CAV1
Hemicrania migraine	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Status Migrainosus	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Subcutaneous lipoma	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CDKN1A
Trophoblastic Tumor, Placental Site	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	AR
Abdominal Migraine	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Abnormal hemoglobin finding	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	HBB
Acute Confusional Migraine	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Insulin resistance in diabetes	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	PIK3R1
Intestinal carcinoma	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CAV1
Adenosquamous cell lung cancer	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	EGFR
Kabuki syndrome eyelids	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CDH1
Anal intraepithelial neoplasia	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CDKN1A
Leukostasis	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	VEGFA
Liver mass	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	VEGFA
Loss of subcutaneous adipose tissue in limbs	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CAV1
Lymphangioma	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	VEGFA
Bladder Adenocarcinoma	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	EGFR
Merkel Cell Polyomavirus Infection	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	EGFR
Metastatic Malignant Neoplasm to the Leptomeninges	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	EGFR
Mild dementia	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Cancer Cell Growth	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	EGFR
cervical cancer metastasis	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	EGFR
Cervical Migraine Syndrome	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Childhood Soft Tissue Sarcoma	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	EGFR
Night sweats	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Oliguria	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CAV1
Congenital euryblepharon	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CDH1
Corneal fibrosis	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	CDKN1A
Penis agenesis	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	AR
Perihilar Cholangiocarcinoma	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	JUN
Deformity of spine	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	AR
Dementia due to Alzheimer's disease (disorder)	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Pressure Ulcer	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	VEGFA
Primary bacterial peritonitis	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	VEGFA
Distemper	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	STAT1
Donohue Syndrome	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	EGFR
Prostatic Adenoma	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	VEGFA
Pulmonary lymphangioleiomyomatosis	1/10	0.008965550093347357	0.019013149335891807	0	0	130.54248366013073	615.425022203049	ESR1
Heartburn	2/162	0.009162295275844844	0.01941444519893949	0	0	15.4859375	72.67021710271118	CAV1;VEGFA
Acute leukemia	3/492	0.00916989517275095	0.01941462232066861	0	0	7.972597137014315	37.406065835709704	NR4A1;STAT1;VEGFA
Pneumonia	3/497	0.009426335994825124	0.0199412169325416	0	0	7.889878542510122	36.80034867819232	JUN;CAV1;VEGFA
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	2/166	0.009601370877517652	0.02016073759519478	0	0	15.105182926829269	70.1764049009769	CDH1;ESR1
Acute GVH disease	2/166	0.009601370877517652	0.02016073759519478	0	0	15.105182926829269	70.1764049009769	CAV1;VEGFA
Malignant neoplasm of brain	2/166	0.009601370877517652	0.02016073759519478	0	0	15.105182926829269	70.1764049009769	EGFR;VEGFA
Childhood Leukemia	2/168	0.009824397358854207	0.02016073759519478	0	0	14.921686746987952	68.98126363240131	CAV1;PIM1
Recurrent Endometrial Cancer	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	EGFR
Refractory Cytopenia of Childhood	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Erosive esophagitis	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Colitis, Ischemic	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Rotator cuff syndrome	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Dendritic Cell Sarcoma, Follicular	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	EGFR
Depressive episode, unspecified	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	ESR1
Familial Partial Lipodystrophy, Type 1	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	CAV1
Familial Partial Lipodystrophy, Type 3	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	CAV1
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Sex Differentiation Disorders	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	AR
SHORT syndrome	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	PIK3R1
Sturge-Weber Syndrome	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Systemic Anaplastic Large Cell Lymphoma	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	CDKN1A
Adenolymphoma	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	AR
Yersinia infections	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Kallmann Syndrome 1	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	EZR
Angioma	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Leukemic Infiltration	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Lipoatrophic Diabetes Mellitus	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	CAV1
Aseptic necrosis	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	HBB
Malignant neoplasm of body of stomach	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	CDKN1A
Malignant neoplasm of fallopian tube	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	EGFR
Malignant tumor of greater curve of stomach	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	CDKN1A
Malignant tumor of lesser curve of stomach	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	CDKN1A
Malignant tumor of parathyroid gland	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	EGFR
Bone infarction	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	HBB
Burn scar	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Multiple Endocrine Neoplasia Type 2b	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	EGFR
Carney Triad	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	EPAS1
Nonproliferative diabetic retinopathy	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Peripheral Nerve Sheath Neoplasm	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Porencephaly	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	AR
Diabetic macular edema	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	VEGFA
Dimple chin	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	PIK3R1
Eccrine dermal cylindroma	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	NFIB
Pulmonary Blastoma	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	EGFR
Electrocardiogram	1/11	0.009857921634816495	0.02016073759519478	0	0	117.48235294117647	542.7073703814344	CAV1
Genetic Diseases, Inborn	3/507	0.009951887448316855	0.02033680797389433	0	0	7.729365079365079	35.63231931613199	CAV1;HBB;PIK3R1
Complete atrioventricular block	2/170	0.010049738815238978	0.02050432492872218	0	0	14.742559523809524	67.81884959907823	STAT1;ESR1
Dental caries	2/170	0.010049738815238978	0.02050432492872218	0	0	14.742559523809524	67.81884959907823	CDH1;CAV1
Keloid	2/171	0.010163275132191495	0.02071960510374951	0	0	14.654585798816568	67.24952102604539	EGFR;VEGFA
Fever	2/173	0.010392073899679458	0.0211693429675647	0	0	14.48172514619883	66.1338663901299	HBB;PIK3R1
Unipolar Depression	3/517	0.010494435401086898	0.02135849817755938	0	0	7.575097276264591	34.519037469247124	ESR1;EGFR;VEGFA
Azoospermia	2/174	0.010507334335242641	0.02135849817755938	0	0	14.396802325581396	65.58724972161193	AR;ESR1
Cataract	3/519	0.01060499511610233	0.02135849817755938	0	0	7.544961240310077	34.302639274795006	PIK3R1;ESR1;EGFR
Ovarian Failure, Premature	2/175	0.010623167464548824	0.02135849817755938	0	0	14.3128612716763	65.04791901106834	AR;ESR1
Liver Failure	2/176	0.010739572284803005	0.02135849817755938	0	0	14.229885057471265	64.5157376875682	CAV1;VEGFA
Mucosa-Associated Lymphoid Tissue Lymphoma	2/176	0.010739572284803005	0.02135849817755938	0	0	14.229885057471265	64.5157376875682	CDH1;PIM1
Reifenstein Syndrome	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	AR
Eye Infections	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	VEGFA
Secondary pulmonary hypertension	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	AR
Senile dementia	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	ESR1
Gangliosidosis GM1	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	NFIB
Sickle Cell Dactylitis	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	VEGFA
Melanoma, Experimental	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	VEGFA
Stage IV Colorectal Cancer	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	EGFR
Pancreatic Intraductal Papillary Mucinous Neoplasm, Gastric-Type	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	CDH1
Hypersplenism	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	HBB
Idiopathic urticaria	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	VEGFA
Urologic Neoplasms	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	VEGFA
Intracranial Arteriovenous Malformation	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	VEGFA
Aseptic Necrosis of Bone	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	HBB
Lymphoepithelial carcinoma	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	EGFR
Malignant neoplasm of anus	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	EGFR
Migraine Variant	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	ESR1
Breast cancer stage II	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	ESR1
Childhood Ependymoma	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	EGFR
Non-small cell lung cancer recurrent	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	EGFR
OROFACIAL CLEFT 1	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	CDH1
Complicated pneumoconiosis	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	VEGFA
Palmar-plantar erythrodysesthesia syndrome	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	VEGFA
Paronychia Inflammation	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	EGFR
Delta-Beta Thalassemia	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	HBB
Priapism	1/12	0.010749534506708167	0.02135849817755938	0	0	106.79679144385027	484.0984098875249	HBB
Carcinoma of larynx	2/177	0.010856547791506637	0.021537989973472844	0	0	14.147857142857143	63.990572490930916	CDKN1A;EGFR
Dengue Fever	2/177	0.010856547791506637	0.021537989973472844	0	0	14.147857142857143	63.990572490930916	STAT1;VEGFA
Scleroderma	2/179	0.011092206858289495	0.02198861881424541	0	0	13.986581920903955	62.960773378309824	CAV1;EGFR
Penile hypospadias	2/180	0.011210888420192971	0.022206844163618438	0	0	13.907303370786517	62.455888603944274	AR;ESR1
Epilepsy, Temporal Lobe	2/181	0.011330136667867058	0.02240868530865284	0	0	13.828910614525139	61.95751806555297	ESR1;VEGFA
insulinoma	2/181	0.011330136667867058	0.02240868530865284	0	0	13.828910614525139	61.95751806555297	CDKN1A;STAT1
Immune thrombocytopenic purpura	2/183	0.011570329235268738	0.02245491077454049	0	0	13.674723756906078	60.97984993065522	AR;STAT1
Recurrent chest infections	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	PRKDC
Adenocarcinoma, intestinal type	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	EGFR
Epithelioid hemangioendothelioma	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
Renal carnitine transport defect	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	HBB
Renal Cell Dysplasia	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	ESR1
Erythrocytosis	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	HBB
Rieger syndrome	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	PIK3R1
Cystadenoma, Mucinous	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
Secondary Open Angle Glaucoma	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	CAV1
Senile cardiac amyloidosis	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
Spinocerebellar ataxia type 8	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	AR
Neoplasms, Vascular Tissue	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
Stage IV Colorectal Cancer AJCC v7	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	EGFR
Scleroderma, Limited	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	CAV1
Tendinosis	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
Hydrosalpinx (disease)	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
stage, pancreatic cancer	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	EGFR
TUBEROUS SCLEROSIS 1 (disorder)	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
Urolithiasis	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	AR
Age-related cognitive decline	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	ESR1
Liver and Intrahepatic Bile Duct Epithelial Neoplasm	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	CDKN1A
Liver and Intrahepatic Bile Duct Neoplasm	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	CDKN1A
Lower Urinary Tract Symptoms	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	AR
Macular retinal edema	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
Malignant Mixed Mesodermal (Mullerian) Tumor	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	EGFR
Nonspherocytic hemolytic anemia	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	HBB
Occupational Diseases	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	EGFR
Olfactory Neuroblastoma	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	CDKN1A
OVERLAP CONNECTIVE TISSUE DISEASE	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	AR
Curling Ulcer	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	VEGFA
Pimples	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	EGFR
pustule	1/13	0.011640389286531055	0.02245491077454049	0	0	97.8921568627451	435.94063546940737	EGFR
Proteinuria	2/184	0.011691271565859305	0.022536234667622824	0	0	13.598901098901099	60.50032428909118	NR4A1;VEGFA
Adrenocortical carcinoma	2/185	0.011812776599693918	0.022753469020886943	0	0	13.523907103825136	60.026856642143386	ESR1;EGFR
Hashimoto Disease	2/186	0.011934843347695623	0.02295435619292464	0	0	13.449728260869565	59.55933945612225	ESR1;VEGFA
Respiratory Distress Syndrome, Adult	2/186	0.011934843347695623	0.02295435619292464	0	0	13.449728260869565	59.55933945612225	EPAS1;VEGFA
Pediatric failure to thrive	3/543	0.011985436772035797	0.023034511296256298	0	0	7.20074074074074	31.856530457140664	NR4A1;PIK3R1;EGFR
Bronchopulmonary Dysplasia	2/188	0.012180658013508787	0.02336913124699211	0	0	13.303763440860216	58.641738614551095	EGFR;VEGFA
Refractory Neoplasm	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	ESR1
Extranodal marginal zone B-cell lymphoma	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Exudative retinopathy	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Familial Exudative Vitreoretinopathy	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Cystadenoma, Serous	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	AR
Depressive Disorder, Treatment-Resistant	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Female pattern alopecia (disorder)	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	AR
Fibromatosis	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	CAV1
Familial Partial Lipodystrophy, Type 2	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	CAV1
Fulminant Hepatic Failure with Cerebral Edema	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	PRKDC
Heredodegenerative Disorders, Nervous System	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	AR
Hydatidiform Mole, Partial	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	EGFR
Stage II Colorectal Cancer AJCC v7	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	EZR
Hepatic Stupor	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	PRKDC
Pyloric Stenosis, Hypertrophic	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	AR
Takotsubo Cardiomyopathy	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	ESR1
Testicular Feminization	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	AR
Supratentorial Embryonal Tumor, Not Otherwise Specified	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	EGFR
Thyroid Lymphoma	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	PIM1
Hypoparathyroidism - autosomal dominant	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	ESR1
Vascular occlusion	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Viral Encephalitis	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Acute myocarditis	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Adenocarcinoma of small intestine	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	EGFR
Amelanotic Skin Melanoma	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	CAV1
Anal squamous cell carcinoma	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	EGFR
B lymphocytopenia	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	STAT1
Maxillary Sinus Squamous Cell Carcinoma	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Methemoglobinemia	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	HBB
Cancer Relapse	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	AR
Central retinal vein occlusion	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Contralateral breast cancer	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	ESR1
Coronary Occlusion	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
POEMS Syndrome	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Delayed epiphyseal ossification	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	ESR1
Delayed maturation of end part of long bone	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	ESR1
Diastolic hypertension	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	VEGFA
Disorder of endocrine ovary	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	ESR1
Disorder of face	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	CAV1
Dyspareunia	1/14	0.01253048655713669	0.02336913124699211	0	0	90.35746606334841	395.7287161899813	CAV1
Transient Ischemic Attack	2/191	0.012553568112905226	0.02337841848279322	0	0	13.090608465608465	57.30741568767214	CAV1;ESR1
Deglutition Disorders	2/191	0.012553568112905226	0.02337841848279322	0	0	13.090608465608465	57.30741568767214	AR;CAV1
Hematopoietic Neoplasms	2/192	0.012678984355525787	0.023577981706496116	0	0	13.021052631578947	56.873476489999355	PIM1;ESR1
Inflammatory disorder	2/192	0.012678984355525787	0.023577981706496116	0	0	13.021052631578947	56.873476489999355	ESR1;VEGFA
Hypospadias	2/195	0.013058557941245752	0.024266370620314948	0	0	12.816709844559586	55.60288072596898	AR;ESR1
Tuberous Sclerosis	2/197	0.013314367890295196	0.02435939065068527	0	0	12.683974358974359	54.780963160336874	EGFR;VEGFA
Allergic asthma	2/197	0.013314367890295196	0.02435939065068527	0	0	12.683974358974359	54.780963160336874	CAV1;VEGFA
Parkinson Disease	4/1064	0.013392050328022652	0.02435939065068527	0	0	5.100269541778975	21.99794199562853	AR;CDKN1A;ESR1;VEGFA
Esophageal Varices	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	VEGFA
Atrophy, Muscular, Spinobulbar	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	AR
Breast Fibrocystic Change, Proliferative Type	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	ESR1
Chromosome 10, monosomy 10q	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	EGFR
Smoker's lung	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	EGFR
Helicobacter Infections	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	CDH1
Hemoglobin H Disease	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	HBB
Stage II Colorectal Cancer	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	EZR
Hepatic Coma	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	PRKDC
Stromal keratitis	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	VEGFA
Hereditary Paraganglioma	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	ESR1
Humoral hypercalcemia of malignancy (disorder)	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	EGFR
Thalassemia Minor	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	HBB
Thanatophoric Dysplasia	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	STAT1
Transient ischemia	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	PIK3R1
Triglyceride storage disease with ichthyosis	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	ESR1
Abnormality of the face	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	CAV1
Juvenile hemochromatosis	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	ESR1
Malignant tumor of peritoneum	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	VEGFA
Multiple renal cysts	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	EPAS1
Chronic hemolytic anemia	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	HBB
Chronic ulcer	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	VEGFA
Pancreatic Endocrine Carcinoma	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	VEGFA
Patent ductus arteriosus - persisting type	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	VEGFA
Peg-shaped teeth	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	CDH1
Phobic anxiety disorder	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	ESR1
Pointed tooth	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	CDH1
Progressive pseudorheumatoid dysplasia	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	ESR1
Pulmonary Pathology	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	EPAS1
Rapidly progressive glomerulonephritis	1/15	0.01341982690512007	0.02435939065068527	0	0	83.89915966386555	361.6911269349327	EGFR
Arthritis, Psoriatic	2/201	0.01383257868654316	0.025090976648413612	0	0	12.426507537688442	53.194507391260906	ESR1;VEGFA
Melanocytic nevus	2/203	0.014094963919602976	0.02538367129503582	0	0	12.301616915422885	52.42872507773333	CDKN1A;EGFR
Recurrent lower respiratory tract infection	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	PRKDC
Reoviridae Infections	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	STAT1
Cystadenocarcinoma, Mucinous	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	ESR1
Depression, Postpartum	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	ESR1
Secondary polycythemia	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EPAS1
Female external genitalia in individual with 46,XY karyotype	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	AR
Focal nodular hyperplasia of liver	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	AR
Glioblastoma, IDH-Mutant	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EGFR
Macular Edema, Cystoid	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	VEGFA
Nephrosis, congenital	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	VEGFA
Other specified forms of pleural effusion, except tuberculous	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	ESR1
Steroid-sensitive nephrotic syndrome	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	VEGFA
Hereditary persistence of fetal hemoglobin thalassemia	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	HBB
RETINOSCHISIS 1, X-LINKED, JUVENILE	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	ESR1
SPHEROCYTOSIS, TYPE 1 (disorder)	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EGFR
Tonsillitis	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EGFR
Tumor thrombus	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	VEGFA
Abnormality of the spleen	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	HBB
Increased number of platelets	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	HBB
Adenocarcinoma of salivary gland	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EGFR
Inverted Papilloma	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EGFR
Juvenile polyp	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	CDKN1A
Lepidic Predominant Adenocarcinoma	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	VEGFA
Asymmetric crying face association	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	AR
Blastoma	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EZR
Non-small cell carcinoma	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EGFR
Codependency	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	ESR1
Ovarian Granulosa Cell Tumor	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EGFR
Pleomorphic Xanthoastrocytoma	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	EGFR
Diverticulitis	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	VEGFA
Empyema	1/16	0.014308410919694987	0.02538367129503582	0	0	78.30196078431372	332.5412031884909	VEGFA
Myxoid cyst	2/209	0.014895145669006871	0.026343547537473557	0	0	11.941425120772946	50.23423084681995	ESR1;VEGFA
Influenza	3/589	0.014912394233783793	0.026343547537473557	0	0	6.619795221843003	27.839963098969722	JUN;STAT1;EGFR
Lupus Nephritis	2/210	0.015030398760730718	0.026343547537473557	0	0	11.883413461538462	49.88277349072922	STAT1;VEGFA
Erythema Multiforme	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	VEGFA
Familial Intestinal Polyposis	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EGFR
Familial partial lipodystrophy	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	CAV1
Gonadal Dysgenesis, 45,X	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	AR
Motor Neuron Disease, Lower	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	AR
Polyposis, Adenomatous Intestinal	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EGFR
Hyperkeratosis lenticularis perstans	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EGFR
Hypertrophy of kidney	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	CDKN1A
Zollinger-Ellison syndrome	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	CDKN1A
Adult Solid Neoplasm	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	VEGFA
Anal carcinoma	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EGFR
Malignant Female Reproductive System Neoplasm	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	ESR1
Autosome Abnormalities	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EPAS1
Mature B-Cell Non-Hodgkin Lymphoma	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	CDKN1A
Melnick-Needles Syndrome	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	VEGFA
Metastatic hepatocellular carcinoma	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EZR
Bone Cysts	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	CAV1
Brain Stem Glioma	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EGFR
Mucosal telangiectasiae	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	CAV1
Central nervous system lesion	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EGFR
Cervical Intraepithelial Neoplasia Grade 2/3	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	AR
Neonatal Deformity	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	ESR1
Chromosome Aberrations	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EPAS1
Non-Functioning Pituitary Gland Neoplasm	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	CDKN1A
Parainfluenza	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	STAT1
Pathologic Neovascularization	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	VEGFA
Corneal diameter increased	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	PIK3R1
Poisoning	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	PRKDC
Portal vein thrombosis	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	ESR1
Dermoid Cyst	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	EGFR
Pseudopelade	1/17	0.015196239191186837	0.026343547537473557	0	0	73.40441176470588	307.3227868353231	AR
Congenital contractural arachnodactyly	2/212	0.015302515802612085	0.02650999216508854	0	0	11.769047619047619	49.19153594031784	CDH1;EGFR
Recurrent respiratory infections	2/213	0.015439377828682313	0.02672916416319465	0	0	11.712677725118484	48.85163485318962	STAT1;PIK3R1
Blast Phase	2/214	0.01557677424323027	0.026948967093277824	0	0	11.65683962264151	48.51546698342316	PRKDC;CDH1
Recurrent Carcinoma	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	AR
Reduced subcutaneous adipose tissue	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	CAV1
Residual Cancer	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	ESR1
B-CELL MALIGNANCY, LOW-GRADE	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	EGFR
Retinal ischemia	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	VEGFA
Carney Complex, Type 1	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	CAV1
Central Nervous System Embryonal Tumor, Not Otherwise Specified	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	EGFR
Small intestine biopsy shows villous atrophy	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	STAT1
Smoldering myeloma	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	VEGFA
SPINOCEREBELLAR ATAXIA 17	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	AR
SPINOCEREBELLAR ATAXIA 8	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	AR
Heat Stroke	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	JUN
Stenosis	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	VEGFA
Psychoses, Substance-Induced	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	ESR1
Teratoma, Malignant	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	EGFR
Thymus Hyperplasia	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	ESR1
Tooth Loss	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	ESR1
Idiopathic scoliosis	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	ESR1
Abnormality of the rib cage	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	AR
Immunosuppression	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	VEGFA
Variable degree of villous atrophy	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	STAT1
Acquired partial lipodystrophy	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	PIK3R1
Villous atrophy	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	STAT1
Villous atrophy of intestine	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	STAT1
Aneurysmal disease	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	JUN
Benign neoplasm of stomach	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	CDH1
Biopsy shows villous atrophy	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	STAT1
Mouth Abnormalities	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	AR
Carcinoma in situ of stomach	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	CDH1
Narrowing	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	ESR1
Neoplasm of uncertain or unknown behavior of stomach	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	CDH1
Choroid Plexus Carcinoma	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	CAV1
Congenital hernia of foramen of Bochdalek	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	PIM1
Congenital hernia of foramen of Morgagni	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	PIM1
Pleural Diseases	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	VEGFA
Primary Cutaneous Anaplastic Large Cell Lymphoma	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	CDKN1A
Diminished ovarian reserve	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	AR
Proliferative Inflammatory Atrophy	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	AR
Duodenal villous atrophy	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	STAT1
Pseudohypoaldosteronism	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	NR4A1
Pulpitis	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	VEGFA
Elevated circulating parathyroid hormone level	1/18	0.0160833123117468	0.02706397114087426	0	0	69.08304498269896	285.3111137768628	CDKN1A
Status Epilepticus	2/221	0.016553431582068703	0.02783692303156475	0	0	11.280251141552512	46.2621356661414	JUN;VEGFA
Adenocarcinoma of lung, stage IV	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	EGFR
Anaplastic Large Cell Lymphoma, ALK-Positive	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	STAT1
Fallopian Tube Carcinoma	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	EGFR
Female Urogenital Diseases	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	ESR1
Skeletal muscle hypertrophy	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	CAV1
Leukemia, Monocytic, Chronic	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	VEGFA
Squamous cell carcinoma of vulva	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	EGFR
Staphylococcal Infections	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	EGFR
HER2-positive carcinoma of breast	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	EGFR
Spondyloepiphyseal Dysplasia Tarda, X-Linked	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	VEGFA
stage, cervical cancer	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	EZR
THANATOPHORIC DYSPLASIA, TYPE I (disorder)	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	STAT1
Hypertrophy	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	CDKN1A
Alcohol Withdrawal Delirium	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	VEGFA
Aortic Rupture	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	STAT1
Borderline ovarian tumour	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	AR
Carcinoma in situ of endometrium	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	EGFR
Cholecystitis	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	VEGFA
Classical phenylketonuria	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	HBB
Congenital keratoglobus	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	PIK3R1
Differentiating Neuroblastoma	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	CDKN1A
Dyschondroplasias	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	VEGFA
Proximal amyotrophy	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	AR
Pseudolymphoma	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	VEGFA
Pulmonary Infiltrate	1/19	0.016969630876880012	0.028079792796272304	0	0	65.24183006535948	265.9472259849427	CAV1
Malnutrition	2/225	0.017123130886384515	0.028315651139264535	0	0	11.07567264573991	45.048360754547126	STAT1;HBB
46, XY Disorders of Sex Development	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	AR
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	EGFR
Rokitansky Kuster Hauser syndrome	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	ESR1
Filarial Elephantiases	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	VEGFA
Sick Sinus Syndrome	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	VEGFA
Squamous cell carcinoma of penis	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	EGFR
Hyperferritinaemia	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	HBB
Thymoma, type C	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	EGFR
Hypoplasia of iris	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	PIK3R1
Increased ferritin	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	HBB
Increased serum ferritin	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	HBB
Arteriosclerosis Obliterans	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	VEGFA
Atrophy of testis	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	AR
malignant neoplasm of breast staging	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	ESR1
Beta thalassemia intermedia	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	HBB
Bifid scrotum	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	AR
Calf muscle hypertrophy	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	AR
Carcinoma of ampulla of Vater	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	EGFR
Chronic multifocal osteomyelitis	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	STAT1
Chronic myocardial ischemia	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	VEGFA
Chronic small plaque psoriasis	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	VEGFA
Clear cell sarcoma of kidney	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	EGFR
Ovarian Clear Cell Adenocarcinoma	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	ESR1
Corneal pannus	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	VEGFA
Cutaneous Fibrous Histiocytoma	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	ESR1
Destructive Arthritis	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	JUN
Pregnancy associated hypertension	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	ESR1
Eczema Herpeticum	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	CAV1
Elevated circulating luteinizing hormone level	1/20	0.017855195476470426	0.02898803891623074	0	0	61.804953560371516	248.79341471282055	AR
Promyelocytic leukemia	2/233	0.018287570765843603	0.029671353824229918	0	0	10.687770562770563	42.76747347574325	CDKN1A;EGFR
Uveal melanoma	2/236	0.018732765916748176	0.030009570568831887	0	0	10.5491452991453	41.95902605220579	EGFR;VEGFA
46, XY female	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	AR
Sandhoff Disease	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	NFIB
Shared Paranoid Disorder	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	ESR1
Simple renal cyst	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	EGFR
Leukomalacia, Periventricular	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	VEGFA
Helicobacter-associated gastritis	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	CAV1
Neoplasms, Neuroepithelial	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	CDH1
Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	STAT1
Sudden Cardiac Arrest	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	ESR1
Herpes encephalitis	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	STAT1
Hypoalphalipoproteinemias	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	ESR1
Van Buchem disease	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	VEGFA
Lumbar disc disease	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	ESR1
Asthma chronic	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	EGFR
Microcytic hypochromic anemia (disorder)	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	HBB
Nodular Goiter	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	VEGFA
Oropharynx (excludes nasopharynx)	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	CDKN1A
Otitis Media with Effusion	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	VEGFA
Pancreatic Intraductal Papillary-Mucinous Neoplasm	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	EGFR
Pseudomyxoma Peritonei	1/21	0.01874000670829494	0.030009570568831887	0	0	58.71176470588235	233.50224496360525	CDH1
Periodontitis	2/237	0.018882190761238017	0.030218524619750803	0	0	10.50372340425532	41.69490912116133	CAV1;VEGFA
Renal Artery Stenosis	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	STAT1
Familial generalized lipodystrophy	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	CAV1
Fibromyxosarcoma	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EZR
Severe depression	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	ESR1
Gastrointestinal inflammation	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	VEGFA
Shwachman syndrome	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	VEGFA
Leukemia, T-Cell, Chronic	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	VEGFA
Hemoglobin F Disease	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	HBB
Pancreatic carcinoma, familial	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	CDKN1A
Herpes zoster disease	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	ESR1
Psychoses, Drug	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	ESR1
THYROID CARCINOMA, SPORADIC MEDULLARY	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EGFR
Abnormality of the immune system	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	PIK3R1
XX males	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	AR
AIDS with Kaposi's sarcoma	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	VEGFA
Anaplastic large B-cell lymphoma	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EGFR
ANOPHTHALMIA AND PULMONARY HYPOPLASIA	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EGFR
Liver calculus	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EGFR
Lower respiratory tract infection	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	PRKDC
Malignant Adrenal Medulla Neoplasm	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EPAS1
Malignant neoplasm of aortic body and other paraganglia	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EPAS1
Benign neoplasm of aortic body and other paraganglia	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EPAS1
myeloblastosis	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	NFIB
Nephrosclerosis	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	VEGFA
Other specified manifestations of hyperkinetic syndrome	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	VEGFA
Diabetic Polyneuropathies	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	VEGFA
Disorder of skeletal system	1/22	0.019624065171284413	0.030889067847305083	0	0	55.91316526610644	219.7945772360195	EGFR
Vitiligo	2/243	0.01978945236558502	0.0311304235446444	0	0	10.239107883817427	40.16398798592782	CDH1;ESR1
Amyotrophic Lateral Sclerosis	3/660	0.020170894048244584	0.03171114992490308	0	0	5.882800608828006	22.963598079297807	AR;EGFR;VEGFA
Leukopenia	2/246	0.020249927978736693	0.03179504230110049	0	0	10.111680327868852	39.43154947838899	STAT1;ESR1
Splenomegaly	2/247	0.02040442772025931	0.03179504230110049	0	0	10.069897959183674	39.19207665748138	HBB;VEGFA
Enthesitis-Related Arthritis	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	ESR1
Retinal Vein Occlusion	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	VEGFA
Squamous Cell Neoplasms	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	VEGFA
Stage III Colon Cancer AJCC v7	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	VEGFA
Stage IV Bladder Cancer AJCC v6	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	CAV1
Hypoxic-Ischemic Encephalopathy	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	VEGFA
Absence of pubertal development	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	ESR1
Job Syndrome	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	STAT1
Aniridia	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	VEGFA
Benign neoplasm of adrenal gland	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	EPAS1
beta^0^ Thalassemia	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	HBB
Bloch Sulzberger syndrome	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	AR
C-cell hyperplasia of thyroid	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	AR
Camurati-Engelmann Syndrome	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	VEGFA
Capillary malformation (disorder)	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	STAT1
Neuroepithelioma	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	EGFR
Chronic glomerulonephritis	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	VEGFA
Depletion of mitochondrial DNA	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	VEGFA
PR interval feature	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	CAV1
Electrocardiogram: P-R interval	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	CAV1
Elevated circulating follicle stimulating hormone level	1/23	0.02050737145707836	0.03179504230110049	0	0	53.36898395721925	207.44368622737056	AR
Erectile abnormalities	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	AR
Candidiasis, Chronic Mucocutaneous	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	STAT1
Fetal overgrowth	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	ESR1
Epilepsy, Benign Psychomotor, Childhood	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	VEGFA
Generalized overgrowth	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	ESR1
Healing ulcer	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	VEGFA
Thymus Neoplasms	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	EGFR
Uncinate Epilepsy	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	VEGFA
Asphyxia Neonatorum	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	VEGFA
Asymptomatic human immunodeficiency virus infection	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	EGFR
Carotid artery occlusion	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	VEGFA
Childhood Solid Neoplasm	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	VEGFA
Norrie disease	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	AR
Cognitive changes	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	ESR1
Complications of Diabetes Mellitus	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	VEGFA
Overgrowth	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	ESR1
Penis carcinoma	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	EGFR
Precocious pubarche	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	AR
Elastosis perforans serpiginosa	1/24	0.02138992615773652	0.03278942389639966	0	0	51.0460358056266	196.26359569838613	VEGFA
Acute Coronary Syndrome	2/255	0.021658434659826305	0.03318133850909333	0	0	9.747529644268775	37.35604571683431	EGFR;VEGFA
Skin Neoplasms	2/256	0.02181742288338004	0.0334050997674989	0	0	9.708661417322835	37.136080534753034	EGFR;VEGFA
MYELODYSPLASTIC SYNDROME	3/683	0.022070069406186717	0.033771913078305855	0	0	5.6770588235294115	21.649650677664553	CDKN1A;CDH1;VEGFA
Excessive wrinkled skin	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	PIK3R1
Temporomandibular Joint Disorders	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	ESR1
Insulin-resistant diabetes mellitus	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	PIK3R1
Adolescent idiopathic scoliosis	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	ESR1
Malignant neoplasm of penis	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	EGFR
Cancer of Digestive System	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	VEGFA
Cervix Diseases	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	CDKN1A
CNS metastases	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	EGFR
Perianal Squamous Intraepithelial Neoplasia	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	CDKN1A
Cyanosis	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	HBB
Port-Wine Stain	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	VEGFA
Diabetic foot ulcer	1/25	0.02227172987906945	0.033839928398609644	0	0	48.916666666666664	186.10038260880106	VEGFA
Renal Insufficiency	2/263	0.022944125421001643	0.03482060867358828	0	0	9.44492337164751	35.651689425059345	HBB;VEGFA
Male infertility	2/263	0.022944125421001643	0.03482060867358828	0	0	9.44492337164751	35.651689425059345	AR;ESR1
Recurrent Childhood Acute Lymphoblastic Leukemia	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	VEGFA
Reticulocytosis	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	HBB
Epilepsy, Lateral Temporal	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	VEGFA
Hypotension, Orthostatic	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	CAV1
Spondyloepiphyseal Dysplasia	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	VEGFA
Osteoarthrosis, localized, not specified whether primary or secondary	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	CAV1
Tuberculosis, Meningeal	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	VEGFA
Malignant Uterine Corpus Neoplasm	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	PIK3R1
Beta thalassemia trait	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	HBB
Multiple lipomata	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	EGFR
Carpal Tunnel Syndrome	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	ESR1
Coronary Thrombosis	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	ESR1
Pituitary carcinoma	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	EGFR
Dermatitis Herpetiformis	1/26	0.023152783214921657	0.03485060550357962	0	0	46.95764705882353	176.82560723797164	VEGFA
Pancreatitis	2/269	0.023928905817327203	0.03580015172565689	0	0	9.229868913857677	34.45203728422377	CAV1;VEGFA
Recurrent skin infections	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	PIK3R1
Extramedullary Hematopoiesis (disorder)	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	VEGFA
Failure to thrive in infant	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	NR4A1
Fluid overload	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	CDKN1A
Gastric lymphoma	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	CDH1
Skin toxicity	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	EGFR
stage, neuroblastoma	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	STAT1
Vascular anomaly	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	VEGFA
Leg Ulcer	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	VEGFA
Loss of appetite (finding)	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	PIK3R1
Benign neoplasm of breast	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	ESR1
Bulbar palsy	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	AR
Mumps	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	STAT1
Nevus elasticus	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	VEGFA
Congenital vascular anomaly	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	VEGFA
Corneal Diseases	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	VEGFA
Premenopausal breast cancer	1/27	0.02403308675659661	0.03580015172565689	0	0	45.14932126696833	168.33128827465845	ESR1
AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	VEGFA
Esophageal atresia with or without tracheoesophageal fistula	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	VEGFA
Seborrheic keratosis	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	AR
GASTRIC CANCER, INTESTINAL	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	CDKN1A
Hereditary non-polyposis colorectal cancer syndrome	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	CDH1
Hyperemia	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	ESR1
Hyperinsulinemic hypoglycemia	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	CDKN1A
Tumor Expansion	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	VEGFA
Absence of secondary sex characteristics	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	ESR1
Increased circulating gonadotropin level	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	ESR1
Agammaglobulinemia	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	PIK3R1
Aortic valve disorder	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	EGFR
Aphthous Stomatitis	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	PRKDC
Malignant Bone Neoplasm	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	ESR1
Malignant Mesothelioma of Peritoneum	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	EGFR
Placental Insufficiency	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	VEGFA
Psoriasiform eczema	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	CAV1
Rat Insulinoma	1/28	0.0249126411012733	0.03672908217156903	0	0	43.474945533769066	160.52601632867996	VEGFA
Cerebral Ischemia	2/275	0.02493105168436333	0.03673525755887648	0	0	9.0242673992674	33.314357302458596	JUN;VEGFA
Congenital Heart Defects	2/277	0.025268925840316356	0.03719067546754254	0	0	8.957727272727272	32.94813209781845	EGFR;VEGFA
Dwarfism	2/277	0.025268925840316356	0.03719067546754254	0	0	8.957727272727272	32.94813209781845	STAT1;PIK3R1
Infant, Premature	2/278	0.025438576192811917	0.03741904459341297	0	0	8.92481884057971	32.76736982113066	EGFR;VEGFA
Pheochromocytoma	2/280	0.025779298986367702	0.037553160778358644	0	0	8.859712230215827	32.41045286489161	EPAS1;VEGFA
alpha-1-Antitrypsin Deficiency, Autosomal Recessive	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	PIM1
Renal hypertension	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	CDKN1A
Scrub Typhus	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	JUN
Gall Bladder Diseases	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	VEGFA
High Grade Cervical Intraepithelial Neoplasia	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	VEGFA
T-Cell Prolymphocytic Leukemia	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	VEGFA
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	ESR1
Lymphoid hyperplasia	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	AR
Autoinflammatory disorder	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	STAT1
Brain Aneurysm	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	STAT1
Bulbar weakness	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	AR
Cardiac Lymphoma	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	VEGFA
Cholesterol gallstones	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	ESR1
Chronic Kidney Insufficiency	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	VEGFA
Collagen Diseases	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	VEGFA
Phenylketonurias	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	HBB
Dysgerminoma	1/29	0.025791446852810002	0.037553160778358644	0	0	41.92016806722689	153.33191684558912	CDH1
Recurrent aphthous ulcer	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	PRKDC
familial atrial fibrillation	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Delirium, Dementia, Amnestic, Cognitive Disorders	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	STAT1
Serum cholesterol raised	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Generalized osteoarthritis	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	ESR1
Stage II Colon Cancer AJCC v7	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	VEGFA
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	VEGFA
High grade serous carcinoma	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	ESR1
Horseshoe Kidney	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	EGFR
Thymic Carcinoma	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	EGFR
Hyperplasia of supraorbital margins	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Hyperplasia of supraorbital ridge	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Hypertrophy of supraorbital margins	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Hypertrophy of supraorbital ridge	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Acute Chest Syndrome	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	VEGFA
Adult Learning Disorders	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	VEGFA
African Burkitt's lymphoma	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	PIK3R1
Learning Disturbance	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	VEGFA
Arteriovenous fistula	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	VEGFA
Malignant transformation	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	EGFR
Bone necrosis	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	HBB
Broad foot	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Childhood Rhabdomyosarcoma	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	EGFR
Christ-Siemens-Touraine syndrome	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	EGFR
Persistent atrial fibrillation	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Poorly differentiated carcinoma	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	AR
Developmental Academic Disorder	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	VEGFA
Prominent supraorbital ridges	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	CAV1
Dysequilibrium syndrome	1/30	0.02666950460061794	0.03820706066744101	0	0	40.47261663286004	146.68225415832842	ESR1
Atrial Fibrillation	2/288	0.027161021533843574	0.03888964446891239	0	0	8.608391608391608	31.041622249508784	CAV1;VEGFA
Migraine Disorders	2/290	0.027511124716411952	0.0390309506263024	0	0	8.547743055555555	30.71344964590975	ESR1;VEGFA
Recurrent upper respiratory tract infection	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	STAT1
Alopecia, Male Pattern	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	AR
Lipomatosis, Multiple	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	NFIB
Stage II Colon Cancer	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	VEGFA
Refractory anemia, without ringed sideroblasts, without excess blasts	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	AR
21-hydroxylase deficiency	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	AR
Acute colitis	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	EGFR
Acute interstitial pneumonia	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	EGFR
Invasive Skin Melanoma	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	VEGFA
AIDS-Associated Nephropathy	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	VEGFA
Large hand	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	CAV1
Male Pseudohermaphroditism	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	AR
Bright Disease	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	ESR1
Muscle weakness of limb	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	AR
Mycoplasma-Induced Stevens-Johnson Syndrome	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	CAV1
Myelomonocytic leukemia	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	CDKN1A
Oral Ulcer	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	VEGFA
Drug-Induced Stevens Johnson Syndrome	1/31	0.027546814940669486	0.0390309506263024	0	0	39.12156862745098	140.51952455455398	CAV1
Fibrillation	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	VEGFA
Folic Acid Deficiency	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	ESR1
Gastro-esophageal reflux disease with esophagitis	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	ESR1
Giant Cell Fibroblastoma	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	EGFR
MICROPHTHALMIA, SYNDROMIC 7	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	EGFR
Hallopeau-Siemens Disease	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	VEGFA
Hydrophthalmos	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	AR
Iron deficiency anemia	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	HBB
Bowen's Disease	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	CDKN1A
Cervical high grade squamous intraepithelial lesion	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	VEGFA
Columnar Cell Change of the Breast	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	VEGFA
Complete hydatidiform mole	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	EGFR
Papillary serous cystadenocarcinoma	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	CDKN1A
Peritoneal Fibrosis	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	VEGFA
Decrease in appetite	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	PIK3R1
Dermatofibrosarcoma Protuberans	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	EGFR
Dysphonia	1/32	0.028423378470110255	0.039900862276247166	0	0	37.85768500948767	134.79392621731594	AR
Epithelial hyperplasia	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	ESR1
Fibrous Dysplasia	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	AR
Harlequin Fetus	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	EPAS1
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	CAV1
Hereditary Motor and Sensory Neuropathies	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	EGFR
Superinfection	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	CDKN1A
High altitude pulmonary edema	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	VEGFA
Thalassemia Intermedia	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	HBB
Thrombotic Microangiopathies	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	VEGFA
Iron-Refractory Iron Deficiency Anemia	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	HBB
Albuminuria	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	VEGFA
Angiomyolipoma	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	EGFR
Leukocytosis	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	HBB
Ataxic	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	VEGFA
Atrioventricular Block	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	CAV1
Congenital adrenal hyperplasia due to 21 hydroxylase deficiency	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	AR
Craniopharyngioma	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	ESR1
CREST Syndrome	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	CAV1
Polyarteritis Nodosa	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	VEGFA
Primary Lesion	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	EGFR
Echinococcosis	1/33	0.02929919579032357	0.0406662131791541	0	0	36.67279411764706	129.4621221594897	HBB
Renal interstitial fibrosis	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	VEGFA
Carcinoma, Ehrlich Tumor	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	VEGFA
Rhabdoid Tumor of the Kidney	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	CDKN1A
Secondary malignant neoplasm of pancreas	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	VEGFA
Gestational trophoblastic disease	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	EGFR
Idiopathic osteoarthritis	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	ESR1
Abnormality of the urinary system	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	VEGFA
Anastomosis	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	VEGFA
Malignant neoplasm of vulva	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	EGFR
Cancer of Urinary Tract	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	VEGFA
Neuroectodermal Tumors	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	EGFR
Cholangitis	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	CDKN1A
Cleft Lip with or without Cleft Palate	1/34	0.030174267482518016	0.041590252351837796	0	0	35.559714795008915	124.48623298308226	CDH1
Serum total cholesterol measurement	2/307	0.03056119161035443	0.042101097562424264	0	0	8.064344262295082	28.128628935596748	CDKN1A;ESR1
Esophageal Atresia	1/35	0.031048594155870846	0.04263610776428197	0	0	34.5121107266436	119.83301120641357	VEGFA
Sparse axillary hair	1/35	0.031048594155870846	0.04263610776428197	0	0	34.5121107266436	119.83301120641357	AR
Abnormal pigmentation	1/35	0.031048594155870846	0.04263610776428197	0	0	34.5121107266436	119.83301120641357	CAV1
Acanthosis	1/35	0.031048594155870846	0.04263610776428197	0	0	34.5121107266436	119.83301120641357	EGFR
Acinar Cell Carcinoma	1/35	0.031048594155870846	0.04263610776428197	0	0	34.5121107266436	119.83301120641357	EGFR
Low Grade Squamous Intraepithelial Neoplasia	1/35	0.031048594155870846	0.04263610776428197	0	0	34.5121107266436	119.83301120641357	EGFR
Celiac Disease	2/312	0.031483154722672484	0.04320987707155315	0	0	7.932258064516129	27.432149060411696	STAT1;EGFR
Benign neoplasm of brain, unspecified	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	VEGFA
EAR, PATELLA, SHORT STATURE SYNDROME	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	VEGFA
Somatotropin deficiency	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	ESR1
Hepatic Encephalopathy	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	PRKDC
Hepatitis E	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	EGFR
Learning Disorders	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	VEGFA
Autoimmune state	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	CAV1
Barrett's Adenocarcinoma	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	EGFR
Oestrogen deficiency	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	ESR1
Peripheral arterial occlusive disease	1/36	0.03192217639649051	0.0435808570994371	0	0	33.52436974789916	115.47316040046559	VEGFA
Cholestasis	2/315	0.032041676010482134	0.043720892305903515	0	0	7.8550319488817895	27.026948624776992	EZR;ESR1
Salivary Gland Pleomorphic Adenoma	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	AR
Fuchs Endothelial Dystrophy	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	CDKN1A
Hemorrhage	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	VEGFA
Hereditary pyropoikilocytosis	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	EGFR
Testicular hypogonadism	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	AR
Truncus Arteriosus, Persistent	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	VEGFA
Hypoxemia	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	HBB
Infantile uterus	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	ESR1
Aggressive Non-Hodgkin Lymphoma	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	NR4A1
Malignant neoplasm of oropharynx	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	EGFR
Multiple Epiphyseal Dysplasia	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	VEGFA
Obstructive azoospermia	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	AR
Combined immunodeficiency	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	STAT1
Ovarian Hyperstimulation Syndrome	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	VEGFA
Paget Disease	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	ESR1
Congenital hypoplasia of breast	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	ESR1
Pelvic Organ Prolapse	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	ESR1
Pseudoxanthoma Elasticum	1/37	0.0327950148043916	0.044327327702639197	0	0	32.591503267973856	111.38077026649427	VEGFA
Salmonella infections	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	EZR
Septic Shock	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	VEGFA
Hyperparathyroidism, Secondary	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	CDKN1A
Growth abnormality	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	AR
Subfertility	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	AR
Idiopathic Membranous Glomerulonephritis	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	VEGFA
Arteriovenous hemangioma	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	VEGFA
Autosomal Recessive Polycystic Kidney Disease	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	EGFR
Bladder neck obstruction	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	ESR1
Milroy Disease	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	VEGFA
Monoparesis - leg	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	CAV1
Painful Bladder Syndrome	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	VEGFA
Disorder of the optic nerve	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	EGFR
DOWN SYNDROME CRITICAL REGION	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	VEGFA
Prostatic Diseases	1/38	0.03366710996592093	0.045151684860837885	0	0	31.70906200317965	107.5328454820737	AR
Recurrent Brain Neoplasm	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	VEGFA
Recurrent pulmonary infections	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	EGFR
Stage 4S neuroblastoma	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	VEGFA
Sweet Syndrome	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	HBB
Klinefelter's syndrome - male with more than two X chromosomes	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	AR
Malignant neoplasm of adrenal cortex	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	ESR1
Benign Ovarian Neoplasm	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	EGFR
Multiple pulmonary infections	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	EGFR
Clonus	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	CAV1
Primary malignant neoplasm of brain	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	VEGFA
Pyelonephritis	1/39	0.03453846248378679	0.04605722694662946	0	0	30.873065015479877	103.9089106040704	PIM1
Osteopenia	2/329	0.03470035613914648	0.0462492362783361	0	0	7.513379204892966	25.252507544234202	STAT1;ESR1
Anemia, severe	1/40	0.03540907294557409	0.046999812650779994	0	0	30.079939668174962	100.49067723322013	HBB
Sparse pubic hair	1/40	0.03540907294557409	0.046999812650779994	0	0	30.079939668174962	100.49067723322013	AR
Hereditary Nonpolyposis Colorectal Neoplasms	1/40	0.03540907294557409	0.046999812650779994	0	0	30.079939668174962	100.49067723322013	CDH1
stage, ovarian epithelial cancer	1/40	0.03540907294557409	0.046999812650779994	0	0	30.079939668174962	100.49067723322013	VEGFA
Malignant neoplasm of stomach stage IV	1/40	0.03540907294557409	0.046999812650779994	0	0	30.079939668174962	100.49067723322013	EGFR
Mitochondrial Respiratory Chain Deficiencies	1/40	0.03540907294557409	0.046999812650779994	0	0	30.079939668174962	100.49067723322013	CDKN1A
Motor symptoms	1/40	0.03540907294557409	0.046999812650779994	0	0	30.079939668174962	100.49067723322013	AR
Osteoarthritis of the hand	1/40	0.03540907294557409	0.046999812650779994	0	0	30.079939668174962	100.49067723322013	ESR1
Graves Disease	2/335	0.035865746220551414	0.047581521565323213	0	0	7.3757507507507505	24.546296279366704	ESR1;VEGFA
Recurrent pneumonia	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	EGFR
Conjunctivitis, recurrent	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	PIK3R1
Genitourinary Cancer	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	EGFR
Gestational Trophoblastic Neoplasms	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	EGFR
Nephrotic Syndrome, Minimal Change	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	EZR
Alcohol withdrawal syndrome	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	AR
alpha 1-Antitrypsin Deficiency	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	PIM1
Laryngeal neoplasm	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	CDH1
Arterial Occlusive Diseases	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	VEGFA
Lytic lesion	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	CAV1
Micronychia (disorder)	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	CDH1
Breaking out	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	ESR1
Chronic viral hepatitis	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	CDKN1A
Endometrioid carcinoma ovary	1/41	0.036278941946159535	0.047786082124900604	0	0	29.326470588235296	97.26176223664352	EGFR
Epiretinal Membrane	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	VEGFA
Ewings sarcoma-primitive neuroectodermal tumor (PNET)	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	EGFR
exudative macular degeneration	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	VEGFA
Ganglioneuroblastoma	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	EGFR
Memory Disorder, Semantic	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	VEGFA
Memory Disorder, Spatial	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	VEGFA
High urine occult blood	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	HBB
Vascular Neoplasms	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	VEGFA
Age-Related Memory Disorders	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	VEGFA
Anaphylaxis (non medication)	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	ESR1
Bulimia Nervosa	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	ESR1
Cervical intraepithelial neoplasia grade 2	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	VEGFA
Clear Cell Sarcoma of Soft Tissue	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	EGFR
Defective tooth enamel	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	PIK3R1
Dyskeratosis Congenita	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	AR
Dystrophic tooth enamel	1/42	0.03714807008538698	0.048534883677569335	0	0	28.609756097560975	94.20744821276294	PIK3R1
Macular dystrophy, corneal type 1	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	VEGFA
High Grade Lymphoma (neoplasm)	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	CDH1
Sarcoma, Epithelioid	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	EGFR
Acute respiratory failure	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	VEGFA
Autoimmune hemolytic anemia	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	STAT1
Peroxisomal Disorders	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	EPAS1
Primary Carcinoma	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	EGFR
Dissection of aorta	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	STAT1
Proliferative retinopathy	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	VEGFA
Pulmonary Cystic Fibrosis	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	CDKN1A
Radial deviation of finger	1/43	0.038016457940095186	0.0493946231686448	0	0	27.92717086834734	91.3144790197023	PIK3R1
Ankylosing spondylitis	2/348	0.03844305153298881	0.04992378185505787	0	0	7.09393063583815	23.116121435030514	AR;VEGFA
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	VEGFA
Sickle Cell Trait	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	HBB
HELLP Syndrome	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	VEGFA
Strawberry nevus of skin	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	VEGFA
Behavior Disorders	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	ESR1
Memory Disorders	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	VEGFA
Birth Weight	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	ESR1
CARCINOMA OF VULVA	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	EGFR
Muscle damage	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	VEGFA
Muscular stiffness	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	ESR1
Neoplasm of uncertain or unknown behavior of breast	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	ESR1
Neurocognitive Disorders	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	STAT1
Osteosclerosis	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	VEGFA
Paranasal Sinus Diseases	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	PIK3R1
Conjunctivitis	1/44	0.038884106119434915	0.05011858588148722	0	0	27.276333789329687	88.57088446864675	PIK3R1
Enteritis	1/45	0.03975101520212152	0.051032242677475095	0	0	26.655080213903744	85.9658295948253	JUN
Leukemia, Plasma Cell	1/45	0.03975101520212152	0.051032242677475095	0	0	26.655080213903744	85.9658295948253	VEGFA
Sleeplessness	1/45	0.03975101520212152	0.051032242677475095	0	0	26.655080213903744	85.9658295948253	PRKDC
Hypopituitarism	1/45	0.03975101520212152	0.051032242677475095	0	0	26.655080213903744	85.9658295948253	AR
LATERAL MENINGOCELE SYNDROME	1/45	0.03975101520212152	0.051032242677475095	0	0	26.655080213903744	85.9658295948253	ESR1
Ascites	1/45	0.03975101520212152	0.051032242677475095	0	0	26.655080213903744	85.9658295948253	VEGFA
Malignant Central Nervous System Neoplasm	1/45	0.03975101520212152	0.051032242677475095	0	0	26.655080213903744	85.9658295948253	EGFR
Mammary adenocarcinoma	1/45	0.03975101520212152	0.051032242677475095	0	0	26.655080213903744	85.9658295948253	ESR1
Sarcoidosis, Pulmonary	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Telangiectasia of the skin	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	CAV1
Thrombasthenia	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Abnormality of dental enamel	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	PIK3R1
Acute periodontitis	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	STAT1
Adult Diffuse Large B-Cell Lymphoma	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Malonic aciduria	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Moyamoya disease 1	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Childhood Diffuse Large B-Cell Lymphoma	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Obstructive nephropathy	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Cutaneous Mastocytosis	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Decreased fertility	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	AR
Drusen	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	VEGFA
Early gastric cancer	1/46	0.04061718578452446	0.05178390467987496	0	0	26.061437908496732	83.48948444789488	EGFR
Carcinoma, Pancreatic Ductal	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	VEGFA
Rhinovirus infection	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	EGFR
Serum triglycerides raised	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	CAV1
Hypertension, Renovascular	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	STAT1
Hemoglobinopathies	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	HBB
Abnormality of the cornea	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	PIK3R1
LIMB-MAMMARY SYNDROME	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	ESR1
Lower limb muscle weakness	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	CAV1
Carcinoma in situ of uterine cervix	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	CDH1
Muscular Atrophy	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	AR
Diabetic Foot	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	VEGFA
Disseminated neuroblastoma	1/47	0.041482618460807204	0.05257586039463445	0	0	25.493606138107417	81.1329113370927	VEGFA
Precursor B-cell lymphoblastic leukemia	2/367	0.04233544581518084	0.05338365621374174	0	0	6.718150684931507	21.243669730540795	PIM1;VEGFA
Fabry Disease	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	VEGFA
Right Ventricular Hypertrophy	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	CDKN1A
Myasthenic Syndromes, Congenital	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	CAV1
Spinocerebellar Ataxia Type 6 (disorder)	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	AR
Synovial Cyst	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	VEGFA
keratoacanthoma	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	CDKN1A
Barrett Epithelium	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	VEGFA
Paresthesia	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	HBB
Corneal Neovascularization	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	VEGFA
Dupuytren Contracture	1/48	0.042347313814152854	0.05338365621374174	0	0	24.94993742177722	78.88796682594588	EGFR
Abnormality of vision	1/49	0.04321127244441888	0.05434017367280135	0	0	24.42892156862745	76.74721626832032	CDH1
Intracranial Hemorrhages	1/49	0.04321127244441888	0.05434017367280135	0	0	24.42892156862745	76.74721626832032	VEGFA
Amenorrhea	1/49	0.04321127244441888	0.05434017367280135	0	0	24.42892156862745	76.74721626832032	AR
Medullary carcinoma	1/49	0.04321127244441888	0.05434017367280135	0	0	24.42892156862745	76.74721626832032	ESR1
Nervous System Neoplasms	1/49	0.04321127244441888	0.05434017367280135	0	0	24.42892156862745	76.74721626832032	VEGFA
Abnormal behavior	2/372	0.04338394314289218	0.05453076649055499	0	0	6.625675675675676	20.78915649950688	AR;ESR1
Hepatomegaly	2/373	0.04359483175430878	0.05476918794814182	0	0	6.607479784366577	20.700022837607225	CAV1;HBB
Renal dysplasia	1/50	0.04407449493169267	0.05521067915061211	0	0	23.92917166866747	74.70385911458476	ESR1
Advanced bone age	1/50	0.04407449493169267	0.05521067915061211	0	0	23.92917166866747	74.70385911458476	CAV1
Lymphedema	1/50	0.04407449493169267	0.05521067915061211	0	0	23.92917166866747	74.70385911458476	VEGFA
Atypical Ductal Breast Hyperplasia	1/50	0.04407449493169267	0.05521067915061211	0	0	23.92917166866747	74.70385911458476	ESR1
Moyamoya Disease	1/50	0.04407449493169267	0.05521067915061211	0	0	23.92917166866747	74.70385911458476	VEGFA
Clostridium; difficile (disorder)	1/50	0.04407449493169267	0.05521067915061211	0	0	23.92917166866747	74.70385911458476	JUN
Hematuria	1/51	0.044936981871191266	0.05607353824796475	0	0	23.449411764705882	72.75166337328601	HBB
Tumors of Adrenal Cortex	1/51	0.044936981871191266	0.05607353824796475	0	0	23.449411764705882	72.75166337328601	VEGFA
Adult Lymphoma	1/51	0.044936981871191266	0.05607353824796475	0	0	23.449411764705882	72.75166337328601	EGFR
Angioimmunoblastic Lymphadenopathy	1/51	0.044936981871191266	0.05607353824796475	0	0	23.449411764705882	72.75166337328601	VEGFA
Congenital adrenal hyperplasia	1/51	0.044936981871191266	0.05607353824796475	0	0	23.449411764705882	72.75166337328601	AR
Cystadenoma	1/51	0.044936981871191266	0.05607353824796475	0	0	23.449411764705882	72.75166337328601	VEGFA
Premature coronary artery disease	1/51	0.044936981871191266	0.05607353824796475	0	0	23.449411764705882	72.75166337328601	ESR1
Rabies (disorder)	1/51	0.044936981871191266	0.05607353824796475	0	0	23.449411764705882	72.75166337328601	STAT1
Generalized hirsutism	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	CAV1
Hereditary Breast and Ovarian Cancer Syndrome	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	AR
Hypocalcemia	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	CAV1
X-linked agammaglobulinemia	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	PIK3R1
Lymphocytic infiltration	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	ESR1
Non-arthropod borne lymphocytic choriomeningitis	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	STAT1
Coronary Stenosis	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	VEGFA
Decreased antibody level in blood	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	PIK3R1
Endocrine System Diseases	1/52	0.04579873384946774	0.05690145720691447	0	0	22.988465974625143	70.88490801561363	AR
Rous Sarcoma	1/53	0.04665975146146969	0.057748988033050404	0	0	22.54524886877828	69.09833217880467	CAV1
Hyperparathyroidism, Primary	1/53	0.04665975146146969	0.057748988033050404	0	0	22.54524886877828	69.09833217880467	ESR1
Thrombocytopenia due to platelet alloimmunization	1/53	0.04665975146146969	0.057748988033050404	0	0	22.54524886877828	69.09833217880467	STAT1
Turner Syndrome, Male	1/53	0.04665975146146969	0.057748988033050404	0	0	22.54524886877828	69.09833217880467	AR
Interstitial Cystitis	1/53	0.04665975146146969	0.057748988033050404	0	0	22.54524886877828	69.09833217880467	CDKN1A
Myeloid neoplasm	1/53	0.04665975146146969	0.057748988033050404	0	0	22.54524886877828	69.09833217880467	NR4A1
Childhood Lymphoma	1/53	0.04665975146146969	0.057748988033050404	0	0	22.54524886877828	69.09833217880467	EGFR
NEUROTICISM	1/53	0.04665975146146969	0.057748988033050404	0	0	22.54524886877828	69.09833217880467	AR
Xeroderma Pigmentosum, Complementation Group D	1/54	0.04752003528742647	0.05872930676910171	0	0	22.118756936736958	67.38709029166962	EGFR
Pancreatic Diseases	1/54	0.04752003528742647	0.05872930676910171	0	0	22.118756936736958	67.38709029166962	VEGFA
Diabetic Cardiomyopathies	1/54	0.04752003528742647	0.05872930676910171	0	0	22.118756936736958	67.38709029166962	PIM1
Russell-Silver syndrome	1/55	0.048379585909741875	0.059563617924148354	0	0	21.70806100217865	65.7467122997584	EGFR
Ganglioneuroma	1/55	0.048379585909741875	0.059563617924148354	0	0	21.70806100217865	65.7467122997584	VEGFA
Hantavirus Infections	1/55	0.048379585909741875	0.059563617924148354	0	0	21.70806100217865	65.7467122997584	VEGFA
Systemic onset juvenile chronic arthritis	1/55	0.048379585909741875	0.059563617924148354	0	0	21.70806100217865	65.7467122997584	STAT1
Scoliosis, unspecified	1/55	0.048379585909741875	0.059563617924148354	0	0	21.70806100217865	65.7467122997584	ESR1
Hypocholesterolemia	1/55	0.048379585909741875	0.059563617924148354	0	0	21.70806100217865	65.7467122997584	CAV1
Adenosquamous carcinoma	1/55	0.048379585909741875	0.059563617924148354	0	0	21.70806100217865	65.7467122997584	EGFR
Lymphocytic Choriomeningitis	1/55	0.048379585909741875	0.059563617924148354	0	0	21.70806100217865	65.7467122997584	STAT1
Anxiety Disorders	2/396	0.04855256614757106	0.0597481078414369	0	0	6.214467005076142	18.79943528132947	AR;ESR1
Glucocorticoid Receptor Deficiency	1/56	0.0492384039303871	0.06044809760085071	0	0	21.312299465240642	64.173068346434	JUN
Gonorrhea	1/56	0.0492384039303871	0.06044809760085071	0	0	21.312299465240642	64.173068346434	CAV1
Hyperandrogenism	1/56	0.0492384039303871	0.06044809760085071	0	0	21.312299465240642	64.173068346434	AR
Carotid Stenosis	1/56	0.0492384039303871	0.06044809760085071	0	0	21.312299465240642	64.173068346434	VEGFA
Pituitary-dependent Cushing's disease	1/56	0.0492384039303871	0.06044809760085071	0	0	21.312299465240642	64.173068346434	EGFR
Geographic Atrophy	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	VEGFA
Heart Septal Defects	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	VEGFA
Hyperaldosteronism	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	AR
Hypertrophy of clitoris	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	AR
Ameloblastoma	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	EGFR
Long eyelashes	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	EGFR
Cardiac defects	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	VEGFA
Obsessive compulsive behavior	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	ESR1
Pallor	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	HBB
Peutz-Jeghers Syndrome	1/57	0.05009648993282979	0.06121061187157017	0	0	20.930672268907564	62.66233736405012	EGFR
Severe Dengue	1/58	0.0509538444953197	0.06208197185443905	0	0	20.562435500515996	61.210979038699676	VEGFA
Substance Withdrawal Syndrome	1/58	0.0509538444953197	0.06208197185443905	0	0	20.562435500515996	61.210979038699676	AR
Intestinal Cancer	1/58	0.0509538444953197	0.06208197185443905	0	0	20.562435500515996	61.210979038699676	CDKN1A
Ambiguous Genitalia	1/58	0.0509538444953197	0.06208197185443905	0	0	20.562435500515996	61.210979038699676	AR
Amnesia	1/58	0.0509538444953197	0.06208197185443905	0	0	20.562435500515996	61.210979038699676	EGFR
Mycoplasma Infections	1/58	0.0509538444953197	0.06208197185443905	0	0	20.562435500515996	61.210979038699676	CDH1
Retinitis Pigmentosa	2/410	0.05166845095482988	0.06288836436964823	0	0	5.996936274509804	17.768369963796623	CAV1;VEGFA
Squamous cell carcinoma of mouth	1/59	0.05181046820697307	0.06288836436964823	0	0	20.20689655172414	59.815708753826954	EGFR
Tooth problem	1/59	0.05181046820697307	0.06288836436964823	0	0	20.20689655172414	59.815708753826954	HBB
Acne	1/59	0.05181046820697307	0.06288836436964823	0	0	20.20689655172414	59.815708753826954	ESR1
Well Differentiated Pancreatic Endocrine Tumor	1/59	0.05181046820697307	0.06288836436964823	0	0	20.20689655172414	59.815708753826954	VEGFA
AICARDI-GOUTIERES SYNDROME 1	1/59	0.05181046820697307	0.06288836436964823	0	0	20.20689655172414	59.815708753826954	VEGFA
Leukocyte adhesion deficiency type 1	1/59	0.05181046820697307	0.06288836436964823	0	0	20.20689655172414	59.815708753826954	EGFR
Chronic lung disease	1/59	0.05181046820697307	0.06288836436964823	0	0	20.20689655172414	59.815708753826954	VEGFA
Cryptorchidism	2/414	0.052571965767079024	0.06371766378396652	0	0	5.9375	17.48933536218089	AR;ESR1
Hypotrichosis	1/60	0.05266636166425417	0.06371766378396652	0	0	19.863409770687937	58.47347515993359	PIK3R1
Absence Epilepsy	1/60	0.05266636166425417	0.06371766378396652	0	0	19.863409770687937	58.47347515993359	ESR1
Androgenetic Alopecia	1/60	0.05266636166425417	0.06371766378396652	0	0	19.863409770687937	58.47347515993359	AR
Bullous pemphigoid	1/60	0.05266636166425417	0.06371766378396652	0	0	19.863409770687937	58.47347515993359	VEGFA
Cavernous Hemangioma of Brain	1/60	0.05266636166425417	0.06371766378396652	0	0	19.863409770687937	58.47347515993359	VEGFA
Oropharyngeal Carcinoma	1/60	0.05266636166425417	0.06371766378396652	0	0	19.863409770687937	58.47347515993359	EGFR
Epithelial hyperplasia of skin	1/61	0.05352152544266997	0.0645406630338079	0	0	19.531372549019608	57.18144005818292	EGFR
Sinusitis	1/61	0.05352152544266997	0.0645406630338079	0	0	19.531372549019608	57.18144005818292	PIK3R1
Viremia	1/61	0.05352152544266997	0.0645406630338079	0	0	19.531372549019608	57.18144005818292	VEGFA
Brain Infarction	1/61	0.05352152544266997	0.0645406630338079	0	0	19.531372549019608	57.18144005818292	VEGFA
Noonan Syndrome	1/61	0.05352152544266997	0.0645406630338079	0	0	19.531372549019608	57.18144005818292	AR
Disorders of Sex Development	1/61	0.05352152544266997	0.0645406630338079	0	0	19.531372549019608	57.18144005818292	AR
Profound intellectual disabilities	1/61	0.05352152544266997	0.0645406630338079	0	0	19.531372549019608	57.18144005818292	EZR
Metabolic Diseases	2/421	0.054167056709522064	0.06528861758315235	0	0	5.836217183770883	17.016555521703083	NR4A1;AR
Xerostomia	1/62	0.05437596012922433	0.06544879077995641	0	0	19.210221793635487	55.93696029523851	CAV1
Macular degeneration	1/62	0.05437596012922433	0.06544879077995641	0	0	19.210221793635487	55.93696029523851	VEGFA
Bardet-Biedl Syndrome	1/62	0.05437596012922433	0.06544879077995641	0	0	19.210221793635487	55.93696029523851	VEGFA
Rheumatic Fever	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	VEGFA
Fibroadenoma	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	ESR1
Lichen Planus, Oral	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	EGFR
Abnormality of the dentition	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	HBB
Viral hepatitis	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	CDKN1A
Iron deficiency	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	EPAS1
Lymphangioleiomyomatosis	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	ESR1
Brain Edema	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	VEGFA
Monocytic leukemia	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	CDKN1A
Chronic ear infection	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	PIK3R1
Papule	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	EGFR
Dystrophia myotonica 2	1/63	0.05522966630423428	0.06610668584978552	0	0	18.89943074003795	54.73757147758474	AR
Esophagitis	1/64	0.05608264454703212	0.06687971877423082	0	0	18.598506069094306	53.58097327195968	CDKN1A
High-Grade Squamous Intraepithelial Lesions	1/64	0.05608264454703212	0.06687971877423082	0	0	18.598506069094306	53.58097327195968	VEGFA
Hirsutism	1/64	0.05608264454703212	0.06687971877423082	0	0	18.598506069094306	53.58097327195968	CAV1
Unspecified visual loss	1/64	0.05608264454703212	0.06687971877423082	0	0	18.598506069094306	53.58097327195968	VEGFA
Autosomal dominant retinitis pigmentosa	1/64	0.05608264454703212	0.06687971877423082	0	0	18.598506069094306	53.58097327195968	PIM1
Mastocytosis	1/64	0.05608264454703212	0.06687971877423082	0	0	18.598506069094306	53.58097327195968	AR
Osteopetrosis	1/64	0.05608264454703212	0.06687971877423082	0	0	18.598506069094306	53.58097327195968	VEGFA
Cytogenetically normal acute myeloid leukemia	1/64	0.05608264454703212	0.06687971877423082	0	0	18.598506069094306	53.58097327195968	CDH1
Adult Liver Carcinoma	1/65	0.0569348954637786	0.06783341096999083	0	0	18.30698529411765	52.46501611587855	CAV1
Melanocytic nevus of skin	1/65	0.0569348954637786	0.06783341096999083	0	0	18.30698529411765	52.46501611587855	CDKN1A
nervous system disorder	2/436	0.05764378189282757	0.06846895498337087	0	0	5.630184331797235	16.065578399870766	AR;VEGFA
Bronchitis, Chronic	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	VEGFA
Shigella Infections	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	EZR
Hypertrophic disorder of skin, unspecified	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	VEGFA
Glycogen storage disease type II	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	VEGFA
GRN-related frontotemporal dementia	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	VEGFA
Bronchiolitis	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	JUN
Cleft palate with cleft lip	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	CDH1
Congenital arteriovenous malformation	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	VEGFA
Paroxysmal atrial fibrillation	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	CAV1
Dentatorubral-Pallidoluysian Atrophy	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	AR
Proliferative vitreoretinopathy	1/66	0.05778641961430449	0.06846895498337087	0	0	18.02443438914027	51.387689221977354	VEGFA
Toxic Epidermal Necrolysis	1/67	0.058637217599069806	0.06938155430984759	0	0	17.750445632798574	50.34710965358108	CAV1
Uremia	1/67	0.058637217599069806	0.06938155430984759	0	0	17.750445632798574	50.34710965358108	EGFR
Pustulosis of Palms and Soles	1/67	0.058637217599069806	0.06938155430984759	0	0	17.750445632798574	50.34710965358108	VEGFA
Recurrent infections	1/68	0.05948728998273248	0.07013038339817344	0	0	17.484635645302898	49.34151245692923	HBB
Carcinoma, Large Cell	1/68	0.05948728998273248	0.07013038339817344	0	0	17.484635645302898	49.34151245692923	EGFR
Thin skin	1/68	0.05948728998273248	0.07013038339817344	0	0	17.484635645302898	49.34151245692923	PIK3R1
Undifferentiated leukemia	1/68	0.05948728998273248	0.07013038339817344	0	0	17.484635645302898	49.34151245692923	VEGFA
Wiskott-Aldrich Syndrome	1/68	0.05948728998273248	0.07013038339817344	0	0	17.484635645302898	49.34151245692923	AR
Angle class 2 malocclusion	1/68	0.05948728998273248	0.07013038339817344	0	0	17.484635645302898	49.34151245692923	PIK3R1
Angle class 3 malocclusion	1/68	0.05948728998273248	0.07013038339817344	0	0	17.484635645302898	49.34151245692923	PIK3R1
Migraine with Aura	1/68	0.05948728998273248	0.07013038339817344	0	0	17.484635645302898	49.34151245692923	ESR1
Underdeveloped nasal alae	1/69	0.06033663736484967	0.07100206574642673	0	0	17.226643598615915	48.3692416453001	PIK3R1
Adenomatous Polyps	1/69	0.06033663736484967	0.07100206574642673	0	0	17.226643598615915	48.3692416453001	VEGFA
Diabetic Angiopathies	1/69	0.06033663736484967	0.07100206574642673	0	0	17.226643598615915	48.3692416453001	VEGFA
Progressive supranuclear palsy	1/69	0.06033663736484967	0.07100206574642673	0	0	17.226643598615915	48.3692416453001	VEGFA
Anemia, Diamond-Blackfan	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	PIM1
Angina, Unstable	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	VEGFA
Respiratory Tract Infections	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	STAT1
Leukoplakia, Oral	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	EGFR
Squamous cell carcinoma of oropharynx	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	EGFR
Hereditary pancreatitis	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	CDH1
Knee joint valgus deformity	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	HBB
alpha-Thalassemia	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	HBB
Benign Neoplasm	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	VEGFA
Cooley's anemia	1/70	0.061185260316693364	0.07167416208526937	0	0	16.97612958226769	47.42874202866335	HBB
Tracheal Diseases	1/71	0.06203315941729082	0.07253583104339618	0	0	16.7327731092437	46.51855173584374	EGFR
Malocclusion	1/71	0.06203315941729082	0.07253583104339618	0	0	16.7327731092437	46.51855173584374	PIK3R1
Pediatric Obesity	1/71	0.06203315941729082	0.07253583104339618	0	0	16.7327731092437	46.51855173584374	VEGFA
Duodenal Ulcer	1/71	0.06203315941729082	0.07253583104339618	0	0	16.7327731092437	46.51855173584374	VEGFA
Familial primary gastric lymphoma	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	CDH1
secondary acute myeloid leukemia	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	VEGFA
Hyperuricemia	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	VEGFA
West Nile viral infection	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	STAT1
alpha^+^ Thalassemia	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	HBB
Learning Disabilities	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	VEGFA
Neutrophil count decreased	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	PIK3R1
Contact hypersensitivity	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	VEGFA
Eating Disorders	1/72	0.0628803352568931	0.07322809105886154	0	0	16.496271748135875	45.63729539644487	ESR1
Cardiomyopathy, Hypertrophic, Familial	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	CAV1
Failure to Thrive	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	NR4A1
Hepatitis, Alcoholic	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	CAV1
Syndactyly of fingers	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	CDH1
hypopigmented skin patch	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	CAV1
Urinary tract infection	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	VEGFA
Long QT Syndrome	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	AR
Attention Deficit Disorder	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	VEGFA
Marfan Syndrome	1/73	0.06372678840915502	0.07391391758457451	0	0	16.266339869281047	44.783677915691136	VEGFA
Spondylarthritis	1/74	0.06457251945477355	0.07472706888516133	0	0	16.042707493956488	43.95647876269956	STAT1
Uveomeningoencephalitic Syndrome	1/74	0.06457251945477355	0.07472706888516133	0	0	16.042707493956488	43.95647876269956	VEGFA
Keratitis	1/74	0.06457251945477355	0.07472706888516133	0	0	16.042707493956488	43.95647876269956	VEGFA
Chronic heart failure	1/74	0.06457251945477355	0.07472706888516133	0	0	16.042707493956488	43.95647876269956	VEGFA
DiGeorge Syndrome	1/74	0.06457251945477355	0.07472706888516133	0	0	16.042707493956488	43.95647876269956	VEGFA
Intellectual Disability	5/2503	0.06483954334720667	0.07500248117592244	0	0	2.691999753649073	7.364879596262478	AR;JUN;STAT1;CAV1;PIK3R1
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor	1/75	0.06541752897671287	0.07550200060180935	0	0	15.825119236883943	43.154546742931096	CAV1
Mitral Valve Stenosis	1/75	0.06541752897671287	0.07550200060180935	0	0	15.825119236883943	43.154546742931096	VEGFA
MYOTONIC DYSTROPHY 1	1/75	0.06541752897671287	0.07550200060180935	0	0	15.825119236883943	43.154546742931096	ESR1
Congenital Bilateral Cataracts	1/75	0.06541752897671287	0.07550200060180935	0	0	15.825119236883943	43.154546742931096	CAV1
Proliferative diabetic retinopathy	1/75	0.06541752897671287	0.07550200060180935	0	0	15.825119236883943	43.154546742931096	VEGFA
Respiration Disorders	1/76	0.06626181755179136	0.07633999765221994	0	0	15.613333333333333	42.376795202067306	VEGFA
Acute Undifferentiated Leukemia	1/76	0.06626181755179136	0.07633999765221994	0	0	15.613333333333333	42.376795202067306	VEGFA
Machado-Joseph Disease	1/76	0.06626181755179136	0.07633999765221994	0	0	15.613333333333333	42.376795202067306	AR
Autoimmune thrombocytopenia	1/76	0.06626181755179136	0.07633999765221994	0	0	15.613333333333333	42.376795202067306	STAT1
Neoplastic Syndromes, Hereditary	1/77	0.06710538575794313	0.07720855742216796	0	0	15.407120743034056	41.62219761611141	CDH1
Niemann-Pick Disease, Type C	1/77	0.06710538575794313	0.07720855742216796	0	0	15.407120743034056	41.62219761611141	VEGFA
Decreased width of tooth	1/77	0.06710538575794313	0.07720855742216796	0	0	15.407120743034056	41.62219761611141	PIK3R1
Sicca Syndrome	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	HBB
Multiple Sclerosis, Relapsing-Remitting	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	VEGFA
Stereotyped Behavior	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	EGFR
Sudden infant death syndrome	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	VEGFA
Acute monocytic leukemia	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	VEGFA
Klinefelter Syndrome	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	AR
Cardiac Hypertrophy	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	CAV1
Cerebral arterial aneurysm	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	STAT1
Peripheral Vascular Diseases	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	VEGFA
Dyskinetic syndrome	1/78	0.06794823417091082	0.07783161368667968	0	0	15.206264323911382	40.88978353793229	VEGFA
Glioblastoma, IDH-Wildtype	1/79	0.0687903633714564	0.07855239106475327	0	0	15.010558069381599	40.178634862671224	EGFR
Gliosis	1/79	0.0687903633714564	0.07855239106475327	0	0	15.010558069381599	40.178634862671224	EGFR
Lysosomal Storage Diseases	1/79	0.0687903633714564	0.07855239106475327	0	0	15.010558069381599	40.178634862671224	VEGFA
Malignancy	1/79	0.0687903633714564	0.07855239106475327	0	0	15.010558069381599	40.178634862671224	EGFR
Chronic granulomatous disease	1/79	0.0687903633714564	0.07855239106475327	0	0	15.010558069381599	40.178634862671224	ESR1
Osteitis Deformans	1/79	0.0687903633714564	0.07855239106475327	0	0	15.010558069381599	40.178634862671224	ESR1
Distal sensory impairment	1/79	0.0687903633714564	0.07855239106475327	0	0	15.010558069381599	40.178634862671224	CAV1
Bloom Syndrome	1/80	0.06963177394208621	0.0794078905485248	0	0	14.819806403574088	39.48788238772356	CDKN1A
Microdontia (disorder)	1/80	0.06963177394208621	0.0794078905485248	0	0	14.819806403574088	39.48788238772356	PIK3R1
Desmoplastic	1/80	0.06963177394208621	0.0794078905485248	0	0	14.819806403574088	39.48788238772356	CAV1
Salivary Gland Neoplasms	1/82	0.0713124414727928	0.08118115307369934	0	0	14.452432824981845	38.16431494463284	CDH1
Thalassemia	1/82	0.0713124414727928	0.08118115307369934	0	0	14.452432824981845	38.16431494463284	HBB
Cerebellar Dysmetria	1/82	0.0713124414727928	0.08118115307369934	0	0	14.452432824981845	38.16431494463284	CAV1
Decreased size of teeth	1/82	0.0713124414727928	0.08118115307369934	0	0	14.452432824981845	38.16431494463284	PIK3R1
Gait Ataxia	1/83	0.07215169959177546	0.08195595428564469	0	0	14.275466284074605	37.52997870137401	CAV1
Hydatidiform Mole	1/83	0.07215169959177546	0.08195595428564469	0	0	14.275466284074605	37.52997870137401	EGFR
Van der Woude syndrome	1/83	0.07215169959177546	0.08195595428564469	0	0	14.275466284074605	37.52997870137401	STAT1
bone destruction	1/83	0.07215169959177546	0.08195595428564469	0	0	14.275466284074605	37.52997870137401	VEGFA
Protein Deficiency	1/83	0.07215169959177546	0.08195595428564469	0	0	14.275466284074605	37.52997870137401	STAT1
Skin Ulcer	1/84	0.0729902413804037	0.08279920662520103	0	0	14.10276399716513	36.91299089130259	CAV1
Venous Thromboembolism	1/84	0.0729902413804037	0.08279920662520103	0	0	14.10276399716513	36.91299089130259	ESR1
Late tooth eruption	1/84	0.0729902413804037	0.08279920662520103	0	0	14.10276399716513	36.91299089130259	PIK3R1
Cicatrix, Hypertrophic	1/85	0.07382806741395515	0.08360276112680673	0	0	13.934173669467787	36.31268374332498	CDKN1A
Hypogammaglobulinemia	1/85	0.07382806741395515	0.08360276112680673	0	0	13.934173669467787	36.31268374332498	PIK3R1
Demyelinating Diseases	1/85	0.07382806741395515	0.08360276112680673	0	0	13.934173669467787	36.31268374332498	EGFR
Downturned corners of mouth	1/85	0.07382806741395515	0.08360276112680673	0	0	13.934173669467787	36.31268374332498	PIK3R1
Recurrent urinary tract infection	1/86	0.07466517827093744	0.08429202599380743	0	0	13.76955017301038	35.728422579909434	VEGFA
Malaria, Cerebral	1/86	0.07466517827093744	0.08429202599380743	0	0	13.76955017301038	35.728422579909434	VEGFA
Headache	1/86	0.07466517827093744	0.08429202599380743	0	0	13.76955017301038	35.728422579909434	VEGFA
Muscle Cramp	1/86	0.07466517827093744	0.08429202599380743	0	0	13.76955017301038	35.728422579909434	AR
Myocardial Reperfusion Injury	1/86	0.07466517827093744	0.08429202599380743	0	0	13.76955017301038	35.728422579909434	VEGFA
Chronic gastritis	1/86	0.07466517827093744	0.08429202599380743	0	0	13.76955017301038	35.728422579909434	CAV1
Diabetic Neuropathies	1/86	0.07466517827093744	0.08429202599380743	0	0	13.76955017301038	35.728422579909434	VEGFA
Triangular face	1/87	0.07550157451990408	0.08501332475366706	0	0	13.60875512995896	35.15960381916263	PIK3R1
Adrenal Gland Neoplasms	1/87	0.07550157451990408	0.08501332475366706	0	0	13.60875512995896	35.15960381916263	CDKN1A
Adult type dermatomyositis	1/87	0.07550157451990408	0.08501332475366706	0	0	13.60875512995896	35.15960381916263	STAT1
Multiple tumors	1/87	0.07550157451990408	0.08501332475366706	0	0	13.60875512995896	35.15960381916263	AR
Contact Dermatitis	1/87	0.07550157451990408	0.08501332475366706	0	0	13.60875512995896	35.15960381916263	VEGFA
DOSAGE-SENSITIVE SEX REVERSAL	1/87	0.07550157451990408	0.08501332475366706	0	0	13.60875512995896	35.15960381916263	NR4A1
Spina Bifida	1/88	0.07633725672986817	0.08584202617903765	0	0	13.451656524678837	34.60565311468726	JUN
Abnormality of the skeletal system	1/88	0.07633725672986817	0.08584202617903765	0	0	13.451656524678837	34.60565311468726	HBB
Alcohol Use Disorder	1/88	0.07633725672986817	0.08584202617903765	0	0	13.451656524678837	34.60565311468726	PIK3R1
Malaria, Falciparum	1/89	0.07717222548711895	0.08663009927563158	0	0	13.29812834224599	34.06602362525984	HBB
Cerebral Palsy	1/89	0.07717222548711895	0.08663009927563158	0	0	13.29812834224599	34.06602362525984	ESR1
Non-obstructive azoospermia	1/89	0.07717222548711895	0.08663009927563158	0	0	13.29812834224599	34.06602362525984	AR
Osteoarthrosis Deformans	1/89	0.07717222548711895	0.08663009927563158	0	0	13.29812834224599	34.06602362525984	EZR
Skin carcinoma	1/90	0.07800648136170299	0.08741463833287584	0	0	13.148050231328487	33.540194413490916	EGFR
Periodontitis, Juvenile	1/90	0.07800648136170299	0.08741463833287584	0	0	13.148050231328487	33.540194413490916	STAT1
Venous Thrombosis	1/90	0.07800648136170299	0.08741463833287584	0	0	13.148050231328487	33.540194413490916	ESR1
Adenovirus Infections	1/90	0.07800648136170299	0.08741463833287584	0	0	13.148050231328487	33.540194413490916	EGFR
Thyroid associated opthalmopathies	1/92	0.07967285673748564	0.08920458992324465	0	0	12.857789269553976	32.527973699604026	STAT1
Dejerine-Sottas Disease (disorder)	1/92	0.07967285673748564	0.08920458992324465	0	0	12.857789269553976	32.527973699604026	NR4A1
Liver Cirrhosis, Alcoholic	1/93	0.08050497738089572	0.08982477605825212	0	0	12.717391304347826	32.040656856642045	CAV1
Small for gestational age (disorder)	1/93	0.08050497738089572	0.08982477605825212	0	0	12.717391304347826	32.040656856642045	PIK3R1
Speech Disorders	1/93	0.08050497738089572	0.08982477605825212	0	0	12.717391304347826	32.040656856642045	PIK3R1
Joint laxity	1/93	0.08050497738089572	0.08982477605825212	0	0	12.717391304347826	32.040656856642045	PIK3R1
Low Birth Weights	1/93	0.08050497738089572	0.08982477605825212	0	0	12.717391304347826	32.040656856642045	PIK3R1
Childhood Medulloblastoma	1/93	0.08050497738089572	0.08982477605825212	0	0	12.717391304347826	32.040656856642045	EGFR
Pregnancy Complications	1/93	0.08050497738089572	0.08982477605825212	0	0	12.717391304347826	32.040656856642045	EGFR
Edema	1/93	0.08050497738089572	0.08982477605825212	0	0	12.717391304347826	32.040656856642045	VEGFA
Undergrowth	2/529	0.0808464342662682	0.09016681334618772	0	0	4.614563567362429	11.606567806164996	PIK3R1;EGFR
AMYOTROPHIC LATERAL SCLEROSIS 1	1/94	0.08133638744417955	0.090674099597892	0	0	12.580012650221379	31.565287091339382	VEGFA
Renal cyst	1/95	0.08216708746364133	0.09128498362089703	0	0	12.445556946182728	31.101452445343085	EGFR
Rheumatism	1/95	0.08216708746364133	0.09128498362089703	0	0	12.445556946182728	31.101452445343085	VEGFA
Sciatic Neuropathy	1/95	0.08216708746364133	0.09128498362089703	0	0	12.445556946182728	31.101452445343085	CAV1
Fragile X Syndrome	1/95	0.08216708746364133	0.09128498362089703	0	0	12.445556946182728	31.101452445343085	AR
Gastric ulcer	1/95	0.08216708746364133	0.09128498362089703	0	0	12.445556946182728	31.101452445343085	VEGFA
Anorexia Nervosa	1/95	0.08216708746364133	0.09128498362089703	0	0	12.445556946182728	31.101452445343085	ESR1
Membranous glomerulonephritis	1/95	0.08216708746364133	0.09128498362089703	0	0	12.445556946182728	31.101452445343085	VEGFA
Polyneuropathy	1/95	0.08216708746364133	0.09128498362089703	0	0	12.445556946182728	31.101452445343085	VEGFA
Renal failure in adulthood	1/96	0.08299707803951369	0.0920092071141905	0	0	12.313931888544891	30.64875924889407	HBB
Retinal Detachment	1/96	0.08299707803951369	0.0920092071141905	0	0	12.313931888544891	30.64875924889407	VEGFA
Telecanthus	1/96	0.08299707803951369	0.0920092071141905	0	0	12.313931888544891	30.64875924889407	PIK3R1
Werner Syndrome	1/96	0.08299707803951369	0.0920092071141905	0	0	12.313931888544891	30.64875924889407	CDKN1A
Aortic Aneurysm	1/96	0.08299707803951369	0.0920092071141905	0	0	12.313931888544891	30.64875924889407	VEGFA
Failure to gain weight	2/539	0.08349618416938036	0.09252279867417823	0	0	4.526303538175046	11.238605044775621	PIK3R1;EGFR
Hemoglobin measurement	1/97	0.08382635971666402	0.09272954481719192	0	0	12.185049019607844	30.20683114705019	VEGFA
Sweating	1/97	0.08382635971666402	0.09272954481719192	0	0	12.185049019607844	30.20683114705019	CAV1
Hyperhidrosis disorder	1/97	0.08382635971666402	0.09272954481719192	0	0	12.185049019607844	30.20683114705019	CAV1
Increased sweating	1/97	0.08382635971666402	0.09272954481719192	0	0	12.185049019607844	30.20683114705019	CAV1
Frontotemporal Lobar Degeneration	1/98	0.08465493309372914	0.09348597357037297	0	0	12.058823529411764	29.775308154544383	VEGFA
Henoch-Schoenlein Purpura	1/98	0.08465493309372914	0.09348597357037297	0	0	12.058823529411764	29.775308154544383	VEGFA
Mycobacterium Infections	1/98	0.08465493309372914	0.09348597357037297	0	0	12.058823529411764	29.775308154544383	STAT1
Myelofibrosis	1/98	0.08465493309372914	0.09348597357037297	0	0	12.058823529411764	29.775308154544383	VEGFA
Aortic Aneurysm, Thoracic	1/99	0.08548279870958994	0.09431955107512636	0	0	11.935174069627852	29.353845802361935	VEGFA
Ischemia of kidney	1/99	0.08548279870958994	0.09431955107512636	0	0	11.935174069627852	29.353845802361935	EPAS1
Polymyositis	1/100	0.08630995715059277	0.0951915539367981	0	0	11.81402257872846	28.942114306609312	VEGFA
Hemangioma	1/101	0.0871364089944587	0.09593919200029276	0	0	11.695294117647059	28.539797811620943	VEGFA
Xeroderma Pigmentosum	1/101	0.0871364089944587	0.09593919200029276	0	0	11.695294117647059	28.539797811620943	PRKDC
Mean corpuscular hemoglobin concentration determination	1/101	0.0871364089944587	0.09593919200029276	0	0	11.695294117647059	28.539797811620943	HBB
Neuromuscular Diseases	1/101	0.0871364089944587	0.09593919200029276	0	0	11.695294117647059	28.539797811620943	AR
Heart Decompensation	1/102	0.08796215478207874	0.09664238443305376	0	0	11.578916715200933	28.146593675405043	VEGFA
Hypertrophy of lower jaw	1/102	0.08796215478207874	0.09664238443305376	0	0	11.578916715200933	28.146593675405043	CAV1
mandibular excess (physical finding)	1/102	0.08796215478207874	0.09664238443305376	0	0	11.578916715200933	28.146593675405043	CAV1
Mandibular hyperplasia	1/102	0.08796215478207874	0.09664238443305376	0	0	11.578916715200933	28.146593675405043	CAV1
Childhood Acute Myeloid Leukemia	1/102	0.08796215478207874	0.09664238443305376	0	0	11.578916715200933	28.146593675405043	VEGFA
Sunken eyes	1/103	0.08878719509547235	0.09746592644777098	0	0	11.46482122260669	27.76221178459644	PIK3R1
HIV Coinfection	1/103	0.08878719509547235	0.09746592644777098	0	0	11.46482122260669	27.76221178459644	CDKN1A
Enophthalmos	1/104	0.08961153050884178	0.09820389618342738	0	0	11.352941176470589	27.38637392725137	PIK3R1
Enterovirus Infections	1/104	0.08961153050884178	0.09820389618342738	0	0	11.352941176470589	27.38637392725137	CAV1
Respiratory distress	1/104	0.08961153050884178	0.09820389618342738	0	0	11.352941176470589	27.38637392725137	EGFR
Increased size of the mandible	1/104	0.08961153050884178	0.09820389618342738	0	0	11.352941176470589	27.38637392725137	CAV1
Bulging forehead	1/105	0.09043516157909659	0.09893859481525052	0	0	11.243212669683258	27.0188131977752	PIK3R1
Premature Obstetric Labor	1/105	0.09043516157909659	0.09893859481525052	0	0	11.243212669683258	27.0188131977752	EGFR
Prominent forehead	1/105	0.09043516157909659	0.09893859481525052	0	0	11.243212669683258	27.0188131977752	PIK3R1
Ehlers-Danlos Syndrome	1/105	0.09043516157909659	0.09893859481525052	0	0	11.243212669683258	27.0188131977752	AR
Heart Failure, Right-Sided	1/106	0.0912580888842393	0.09979663149364525	0	0	11.135574229691876	26.659273431080635	VEGFA
Alcohol abuse	1/107	0.09208031298724499	0.10065317327382726	0	0	11.029966703662597	26.307508679008535	EGFR
Autism Spectrum Disorders	2/572	0.09243240160581494	0.100995301754577	0	0	4.257017543859649	10.137140924732144	AR;NFIB
Vesico-Ureteral Reflux	1/108	0.0929018344244166	0.10137956836428731	0	0	10.926333150082463	25.96328271398022	VEGFA
Myocardial Failure	1/108	0.0929018344244166	0.10137956836428731	0	0	10.926333150082463	25.96328271398022	VEGFA
Class III malocclusion	1/108	0.0929018344244166	0.10137956836428731	0	0	10.926333150082463	25.96328271398022	CAV1
Hyperplastic Polyp	1/110	0.0945427716606664	0.102996195360397	0	0	10.724770642201834	25.296548009342803	EGFR
Weight Gain	1/110	0.0945427716606664	0.102996195360397	0	0	10.724770642201834	25.296548009342803	CAV1
Bone Density	1/110	0.0945427716606664	0.102996195360397	0	0	10.724770642201834	25.296548009342803	ESR1
Post-Traumatic Stress Disorder	1/110	0.0945427716606664	0.102996195360397	0	0	10.724770642201834	25.296548009342803	ESR1
Congenital cataract	1/111	0.0953621885731626	0.10380132030530087	0	0	10.626737967914439	24.973611307863486	CAV1
Plasmacytoma	1/111	0.0953621885731626	0.10380132030530087	0	0	10.626737967914439	24.973611307863486	STAT1
Glomerulosclerosis (disorder)	1/112	0.09618090509764518	0.10451631378511464	0	0	10.530471648118708	24.657356652146074	VEGFA
Infectious disease of lung	1/112	0.09618090509764518	0.10451631378511464	0	0	10.530471648118708	24.657356652146074	EGFR
Bilateral cataracts (disorder)	1/112	0.09618090509764518	0.10451631378511464	0	0	10.530471648118708	24.657356652146074	EGFR
Bronchiectasis	1/112	0.09618090509764518	0.10451631378511464	0	0	10.530471648118708	24.657356652146074	STAT1
Obesity, Morbid	1/113	0.09699892180024121	0.10531660992434765	0	0	10.4359243697479	24.3475898718272	ESR1
Paresis	1/113	0.09699892180024121	0.10531660992434765	0	0	10.4359243697479	24.3475898718272	AR
Neuroectodermal Tumor, Primitive	1/114	0.09781623925032576	0.10607025440117189	0	0	10.343050494534097	24.044124066955682	EGFR
Joint hyperflexibility	1/114	0.09781623925032576	0.10607025440117189	0	0	10.343050494534097	24.044124066955682	PIK3R1
Obsessive-Compulsive Disorder	1/114	0.09781623925032576	0.10607025440117189	0	0	10.343050494534097	24.044124066955682	ESR1
Ataxia, Spinocerebellar	1/116	0.09944877860449487	0.10765976325876372	0	0	10.162148337595909	23.455382166428734	AR
Respiratory Syncytial Virus Infections	1/116	0.09944877860449487	0.10765976325876372	0	0	10.162148337595909	23.455382166428734	STAT1
Experimental Hepatoma	1/116	0.09944877860449487	0.10765976325876372	0	0	10.162148337595909	23.455382166428734	CDH1
Liver Neoplasms, Experimental	1/116	0.09944877860449487	0.10765976325876372	0	0	10.162148337595909	23.455382166428734	CDH1
Red Blood Cell Count measurement	1/118	0.1010785276838921	0.10928666262347982	0	0	9.987430869783811	22.889768968042276	VEGFA
Anemia, Hemolytic	1/118	0.1010785276838921	0.10928666262347982	0	0	9.987430869783811	22.889768968042276	HBB
Mental Retardation, X-Linked	1/118	0.1010785276838921	0.10928666262347982	0	0	9.987430869783811	22.889768968042276	AR
Hepatoma, Novikoff	1/119	0.10189235727874027	0.11002841089088047	0	0	9.902293120638086	22.615236719842347	CDH1
Giant Cell Arteritis	1/119	0.10189235727874027	0.11002841089088047	0	0	9.902293120638086	22.615236719842347	VEGFA
Premature Birth	1/119	0.10189235727874027	0.11002841089088047	0	0	9.902293120638086	22.615236719842347	VEGFA
Liver Failure, Acute	1/120	0.10270549097155077	0.11081381920614689	0	0	9.818586258032624	22.3460193071682	AR
Neurologic Symptoms	1/120	0.10270549097155077	0.11081381920614689	0	0	9.818586258032624	22.3460193071682	AR
Hepatoma, Morris	1/121	0.10351792932446745	0.11164376260755718	0	0	9.736274509803922	22.08197234292852	CDH1
Congenital heart disease	1/122	0.1043296729179585	0.11247226425170569	0	0	9.655323286339328	21.82295649315513	VEGFA
Precursor Cell Lymphoblastic Leukemia Lymphoma	2/618	0.10534711299147605	0.11352173252272951	0	0	3.929788961038961	8.843968612274734	CDKN1A;VEGFA
Encephalitis, St. Louis	1/124	0.10595107803152952	0.1140773799730891	0	0	9.49736967957915	21.31948479946905	STAT1
Upward slant of palpebral fissure	1/124	0.10595107803152952	0.1140773799730891	0	0	9.49736967957915	21.31948479946905	HBB
Tetralogy of Fallot	1/125	0.10676074066511165	0.11475779989096271	0	0	9.420303605313093	21.074773673487663	VEGFA
Arthropathy	1/125	0.10676074066511165	0.11475779989096271	0	0	9.420303605313093	21.074773673487663	VEGFA
Myotonic Dystrophy	1/125	0.10676074066511165	0.11475779989096271	0	0	9.420303605313093	21.074773673487663	AR
Peripheral Arterial Diseases	1/125	0.10676074066511165	0.11475779989096271	0	0	9.420303605313093	21.074773673487663	VEGFA
Hypogonadotropic hypogonadism	1/126	0.10756971077056704	0.11548319323373843	0	0	9.344470588235295	20.83458271705315	AR
Left-Sided Heart Failure	1/126	0.10756971077056704	0.11548319323373843	0	0	9.344470588235295	20.83458271705315	VEGFA
Congenital anomaly of face	1/126	0.10756971077056704	0.11548319323373843	0	0	9.344470588235295	20.83458271705315	CAV1
Hyperkeratosis	1/127	0.10837798888948488	0.11625429622156953	0	0	9.26984126984127	20.598794838572697	CAV1
Interstitial lung fibrosis	1/127	0.10837798888948488	0.11625429622156953	0	0	9.26984126984127	20.598794838572697	VEGFA
Sarcomatoid Renal Cell Carcinoma	1/128	0.10918557558475199	0.1169748410350122	0	0	9.196387216303844	20.36729685335	EPAS1
Arthralgia	1/128	0.10918557558475199	0.1169748410350122	0	0	9.196387216303844	20.36729685335	CAV1
beta^+^ Thalassemia	1/128	0.10918557558475199	0.1169748410350122	0	0	9.196387216303844	20.36729685335	HBB
Rett Syndrome	1/129	0.10999247141798286	0.11759542784463979	0	0	9.124080882352942	20.13997932609556	VEGFA
Cleft palate, isolated	1/129	0.10999247141798286	0.11759542784463979	0	0	9.124080882352942	20.13997932609556	ESR1
tumor vasculature	1/129	0.10999247141798286	0.11759542784463979	0	0	9.124080882352942	20.13997932609556	VEGFA
Malignant neoplasm of larynx	1/129	0.10999247141798286	0.11759542784463979	0	0	9.124080882352942	20.13997932609556	EGFR
Pervasive Development Disorder	1/129	0.10999247141798286	0.11759542784463979	0	0	9.124080882352942	20.13997932609556	AR
Primary sclerosing cholangitis	1/130	0.11079867694361764	0.1184083502463237	0	0	9.052895576835386	19.91673641957648	EGFR
Juvenile rheumatoid arthritis	1/131	0.11160419271751376	0.11917057866446386	0	0	8.982805429864253	19.697465749311625	VEGFA
Disorder of eye	1/131	0.11160419271751376	0.11917057866446386	0	0	8.982805429864253	19.697465749311625	VEGFA
Nausea and vomiting	1/132	0.11240901927776754	0.11998037057622875	0	0	8.913785361472833	19.48206824738867	CAV1
Vesicular Stomatitis	1/133	0.11321315720990713	0.12068905698439543	0	0	8.845811051693405	19.270448026035922	STAT1
Lewy Body Disease	1/133	0.11321315720990713	0.12068905698439543	0	0	8.845811051693405	19.270448026035922	VEGFA
beta Thalassemia	1/133	0.11321315720990713	0.12068905698439543	0	0	8.845811051693405	19.270448026035922	HBB
Tumor Immunity	1/134	0.11401660706245109	0.12134523940762719	0	0	8.778858911985846	19.06251225929767	JUN
Large auricle	1/134	0.11401660706245109	0.12134523940762719	0	0	8.778858911985846	19.06251225929767	PIK3R1
Large pinnae	1/134	0.11401660706245109	0.12134523940762719	0	0	8.778858911985846	19.06251225929767	PIK3R1
Macrotia	1/134	0.11401660706245109	0.12134523940762719	0	0	8.778858911985846	19.06251225929767	PIK3R1
Flexion contractures of joints	1/135	0.11481936936728154	0.12204873706818445	0	0	8.712906057945567	18.858171061974925	CAV1
Middle Cerebral Artery Occlusion	1/135	0.11481936936728154	0.12204873706818445	0	0	8.712906057945567	18.858171061974925	VEGFA
Mycoses	1/135	0.11481936936728154	0.12204873706818445	0	0	8.712906057945567	18.858171061974925	STAT1
Amyotrophic Lateral Sclerosis, Sporadic	1/136	0.11562144467891255	0.12280024325889438	0	0	8.647930283224401	18.657337372791083	VEGFA
Flexion contracture	1/136	0.11562144467891255	0.12280024325889438	0	0	8.647930283224401	18.657337372791083	CAV1
Lymphopenia	1/137	0.11642283357542343	0.12360056684147915	0	0	8.583910034602075	18.459926845841217	STAT1
Spontaneous abortion	1/138	0.11722353661557976	0.12424636646616435	0	0	8.520824388149421	18.265857750150612	AR
Abdominal discomfort	1/138	0.11722353661557976	0.12424636646616435	0	0	8.520824388149421	18.265857750150612	HBB
Ureteral obstruction	1/138	0.11722353661557976	0.12424636646616435	0	0	8.520824388149421	18.265857750150612	VEGFA
Collecting Duct Carcinoma of the Kidney	1/138	0.11722353661557976	0.12424636646616435	0	0	8.520824388149421	18.265857750150612	EPAS1
Gastrointestinal pain	1/140	0.11882288723970202	0.1257351567964565	0	0	8.39737621667372	17.887429414854076	HBB
Thyroid Diseases	1/140	0.11882288723970202	0.1257351567964565	0	0	8.39737621667372	17.887429414854076	JUN
Acid reflux	1/140	0.11882288723970202	0.1257351567964565	0	0	8.39737621667372	17.887429414854076	CAV1
Contracture of joint	1/140	0.11882288723970202	0.1257351567964565	0	0	8.39737621667372	17.887429414854076	CAV1
Clear-cell metastatic renal cell carcinoma	1/142	0.12041950100185367	0.1273724697329189	0	0	8.277430120984564	17.521447135021635	VEGFA
Encephalitis	1/144	0.12201338230456223	0.1290055532102678	0	0	8.160839160839162	17.167341601168975	STAT1
Autistic Disorder	2/677	0.12260786165086729	0.12958105836505326	0	0	3.5753703703703703	7.50385909602688	AR;VEGFA
Frontotemporal dementia	1/145	0.12280929965737811	0.12968782543540788	0	0	8.10375816993464	16.99457388468717	VEGFA
Babinski Reflex	1/145	0.12280929965737811	0.12968782543540788	0	0	8.10375816993464	16.99457388468717	CAV1
Glaucoma, Primary Open Angle	1/147	0.12439909049755812	0.13131297538013595	0	0	7.991941982272361	16.65728827120197	CAV1
Chromophobe Renal Cell Carcinoma	1/149	0.12598615986692616	0.1329339260360581	0	0	7.883147853736089	16.33059681765117	EPAS1
Hyperlipoproteinemia Type IIa	1/153	0.1291521517198897	0.13616326852754085	0	0	7.674148606811145	15.70717185844932	ESR1
Abdominal Pain	1/153	0.1291521517198897	0.13616326852754085	0	0	7.674148606811145	15.70717185844932	HBB
Icterus	1/154	0.12994195560176186	0.13694005357786654	0	0	7.623606305267205	15.557245037558799	HBB
Substance abuse problem	1/155	0.1307310829477655	0.1376593506946915	0	0	7.573720397249809	15.409588975790413	ESR1
Aplastic Anemia	1/155	0.1307310829477655	0.1376593506946915	0	0	7.573720397249809	15.409588975790413	AR
Elevated creatine kinase	1/156	0.13151953428970917	0.1384331528403907	0	0	7.524478178368121	15.264155594900606	AR
Hypertriglyceridemia	1/157	0.13230731019735142	0.13914893413670956	0	0	7.475867269984917	15.120898125775808	CAV1
Anxiety disease	1/157	0.13230731019735142	0.13914893413670956	0	0	7.475867269984917	15.120898125775808	HBB
Small midface	1/158	0.13309441119210802	0.13974913175171344	0	0	7.427875608842263	14.979771069640405	PIK3R1
Hypotrophic midface	1/158	0.13309441119210802	0.13974913175171344	0	0	7.427875608842263	14.979771069640405	PIK3R1
Midface retrusion	1/158	0.13309441119210802	0.13974913175171344	0	0	7.427875608842263	14.979771069640405	PIK3R1
Decreased projection of midface	1/158	0.13309441119210802	0.13974913175171344	0	0	7.427875608842263	14.979771069640405	PIK3R1
Creatine phosphokinase serum increased	1/159	0.13388083782596377	0.1405177586771493	0	0	7.380491437081162	14.840730151520052	AR
Eosinophilic disorder	1/161	0.1354516701926492	0.1419933701735442	0	0	7.2875	14.568735518025488	AR
Weight decreased	1/161	0.1354516701926492	0.1419933701735442	0	0	7.2875	14.568735518025488	PIK3R1
Juvenile psoriatic arthritis	1/161	0.1354516701926492	0.1419933701735442	0	0	7.2875	14.568735518025488	JUN
Inflammatory dermatosis	1/163	0.13701981164116683	0.14357897503818823	0	0	7.19680464778504	14.304583045111348	EGFR
Contracture	1/166	0.13936698781759904	0.14597929015930997	0	0	7.06488413547237	13.922375947326568	CAV1
Ataxias, Hereditary	1/167	0.1401480391121003	0.14661902998240384	0	0	7.021970233876683	13.798564689487433	AR
Hereditary hemochromatosis	1/167	0.1401480391121003	0.14661902998240384	0	0	7.021970233876683	13.798564689487433	EGFR
Irritable Bowel Syndrome	1/167	0.1401480391121003	0.14661902998240384	0	0	7.021970233876683	13.798564689487433	CDH1
Juvenile-Onset Still Disease	1/168	0.1409284209179603	0.14737575353485483	0	0	6.979570271222261	13.676490075658847	JUN
Tuberculosis, Pulmonary	1/169	0.14170813378799807	0.14807124173721642	0	0	6.937675070028011	13.556118103313043	EGFR
Cleft upper lip	1/169	0.14170813378799807	0.14807124173721642	0	0	6.937675070028011	13.556118103313043	CDH1
Developmental Disabilities	1/170	0.1424871782645395	0.14882506326619713	0	0	6.896275670031327	13.43741562775988	EGFR
Coinfection	1/171	0.1432655548821484	0.14957757811664887	0	0	6.855363321799308	13.320350335547356	PRKDC
Short stature	2/750	0.14488841101448444	0.1512108144042074	0	0	3.2142379679144386	6.209237302702514	STAT1;CAV1
Increase in blood pressure	1/174	0.14559668293998512	0.15188862360015412	0	0	6.735464127847671	12.97866635801621	EGFR
Drug Dependence	1/175	0.14637239348820374	0.1526362100847922	0	0	6.696416497633536	12.867842408171857	EGFR
Hemoglobin low	1/177	0.14792181960717649	0.15418969331934498	0	0	6.619652406417113	12.650628330192763	HBB
Cerebrovascular Disorders	1/178	0.14869553623762846	0.15487119762169124	0	0	6.581920903954802	12.544183208435394	HBB
Neutropenia	1/178	0.14869553623762846	0.15487119762169124	0	0	6.581920903954802	12.544183208435394	ESR1
Myasthenia Gravis	1/179	0.1494685893137094	0.15561360991427303	0	0	6.544613350958361	12.439143799224476	ESR1
Conductive hearing loss	1/181	0.1510127069380722	0.15715786543958118	0	0	6.47124183006536	12.233179215630082	CDH1
Nephrotic Syndrome	1/182	0.1517837725378262	0.15783312579114536	0	0	6.435164120896977	12.132204106132908	VEGFA
Primary Myelofibrosis	1/182	0.1517837725378262	0.15783312579114536	0	0	6.435164120896977	12.132204106132908	VEGFA
Respiratory Failure	1/185	0.15409300295523198	0.16010548134889951	0	0	6.329283887468031	11.83702003982296	EGFR
MIXED LINEAGE LEUKEMIA	1/185	0.15409300295523198	0.16010548134889951	0	0	6.329283887468031	11.83702003982296	ESR1
Eosinophilia	1/186	0.15486142607713563	0.16083918920677176	0	0	6.294753577106518	11.741129142703194	AR
Vomiting	1/187	0.15562918990318997	0.161506708525488	0	0	6.260594560404807	11.646453145759256	EGFR
Craniofacial Abnormalities	1/187	0.15562918990318997	0.161506708525488	0	0	6.260594560404807	11.646453145759256	EGFR
Acquired Immunodeficiency Syndrome	1/188	0.15639629495093366	0.1622376023527155	0	0	6.22680088078012	11.552970612023577	AR
Muscular Dystrophy, Duchenne	1/190	0.15792853095483322	0.16369558405149848	0	0	6.160286336756925	11.369502600305923	AR
Dermatitis	1/190	0.15792853095483322	0.16369558405149848	0	0	6.160286336756925	11.369502600305923	EGFR
Eclampsia	1/194	0.16098512126812686	0.16679685849802314	0	0	6.03139286802804	11.01599729101681	VEGFA
Gait abnormality	1/195	0.1617476299130038	0.1674525563387931	0	0	6.0	10.93030799092462	AR
Decreased tendon reflex	1/195	0.1617476299130038	0.1674525563387931	0	0	6.0	10.93030799092462	AR
Spinal Muscular Atrophy	1/196	0.16250948405474008	0.16817387712876347	0	0	5.968929110105581	10.845657098350197	AR
Speech impairment	1/200	0.16555036603580536	0.17125214075710263	0	0	5.847768253029855	10.517093101327859	PIK3R1
Reticulocyte count (procedure)	1/202	0.16706689368968466	0.17275171593292854	0	0	5.788996195493123	10.358603938884775	CDH1
Osteogenesis Imperfecta	1/204	0.16858081808691658	0.17424740020748522	0	0	5.731382208055636	10.203809066850313	ESR1
Hypogonadism	1/205	0.16933680536594956	0.17488883177139053	0	0	5.702998846597462	10.127759560628935	AR
Embryonal Carcinoma	1/205	0.16933680536594956	0.17488883177139053	0	0	5.702998846597462	10.127759560628935	EGFR
Language Delay	1/206	0.17009214339283707	0.1755285682715534	0	0	5.674892395982783	10.052589336651343	PIK3R1
Cytopenia	1/206	0.17009214339283707	0.1755285682715534	0	0	5.674892395982783	10.052589336651343	HBB
Ataxia	1/208	0.17160087383276076	0.1769441345748587	0	0	5.619494174481387	9.904830518211897	PRKDC
Congenital anemia	1/208	0.17160087383276076	0.1769441345748587	0	0	5.619494174481387	9.904830518211897	HBB
Speech Delay	1/213	0.17536137486931605	0.18074957353848498	0	0	5.485571587125416	9.549866875601245	PIK3R1
Craniosynostosis	1/214	0.1761115378256675	0.18145037981798928	0	0	5.459541563104115	9.481245959938741	EGFR
Skeletal muscle atrophy	1/215	0.17686105623079498	0.1820773647844334	0	0	5.4337548103353495	9.413387102196012	AR
Neurogenic muscle atrophy, especially in the lower limbs	1/215	0.17686105623079498	0.1820773647844334	0	0	5.4337548103353495	9.413387102196012	AR
Frontal bossing	1/216	0.17760993065574496	0.18277547843975667	0	0	5.4082079343365255	9.346278553544366	PIK3R1
Neoplasm, Residual	1/220	0.18059899854553457	0.1856296113183907	0	0	5.3083534783776525	9.085120550073487	ESR1
Nonorganic psychosis	1/220	0.18059899854553457	0.1856296113183907	0	0	5.3083534783776525	9.085120550073487	ESR1
Delayed speech and language development	1/220	0.18059899854553457	0.1856296113183907	0	0	5.3083534783776525	9.085120550073487	PIK3R1
Tremor	1/226	0.1850633684088648	0.19006706982111246	0	0	5.165228758169935	8.714035232942257	AR
Ventricular Septal Defects	1/226	0.1850633684088648	0.19006706982111246	0	0	5.165228758169935	8.714035232942257	VEGFA
Neurogenic Muscular Atrophy	1/228	0.18654637973464205	0.19151402975142304	0	0	5.119201865768334	8.5955258483212	AR
Hyperlipidemia	1/232	0.1895047592338975	0.19439666127925231	0	0	5.029539088362617	8.36583928133549	VEGFA
Hypoglycemia	1/232	0.1895047592338975	0.19439666127925231	0	0	5.029539088362617	8.36583928133549	VEGFA
Encephalopathies	1/234	0.19098013565471894	0.19583235029620447	0	0	4.985862156021207	8.254522876203074	VEGFA
Plaque, Amyloid	1/235	0.19171687232880183	0.19643184499218372	0	0	4.964303670186023	8.199717193438136	NFIB
Microcephaly	1/235	0.19171687232880183	0.19643184499218372	0	0	4.964303670186023	8.199717193438136	PIK3R1
Feeding difficulties	1/239	0.194657487474515	0.1993656979169993	0	0	4.87988136431043	7.985992898936452	HBB
Acute myocardial infarction	1/247	0.2005084325946525	0.20519543636766538	0	0	4.719273075083692	7.583395068471468	VEGFA
Diabetic Retinopathy	1/247	0.2005084325946525	0.20519543636766538	0	0	4.719273075083692	7.583395068471468	VEGFA
Brain Diseases	1/250	0.2026921685902864	0.20734806790839994	0	0	4.661705646113867	7.440393900949895	VEGFA
Patent ductus arteriosus	1/251	0.20341882787580554	0.20800903895613843	0	0	4.642823529411765	7.393641842618357	VEGFA
Hydrocephalus	1/253	0.2048702704288094	0.20941033182335364	0	0	4.605508870214752	7.301473949210147	NFIB
Behcet Syndrome	1/258	0.20848795694495845	0.2130238895525426	0	0	4.514763103685054	7.078579685828059	VEGFA
Muscle degeneration	1/259	0.2092096263302128	0.2136767357892209	0	0	4.49703602371181	7.0352464985563365	AR
Trichohepatoenteric Syndrome	1/267	0.2149606508362844	0.21937706879104016	0	0	4.360017691287041	6.7026564480128155	AR
Memory impairment	1/267	0.2149606508362844	0.21937706879104016	0	0	4.360017691287041	6.7026564480128155	VEGFA
Infant, Small for Gestational Age	1/275	0.22067215860230568	0.22493929979074806	0	0	4.2310004293688275	6.393367960864164	PIK3R1
Concave bridge of nose	1/275	0.22067215860230568	0.22493929979074806	0	0	4.2310004293688275	6.393367960864164	HBB
Depressed nasal root/bridge	1/275	0.22067215860230568	0.22493929979074806	0	0	4.2310004293688275	6.393367960864164	HBB
Depressed nasal bridge	1/277	0.22209389106136293	0.2262992191761343	0	0	4.199914748508099	6.319422951921614	HBB
Essential Hypertension	1/278	0.22280383833684378	0.22684363989912	0	0	4.184540242089616	6.282934619193975	VEGFA
Intrauterine retardation	1/278	0.22280383833684378	0.22684363989912	0	0	4.184540242089616	6.282934619193975	PIK3R1
Dysarthria	1/282	0.22563751283129008	0.22963817795241223	0	0	4.124136487335147	6.140119538546618	AR
Neuropathy	1/284	0.2270506882292785	0.2309853988563318	0	0	4.094574932446477	6.070543052629082	AR
Congenital hypoplasia of penis	1/285	0.22775636221339032	0.23161208015637294	0	0	4.079950289975145	6.036199992352182	AR
hearing impairment	1/294	0.23408010495514686	0.23794919759903357	0	0	3.9528207187311786	5.739858921485836	STAT1
Charcot-Marie-Tooth Disease	1/298	0.23687493033870088	0.24069549373126056	0	0	3.8987918399683106	5.6151296693355315	AR
Fetal Growth Retardation	1/304	0.24104911513828853	0.24484068596232766	0	0	3.8204232187924676	5.435524590054537	PIK3R1
Body Height	1/314	0.2479582075837269	0.25175945369055286	0	0	3.696485623003195	5.154730958476106	ESR1
Psychotic Disorders	1/317	0.2500193240039598	0.25375242196551206	0	0	3.6608339538346986	5.074710510253578	ESR1
High density lipoprotein measurement	1/324	0.2548078674156933	0.25851088826973123	0	0	3.580222181751958	4.895042591576459	ESR1
Hepatitis, Toxic	1/325	0.25548958318098075	0.2587959189633229	0	0	3.5689905591866378	4.870150440253562	PRKDC
Chemical and Drug Induced Liver Injury	1/325	0.25548958318098075	0.2587959189633229	0	0	3.5689905591866378	4.870150440253562	PRKDC
Chemically-Induced Liver Toxicity	1/325	0.25548958318098075	0.2587959189633229	0	0	3.5689905591866378	4.870150440253562	PRKDC
Drug-Induced Acute Liver Injury	1/325	0.25548958318098075	0.2587959189633229	0	0	3.5689905591866378	4.870150440253562	PRKDC
Hepatitis, Drug-Induced	1/329	0.2582105606693922	0.26124476232238153	0	0	3.524748923959828	4.772439196593552	PRKDC
Mental disorders	1/329	0.2582105606693922	0.26124476232238153	0	0	3.524748923959828	4.772439196593552	ESR1
Primary biliary cirrhosis	1/329	0.2582105606693922	0.26124476232238153	0	0	3.524748923959828	4.772439196593552	CDKN1A
Fatigue	1/330	0.2588893360476438	0.2617264794563851	0	0	3.513856606472376	4.748466227535915	PIK3R1
Broad flat nasal bridge	1/330	0.2588893360476438	0.2617264794563851	0	0	3.513856606472376	4.748466227535915	PIK3R1
Nasal bridge wide	1/333	0.26092214429885674	0.2636783641329996	0	0	3.4815733522324592	4.677609435230168	PIK3R1
Lens Opacities	1/339	0.26497197303655384	0.2676662519958618	0	0	3.4187260703097806	4.540516829051868	PIK3R1
Thrombocytopenia	1/341	0.2663172520343859	0.2689200398767861	0	0	3.3982698961937716	4.496138770522036	STAT1
Mental Retardation	2/1158	0.2801227896183502	0.28274996701219174	0	0	2.0356833910034604	2.590462562160913	AR;CAV1
Orbital separation excessive	1/368	0.28425243332773514	0.286806263783414	0	0	3.14393332264786	3.954730417023335	CDH1
Drug-Induced Liver Disease	1/377	0.2901382347816707	0.29263063664234884	0	0	3.0672715894868587	3.795435110430706	PRKDC
Erythrocyte Mean Corpuscular Hemoglobin Test	1/387	0.29662439162934084	0.2989390571902409	0	0	2.9862846693081377	3.6291977603683803	CDH1
Finding of Mean Corpuscular Hemoglobin	1/387	0.29662439162934084	0.2989390571902409	0	0	2.9862846693081377	3.6291977603683803	CDH1
Retrusion of lower jaw	1/395	0.30177297418416454	0.3036539120832478	0	0	2.9244550612123024	3.503731954430349	PIK3R1
Hypoplastic mandible condyle	1/395	0.30177297418416454	0.3036539120832478	0	0	2.9244550612123024	3.503731954430349	PIK3R1
Decreased projection of lower jaw	1/395	0.30177297418416454	0.3036539120832478	0	0	2.9244550612123024	3.503731954430349	PIK3R1
Decreased projection of mandible	1/395	0.30177297418416454	0.3036539120832478	0	0	2.9244550612123024	3.503731954430349	PIK3R1
Aplasia/Hypoplasia of the mandible	1/397	0.30305454706636054	0.3048247254954865	0	0	2.9093879976232917	3.4733509426624423	PIK3R1
Micrognathism	1/400	0.3049727415814978	0.30663471837485745	0	0	2.8870706177207723	3.428491280322633	PIK3R1
Myopathy	1/415	0.3144891544870112	0.3160799556575681	0	0	2.780335322534811	3.216307716696047	AR
Muscle hypotonia	1/460	0.34230544971014554	0.3439031414240786	0	0	2.501986415481225	2.682259072100979	AR
Malaria	1/469	0.3477392393378797	0.3492264600348924	0	0	2.4527400703871294	2.5908352041132687	HBB
Sensorineural Hearing Loss (disorder)	1/471	0.34894097656346934	0.3502971404832652	0	0	2.442052565707134	2.5711211310530757	PIK3R1
Nystagmus	1/500	0.3661328787804519	0.3674130636712927	0	0	2.296711069197218	2.3076410131178515	CAV1
Cerebellar Ataxia	1/565	0.40312186213533147	0.4043742795710917	0	0	2.0252398831873175	1.8399635978121285	PRKDC
Small head	1/570	0.40588106109963	0.40698399876566166	0	0	2.0069264964333713	1.8096358185119705	PRKDC
Tuberculosis	1/602	0.42325670461681725	0.42424216842267715	0	0	1.8969364784183225	1.6309412492574684	STAT1
Low intelligence	1/947	0.5825194587180456	0.5834229398482791	0	0	1.1836836214401194	0.6396539746130375	CAV1
Dull intelligence	1/947	0.5825194587180456	0.5834229398482791	0	0	1.1836836214401194	0.6396539746130375	CAV1
Poor school performance	1/985	0.5972619803383841	0.597956471013196	0	0	1.1357006217120995	0.5853394574068373	CAV1
Mental deficiency	1/1032	0.6148163654686547	0.6152927826445312	0	0	1.0812460774804586	0.5259523118999511	CAV1
Seizures	1/1174	0.66356681376936	0.6638238109861568	0	0	0.9432325359811444	0.3868439336104166	ESR1
Epilepsy	1/1177	0.6645309550150478	0.6645309550150478	0	0	0.9406762705082032	0.38442976296449405	ESR1
